Tissue Pathology and Diagnostic Oncology Research

Tissue Pathology and Diagnostic Oncology at RPA has a broad-based research program encompassing basic, translational and clinical studies in a wide range of organs, including skin, head and neck, lung, breast, colorectum, prostate, liver and pancreas.

The melanoma group studies causes, diagnosis, prognostication and treatment in one of Australia's most common malignancies and are recognised international leaders in this field. The head and neck, lung, prostate and breast groups have established national and international profiles in pathology research focusing on diagnosis and prediction of behaviour in these tumours, as well as developing predictive markers for targeted therapy.

Man wearing a white lab coat using a computer — **SydneyConnect Image:** Researcher Professor Richard Scolyer AO

Selected Grants

Amount awarded	Grant and project details
$7,000,000	Medical Research Future Fund (MRFF), 2021-2026 Cartilage based stem cell therapies for joint deformity and facial disfigurement. A framework for point of care manufacturing and delivery (ARISTOCRAT). Investigators: Chung P, Clark J, Mukherjee P, Gupta R
$3,937,110	NHMRC Investigator Grant, 2023-2027 Melanoma: Getting the Diagnosis and Treatment Right for Better Patient Outcomes. Investigator: Scolyer R (CIA)
$3,750,000	CINSW, 2021-2025 Improving Outcomes in Head and Neck Cancer Investigators: Clark JR, Gupta R, Ashford BA, Ranson M, Boyer MB, Lee J, Rizos H
$3,747,602	Cancer Council NSW Translational Program Grant, 2020-2024 INOVATe 2.0 - Individualised Ovarian Cancer Treatment Through Integration of Genomic Pathology into Multidisciplinary Care - Phase 2: Evaluation, Implementation and Integration into Clinical Practice Investigators: deFazio A, Harnett P, Friedlander M, Balleine R, Bowtell D, Samimi G, Brand A, Marsh D, Beale P, Anderson L
$3,230,670	Medical Research Future Fund (MRFF) - International Clinical Trial Collaborations Grant Program RC Ideas Grant, 2020-2025 Circulating tumour DNA guidEd Therapy for stage IIB/C BRAF mutant positive mElanoma after surgiCal resecTION (DETECTION) Investigators: Sandhu S, Dawson S-J, Long GV, Carlino M, Menzies A, Scolyer RA, Rizos H, Lorigan P, Atkinson V, Henderson M.
$3,217,920	NHMRC Clinical Trials and Cohort Studies Grant, 2021-2026 Reconceiving early detection of melanoma Investigators: Mar V, Janda M, Soyer P, Penas PF, Cust A, Morton R, Wolfe R, Scolyer R, Ge Z, Lawn C.
$2,500,000	NHMRC Centres of Research Excellence, 2021-2025 Centre of Excellence in Skin Imaging and Precision Diagnosis Investigators: Janda M, Soyer HP, Mar V, Fernandez-Penas P, Morton R, Cust A, Wolfe R, Scolyer RA, Caffery L, Ge Z.
$2,023,376	Medical Research Future Fund (MRFF) - Efficient Use of Existing Medicines Grant,2021-2025 NADINA Phase 3 trial comparing response driven neo-adjuvant combination of ipilimumab + nivolumab versus adjuvant nivolumab Investigators: Long G, Scolyer RA, McArthur G, Menzies A, Spillane A, Carlino M, Gyorki D, Saw R, Lo S, Morton RL.
US$1,000,000	American Cancer Society (ACS) & Melanoma Research Alliance (MRA) Joint Award, 2020-2023 Molecular predictors and vulnerabilities of melanoma brain metastasis Investigators: Davies M, Huse JT, Gershenwald JE, Tetzlaff MT, Scolyer R
$859,000	NHMRC, 2021-2024 From Functional Genomics to Precision Medicine: Identifying the Cause and Finding Optimal Therapy Investigators: Gupta R (CIB)
$598,000	NHMRC, 2020-2023 High Risk Cutaneous Squamous Cell Carcinoma: Defining Prognostic Markers of Metastases Investigators: Gupta R (CIC)
$520,413	Medical Research Future Fund (MRFF), 2020-2023 Combination of Avelumab with Peptide Receptor Radionuclide Therapy (PRRT) or Conventional Fractionated Radiotherapy (RT) in Metastatic Merkel Cell Carcinoma (MCC). Investigators: Shackleton M, Poulsen M, Scolyer RA
$148,150	Tour de Cure Community Grant 2022, 2022-2023 Digital Histological Imaging for Melanoma. Investigator: Scolyer RA
$100,000	NSW Government - Biospecimen Collection Grants, 2020-2024 Head and Neck Cancer Biobank. Investigator: Gupta R (CIA)
$100,000	NSW Government - Biospecimen Collection Grants, 2020-2024 The Melanoma Institute Australia Biospecimen Bank – External Collections Investigators: Scolyer RA

Our Publications

2023

Adegoke NA, Gide TN, Mao Y, Quek C, Patrick E, Carlino MS, Lo SN, Menzies AM, Pires da Silva I, Vergara IA, Long G, Scolyer RA, Wilmott JS. Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies. J Immunother Cancer. 2023 Oct;11(10):e007144. doi: 10.1136/jitc-2023-007144.

Akdemir KC, Le VT, Chandran S, Li Y, Verhaak RG, Beroukhim R, Campbell PJ, Chin L, Dixon JR, Futreal PA; PCAWG Structural Variation Working Group; PCAWG Consortium. Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer. Nat Genet. 2023 Jun;55(6):1079. doi: 10.1038/s41588-023-01318-w. Erratum for: Nat Genet. 2020 Mar;52(3):294-305. doi: 10.1038/s41588-019-0564-y.

Al Maruf DSA, Cheng K, Xin H, Cheung VKY, Foley M, Wise IK, Lewin W, Froggatt C, Wykes J, Parthasarathi K, Leinkram D, Howes D, Suchowerska N, McKenzie DR, Gupta R, Crook JM, Clark JR. A Comparison of In Vivo Bone Tissue Generation Using Calcium Phosphate Bone Substitutes in a Novel 3D Printed Four-Chamber Periosteal Bioreactor. Bioengineering (Basel). 2023 Oct 21;10(10):1233. doi: 10.3390/bioengineering10101233.

Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, Boot A, Covington KR, Gordenin DA, Bergstrom EN, Islam SMA, Lopez-Bigas N, Klimczak LJ, McPherson JR, Morganella S, Sabarinathan R, Wheeler DA, Mustonen V; PCAWG Mutational Signatures Working Group; Getz G, Rozen SG, Stratton MR; PCAWG Consortium. Author Correction: The repertoire of mutational signatures in human cancer. Nature. 2023 Feb;614(7948):E41. doi: 10.1038/s41586-022-05600-5. Erratum for: Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3.

Allen NC, Martin AJ, Snaidr VA, Eggins R, Chong AH, Fernandéz-Peñas P, Gin D, Sidhu S, Paddon VL, Banney LA, Lim A, Upjohn E, Schaider H, Ganhewa AD, Nguyen J, McKenzie CA, Prakash S, McLean C, Lochhead A, Ibbetson J, Dettrick A, Landgren A, Allnutt KJ, Allison C, Davenport RB, Mumford BP, Wong B, Stagg B, Tedman A, Gribbin H, Edwards HA, De Rosa N, Stewart T, Doolan BJ, Kok Y, Simpson K, Low ZM, Kovitwanichkanont T, Scolyer RA, Dhillon HM, Vardy JL, Chadban SJ, Bowen DG, Chen AC, Damian DL. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients. N Engl J Med. 2023 Mar 2;388(9):804-812. doi: 10.1056/NEJMoa2203086.

Allen NC, Paver EC, Agar N, Scolyer RA, Moloney FJ. A sheep in wolf's clothing: Agminated blue naevi masquerading as in-transit melanoma metastases. Australas J Dermatol. 2023 May;64(2):e196-e199. doi: 10.1111/ajd.14002. Epub 2023 Feb 25.

Barnhill RL, Elder DE, Piepkorn MW, Knezevich SR, Reisch LM, Eguchi MM, Bastian BC, Blokx W, Bosenberg M, Busam KJ, Carr R, Cochran A, Cook MG, Duncan LM, Elenitsas R, de la Fouchardière A, Gerami P, Johansson I, Ko J, Landman G, Lazar AJ, Lowe L, Massi D, Messina J, Mihic-Probst D, Parker DC, Schmidt B, Shea CR, Scolyer RA, Tetzlaff M, Xu X, Yeh I, Zembowicz A, Elmore JG. Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement. JAMA Netw Open. 2023 Jan 3;6(1):e2250613. doi: 10.1001/jamanetworkopen.2022.50613.

Blake SC, Guitera P, Cust AE, Galea C, Lo SN, Scolyer RA, Armstrong BK, Thompson JF, Menzies SW, Madronio C, Morton RL, Mann GJ, Watts CG. The association of dermatologist demographic density with melanoma survival in New South Wales, Australia. Australas J Dermatol. 2023 Aug;64(3):425-429. doi: 10.1111/ajd.14113. Epub 2023 Jun 24.

Bonazzi VF, Aoude LG, Brosda S, Bradford JJ, Lonie JM, Loffler KA, Gartside MG, Patel K, Mukhopadhyay P, Keane C, Gebski V, Kench JG, Goldstein D, Waddell N, Barbour AP; Australasian Gastro-Intestinal Trials Group (AGITG) GAP investigators. C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients. Asia Pac J Clin Oncol. 2023 Jul 6. doi: 10.1111/ajco.13993. Epub ahead of print.

Busam KJ, Gerami P, Scolyer RA. Perspectives and Strategies to Minimize Harm From Melanoma Diagnosis. JAMA Dermatol. 2023 Dec 1;159(12):1307-1309. doi: 10.1001/jamadermatol.2023.4324.

Chakraborty A, Perez M, Carroll JD, Antonopoulos A, Dell A, Ortega L, Mohammed NBB, Wells M, Staudinger C, Griswold A, Chandler KB, Marrero C, Jimenez R, Tani Y, Wilmott JS, Thompson JF, Wang W, Sackstein R, Scolyer RA, Murphy GF, Haslam SM, Dimitroff CJ. Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma. J Invest Dermatol. 2023 Mar;143(3):456-469.e8. doi: 10.1016/j.jid.2022.07.033. Epub 2022 Sep 27.

Chitty JL, Yam M, Perryman L, Parker AL, Skhinas JN, Setargew YFI, Mok ETY, Tran E, Grant RD, Latham SL, Pereira BA, Ritchie SC, Murphy KJ, Trpceski M, Findlay AD, Melenec P, Filipe EC, Nadalini A, Velayuthar S, Major G, Wyllie K, Papanicolaou M, Ratnaseelan S, Phillips PA, Sharbeen G, Youkhana J, Russo A, Blackwell A, Hastings JF, Lucas MC, Chambers CR, Reed DA, Stoehr J, Vennin C, Pidsley R, Zaratzian A, Da Silva AM, Tayao M, Charlton B, Herrmann D, Nobis M, Clark SJ, Biankin AV, Johns AL, Croucher DR, Nagrial A, Gill AJ, Grimmond SM; Australian Pancreatic Cancer Genome Initiative (APGI); Australian Pancreatic Cancer Matrix Atlas (APMA); Pajic M, Timpson P, Jarolimek W, Cox TR. A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Nat Cancer. 2023 Sep;4(9):1326-1344. doi: 10.1038/s43018-023-00614-y. Epub 2023 Aug 28.

Chu GJ, Linton A, Kao S, Klebe S, Adelstein S, Yeo D, Rasko JEJ, Cooper WA. High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma. Histopathology. 2023 Aug;83(2):202-210. doi: 10.1111/his.14916. Epub 2023 Apr 11.

Conway JW, Braden J, Lo SN, Scolyer RA, Carlino MS, Menzies AM, Long GV, Silva IPD. VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types-A Meta-Analysis. Cancers (Basel). 2023 Oct 16;15(20):5012. doi: 10.3390/cancers15205012.

Cooper WA, John T. Rethinking Biomarkers for Combination Chemoimmunotherapy. J Thorac Oncol. 2023 Jul;18(7):841-843. doi: 10.1016/j.jtho.2023.04.015.

Cooper WA. Lessons and opportunities from improved understanding of global lung cancer histological subtypes. Lancet Oncol. 2023 Nov;24(11):1159-1161. doi: 10.1016/S1470-2045(23)00475-8. Epub 2023 Oct 11.

Cortés-Ciriano I, Lee JJ, Xi R, Jain D, Jung YL, Yang L, Gordenin D, Klimczak LJ, Zhang CZ, Pellman DS; PCAWG Structural Variation Working Group; Park PJ; PCAWG Consortium. Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat Genet. 2023 Jun;55(6):1076. doi: 10.1038/s41588-023-01315-z. Erratum for: Nat Genet. 2020 Mar;52(3):331-341. doi: 10.1038/s41588-019-0576-7.

Cust AE, Scolyer RA. Melanoma In Situ-Getting the Diagnosis and Prognosis Right. JAMA Dermatol. 2023 Jul 1;159(7):699-701. doi: 10.1001/jamadermatol.2023.1485.

Dacic S, Travis W, Redman M, Saqi A, Cooper WA, Borczuk A, Chung JH, Glass C, Lopez JM, Roden AC, Sholl L, Weissferdt A, Posadas J, Walker A, Zhu H, Wijeratne MT, Connolly C, Wynes M, Bota-Rabassedas N, Sanchez-Espiridion B, Lee JJ, Berezowska S, Chou TY, Kerr K, Nicholson A, Poleri C, Schalper KA, Tsao MS, Carbone DP, Ready N, Cascone T, Heymach J, Sepesi B, Shu C, Rizvi N, Sonett J, Altorki N, Provencio M, Bunn PA Jr, Kris MG, Belani CP, Kelly K, Wistuba I; IASLC Pathology Committee. International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy. J Thorac Oncol. 2023 Oct;18(10):1290-1302. doi: 10.1016/j.jtho.2023.07.017. Epub 2023 Sep 12.

Eghtedari M, McKenzie C, Tang LCY, Majumdar A, Kench JG. Banff 2016 Global Assessment and Quantitative Scoring for T Cell-Mediated Liver Transplant Rejection are Interchangeable. J Transplant. 2023 Mar 27;2023:3103335. doi: 10.1155/2023/3103335.

El Sharouni MA, Lo SN, Scolyer RA, van Gils CH, Thompson JF. Reply to: "Estrogen could also play a key role in the development of pediatric melanoma". J Am Acad Dermatol. 2023 Aug;89(2):e97-e98. doi: 10.1016/j.jaad.2023.03.008. Epub 2023 Mar 18.

El Sharouni MA, Rawson RV, Potter AJ, Paver EC, Wilmott JS, Witkamp AJ, Sigurdsson V, van Diest PJ, Scolyer RA, Thompson JF, Lo SN, van Gils CH. Melanomas in children and adolescents: Clinicopathologic features and survival outcomes. J Am Acad Dermatol. 2023 Mar;88(3):609-616. doi: 10.1016/j.jaad.2022.08.067. Epub 2022 Dec 9.

Fernando CD, Jayasekara WSN, Inampudi C, Kohonen-Corish MRJ, Cooper WA, Beilharz TH, Josephs TM, Garama DJ, Gough DJ. A STAT3 protein complex required for mitochondrial mRNA stability and cancer. Cell Rep. 2023 Sep 26;42(9):113033. doi: 10.1016/j.celrep.2023.113033. Epub 2023 Sep 12.

Fullard K, Steffens D, Solomon M, Shin JS, Koh C. Measuring the impact of the COVID-19 pandemic on colorectal cancer presentation: a retrospective comparative study. ANZ J Surg. 2023 Dec;93(12):2951-2957. doi: 10.1111/ans.18701. Epub 2023 Oct 17.

Garbe C, Dummer R, Amaral T, Amaria RN, Ascierto PA, Burton EM, Dreno B, Eggermont AMM, Hauschild A, Hoeller C, Kaufmann R, Lebbe C, Mandala M, Menzies AM, Moreno D, Michielin O, Nathan P, Patel SP, Robert C, Schadendorf D, Lorigan PC, Scolyer RA, Tawbi HA, van de Wiel BA, Blank C, Long GV. Neoadjuvant immunotherapy for melanoma is now ready for clinical practice. Nat Med. 2023 Jun;29(6):1310-1312. doi: 10.1038/s41591-023-02336-1.

Georgevsky D, Ying L, Krishnan S, Laurence J, Robinson D, Campbell N, Wyburn K, Marinelli T, Davis R, Narayan R, Lutz T, Chan A, Heaney SA, Kitzing YX, Anderson L, Liyanagama K, Robson J, Carter J, Testa G, Johannesson L, Marren A. First uterine transplant case at the Royal Prince Alfred Hospital. Aust N Z J Obstet Gynaecol. 2023 Aug;63(4):599-602. doi: 10.1111/ajo.13700. Epub 2023 May 18.

Gerstung M, Jolly C, Leshchiner I, Dentro SC, Gonzalez S, Rosebrock D, Mitchell TJ, Rubanova Y, Anur P, Yu K, Tarabichi M, Deshwar A, Wintersinger J, Kleinheinz K, Vázquez-García I, Haase K, Jerman L, Sengupta S, Macintyre G, Malikic S, Donmez N, Livitz DG, Cmero M, Demeulemeester J, Schumacher S, Fan Y, Yao X, Lee J, Schlesner M, Boutros PC, Bowtell DD, Zhu H, Getz G, Imielinski M, Beroukhim R, Sahinalp SC, Ji Y, Peifer M, Markowetz F, Mustonen V, Yuan K, Wang W, Morris QD; PCAWG Evolution & Heterogeneity Working Group; Spellman PT, Wedge DC, Van Loo P; PCAWG Consortium. Author Correction: The evolutionary history of 2,658 cancers. Nature. 2023 Feb;614(7948):E42. doi: 10.1038/s41586-022-05601-4. Erratum for: Nature. 2020 Feb;578(7793):122-128. doi: 10.1038/s41586-019-1907-7.

Gide TN, Paver EC, Yaseen Z, Maher N, Adegoke N, Menzies AM, Pires da Silva I, Wilmott JS, Long GV, Scolyer RA. Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapies. Oncoimmunology. 2023 Oct 4;12(1):2261248. doi: 10.1080/2162402X.2023.2261248.

Gjorup CA, Pires da Silva I, Martin L, Stretch JR, Scolyer RA, Long GV, Hong A. Definitive treatment with PD-1 blockade and radiation therapy of unresected primary desmoplastic melanoma of the nose. Melanoma Res. 2023 Oct 1;33(5):422-424. doi: 10.1097/CMR.0000000000000905. Epub 2023 Aug 3.

Gouveia BM, Carlos G, Wadell A, Sinz C, Ahmed T, Lo SN, Rawson RV, Ferguson PM, Scolyer RA, Guitera P. In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case-control study. J Eur Acad Dermatol Venereol. 2023 Jul;37(7):1293-1301. doi: 10.1111/jdv.18998. Epub 2023 Mar 25.

Gupta R, Bal M, Bishop JA, Hunter KD, Magliocca K, Seethala RR, Thompson LDR, Weinreb I, Angelos P, Beadle B, Bell RB, Clark JR, Ferris R, Huang SH, Hayes DN, Ladwa R, Yang J, Cipriani NA, Nelson BL, Sadow PM, Lewis JS. HN-CLEAR: Head and Neck Consensus Language for Ease and Reproducibility, a Multidisciplinary Consensus Mechanism for Head and Neck Pathology. Head Neck Pathol. 2023 Sep;17(3):877-880. doi: 10.1007/s12105-023-01570-w. Epub 2023 Jul 24.

Gupta R, Selinger CI, Ashford B, Chua MST, Clark JR, Damian DL, Jackett LA, James C, Johnson S, Ladwa R, Lambie D, McKenzie C, Tan ST, Scolyer RA. Implementing structured pathology reporting protocol for non-melanocytic skin cancers: practical considerations. Pathology. 2023 Oct;55(6):743-759. doi: 10.1016/j.pathol.2023.07.003. Epub 2023 Jul 28.

Gupta R, Strbenac D, Satgunaseelan L, Cheung VK, Narayanappa H, Ashford B, Mitchell J, Thind A, Palme CE, Ch'ng S, Low TH, Wykes J, Willet CE, Chew T, Yang J, Ranson M, Clark JR. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers. Mod Pathol. 2023 Aug;36(8):100190. doi: 10.1016/j.modpat.2023.100190. Epub 2023 Apr 18.

Habashy P, Lea V, Wilkinson K, Wang B, Wu XJ, Roberts TL, Ng W, Rutland T, Po JW, Becker T, Descallar J, Lee M, Mackenzie S, Gupta R, Cooper W, Lim S, Chua W, Lee CS. KRAS and BRAF Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort. Int J Mol Sci. 2023 Dec 15;24(24):17509. doi: 10.3390/ijms242417509.

Hahn AW, Menk AV, Rivadeneira DB, Augustin RC, Xu M, Li J, Wu X, Mishra AK, Gide TN, Quek C, Zang Y, Spencer CN, Menzies AM, Daniel CR, Hudgens CW, Nowicki T, Haydu LE, Khan MAW, Gopalakrishnan V, Burton EM, Malke J, Simon JM, Bernatchez C, Putluri N, Woodman SE, Vashisht Gopal YN, Guerrieri R, Fischer GM, Wang J, Wani KM, Thompson JF, Lee JE, Hwu P, Ajami N, Gershenwald JE, Long GV, Scolyer RA, Tetzlaff MT, Lazar AJ, Schadendorf D, Wargo JA, Kirkwood JM, DeBerardinis RJ, Liang H, Futreal A, Zhang J, Wilmott JS, Peng W, Davies MA, Delgoffe GM, Najjar YG, McQuade JL. Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma. Clin Cancer Res. 2023 Jan 4;29(1):154-164. doi: 10.1158/1078-0432.CCR-22-2661.

Hasmat S, Heller G, Cook L, Gupta R, Clark JR, Ooi EH, Low TH. The impact of multifocal perineural invasion in predicting survival in patients with oral squamous cell carcinoma: A multicenter investigation. Head Neck. 2023 Oct;45(10):2605-2612. doi: 10.1002/hed.27485. Epub 2023 Aug 10.

Huang C, Burke H, Scolyer RA, Guitera P. Lentigo maligna and lentigo maligna melanoma in young patients in Australian tertiary centres. Clin Exp Dermatol. 2023 Jul 7;48(7):799-800. doi: 10.1093/ced/llad089.

ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Author Correction: Pan-cancer analysis of whole genomes. Nature. 2023 Feb;614(7948):E39. doi: 10.1038/s41586-022-05598-w. Erratum for: Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6.

Kvorning Ternov N, Tolsgaard M, Konge L, Christensen AN, Kristensen SIP, Hölmich LR, Stretch J, Scolyer RA, Vestergaard T, Guitera P, Chakera AH. Effect of Histopathological Explanations for Dermoscopic Criteria on Learning Curves in Skin Cancer Training: a Randomized Controlled Trial. Dermatol Pract Concept. 2023 Apr 1;13(2):e2023105. doi: 10.5826/dpc.1302a105. Epub ahead of print.

Lau NS, Ly M, Dennis C, Ewenson K, Ly H, Huang JL, Cabanes-Creus M, Chanda S, Wang C, Lisowski L, Liu K, Kench J, McCaughan G, Crawford M, Pulitano C. Liver splitting during normothermic machine perfusion: a novel method to combine the advantages of both in-situ and ex-vivo techniques. HPB (Oxford). 2023 May;25(5):543-555. doi: 10.1016/j.hpb.2023.02.003. Epub 2023 Feb 8.

Lau NS, Ly M, Dennis C, Jacques A, Cabanes-Creus M, Toomath S, Huang J, Mestrovic N, Yousif P, Chanda S, Wang C, Lisowski L, Liu K, Kench JG, McCaughan G, Crawford M, Pulitano C. Long-term ex situ normothermic perfusion of human split livers for more than 1 week. Nat Commun. 2023 Aug 8;14(1):4755. doi: 10.1038/s41467-023-40154-8.

Lee H, Ferguson AL, Quek C, Vergara IA, Pires daSilva I, Allen R, Gide TN, Conway JW, Koufariotis LT, Hayward NK, Waddell N, Carlino MS, Menzies AM, Saw RPM, Shklovskaya E, Rizos H, Lo S, Scolyer RA, Long GV, Palendira U, Wilmott JS. Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy. Clin Cancer Res. 2023 Jul 5;29(13):2513-2524. doi: 10.1158/1078-0432.CCR-22-2657.

Lezcano C, Berwick M, Luo L, Barnhill R, Duncan LM, Gerami P, Lowe L, Messina JL, Scolyer RA, Wood B, Yeh I, Zembowicz A, Busam KJ. Interobserver agreement in the histopathological classification of desmoplastic melanomas. Pathology. 2023 Mar;55(2):223-226. doi: 10.1016/j.pathol.2022.12.347. Epub 2023 Jan 2.

Li AT, Law J, Ch'ng S, Scolyer RA, Thompson JF, Lo SN, Varey AHR. External validation in an Australian population of the EORTC-DeCOG nomogram predicting recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes. Eur J Cancer. 2023 Aug;189:112901. doi: 10.1016/j.ejca.2023.04.017. Epub 2023 May 2.

Li Y, Roberts ND, Wala JA, Shapira O, Schumacher SE, Kumar K, Khurana E, Waszak S, Korbel JO, Haber JE, Imielinski M; PCAWG Structural Variation Working Group; Weischenfeldt J, Beroukhim R, Campbell PJ; PCAWG Consortium. Author Correction: Patterns of somatic structural variation in human cancer genomes. Nature. 2023 Feb;614(7948):E38. doi: 10.1038/s41586-022-05597-x. Erratum for: Nature. 2020 Feb;578(7793):112-121. doi: 10.1038/s41586-019-1913-9.

Lim SY, Shklovskaya E, Lee JH, Pedersen B, Stewart A, Ming Z, Irvine M, Shivalingam B, Saw RPM, Menzies AM, Carlino MS, Scolyer RA, Long GV, Rizos H. The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma. Nat Commun. 2023 Mar 18;14(1):1516. doi: 10.1038/s41467-023-36979-y.

Liu K, Chen J, Zhao Y, Boland J, Ting KK, Lockwood G, McKenzie C, Kench J, Vadas MA, Gamble JR, McCaughan GW. Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate. Front Immunol. 2023 Sep 18;14:1245708. doi: 10.3389/fimmu.2023.1245708.

Long GV, Menzies AM, Scolyer RA. Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now. J Clin Oncol. 2023 Jun 10;41(17):3236-3248. doi: 10.1200/JCO.22.02575. Epub 2023 Apr 27.

Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA. Cutaneous melanoma. Lancet. 2023 Aug 5;402(10400):485-502. doi: 10.1016/S0140-6736(23)00821-8. Epub 2023 Jul 24. Erratum in: Lancet. 2023 Aug 5;402(10400):450. doi: 10.1016/S0140-6736(23)01581-7.

Ly M, Lau NS, McKenzie C, Kench JG, McCaughan G, Crawford M, Pulitano C. Does an Additional Bile Duct Flush With Low-viscosity Preservation Solution Reduce Bile Duct Injury? A Single-blinded Randomized Clinical Trial. Transplant Direct. 2023 Feb 8;9(3):e1443. doi: 10.1097/TXD.0000000000001443.

Ly M, Lau NS, McKenzie C, Kench JG, Seyfi D, Majumdar A, Liu K, McCaughan G, Crawford M, Pulitano C. Histological Assessment of the Bile Duct before Liver Transplantation: Does the Bile Duct Injury Score Predict Biliary Strictures? J Clin Med. 2023 Oct 27;12(21):6793. doi: 10.3390/jcm12216793.

Maher NG, Prosser N, Aivazian K, Colebatch AJ, Ferguson PM, Karim RZ, McKenzie CA, Rawson RV, Lo SN, Scolyer RA. Inter-rater concordance of basal cell carcinoma subtypes: influences on reporting format and opportunities for further classification modifications. Pathology. 2023 Oct;55(6):800-805. doi: 10.1016/j.pathol.2023.04.003. Epub 2023 Jun 7.

Maher NG, Scolyer RA, Colebatch AJ. Biology and genetics of acquired and congenital melanocytic naevi. Pathology. 2023 Mar;55(2):169-177. doi: 10.1016/j.pathol.2022.12.344. Epub 2022 Dec 29.

Maleszewski JJ, Basso C, Burke A, Castonguay M, Leduc C, Tavora F, Sheppard M, Suri R, Judge M, Cooper WA. Dataset for the reporting of neoplasms of the heart, pericardium, and great vessels: recommendations from the International Collaboration on Cancer Reporting (ICCR). Virchows Arch. 2023 Feb;482(2):303-309. doi: 10.1007/s00428-022-03473-7. Epub 2022 Dec 13.

Mao Y, Gide TN, Adegoke NA, Quek C, Maher N, Potter A, Patrick E, Saw RPM, Thompson JF, Spillane AJ, Shannon KF, Carlino MS, Lo SN, Menzies AM, da Silva IP, Long GV, Scolyer RA, Wilmott JS. Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach. J Transl Med. 2023 Apr 13;21(1):257. doi: 10.1186/s12967-023-04092-9.

McKenzie CA, Gupta R, Jackett L, Anderson L, Chen V, Dahlstrom JE, Dray M, Farshid G, Hemmings C, Karim R, Kench JG, Klebe S, Kramer N, Kumarasinghe P, Maclean F, Morey A, Nguyen MA, O'Toole S, Rowbotham B, Salisbury ELC, Scolyer RA, Stewart K, Waring L, Cooper CL, Cooper WA. Looking beyond workforce parity: addressing gender inequity in pathology. Pathology. 2023 Oct;55(6):760-771. doi: 10.1016/j.pathol.2023.07.002. Epub 2023 Jul 25.

McMullen L, Khoo L, Anderson L, Strasser S, Gracey DM. BK viraemia as a cause of anaemia in after ABO-incompatible liver transplant: a case report. BMC Infect Dis. 2023 Sep 18;23(1):609. doi: 10.1186/s12879-023-08601-5.

Menzies SW, Sinz C, Menzies M, Lo SN, Yolland W, Lingohr J, Razmara M, Tschandl P, Guitera P, Scolyer RA, Boltz F, Borik-Heil L, Herbert Chan H, Chromy D, Coker DJ, Collgros H, Eghtedari M, Corral Forteza M, Forward E, Gallo B, Geisler S, Gibson M, Hampel A, Ho G, Junez L, Kienzl P, Martin A, Moloney FJ, Regio Pereira A, Ressler JM, Richter S, Silic K, Silly T, Skoll M, Tittes J, Weber P, Weninger W, Weiss D, Woo-Sampson P, Zilberg C, Kittler H. Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial. Lancet Digit Health. 2023 Oct;5(10):e679-e691. doi: 10.1016/S2589-7500(23)00130-9.

Miller JR 3rd, Lo SN, Nosrati M, Stretch JR, Spillane AJ, Saw RPM, Shannon KF, Nieweg OE, Ch'ng S, Kim KB, Leong SP, Thompson JF, Scolyer RA, Kashani-Sabet M. Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma. JAMA Netw Open. 2023 Apr 3;6(4):e236356. doi: 10.1001/jamanetworkopen.2023.6356.

Ming Z, Lim SY, Stewart A, Pedersen B, Shklovskaya E, Menzies AM, Carlino MS, Kefford RF, Lee JH, Scolyer RA, Long GV, Rizos H. IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics. J Invest Dermatol. 2023 Jul;143(7):1246-1256.e8. doi: 10.1016/j.jid.2023.01.017. Epub 2023 Feb 1.

Moscarella E, Guitera P, Scolyer RA, Rocha L, Thomas L, Ronchi A, Scharf C, Brancaccio G, Argenziano G. Junctional Nevus and Early Melanoma on Sun-Damaged Skin of the Head/Neck: a Clinico-Pathologic Challenge. Dermatol Pract Concept. 2023 Apr 1;13(2):e2023122. doi: 10.5826/dpc.1302a122. Epub ahead of print.

Nash E, Kench J, Watson G, Liu K. A case of drug reaction with eosinophilia and systemic symptoms (DRESS) due to rivaroxaban. Pathology. 2023 Dec;55(7):1022-1024. doi: 10.1016/j.pathol.2023.05.012. Epub 2023 Jul 20.

Nguyen MA, Colebatch AJ, Van Beek D, Tierney G, Gupta R, Cooper WA. NTRK fusions in solid tumours: what every pathologist needs to know. Pathology. 2023 Aug;55(5):596-609. doi: 10.1016/j.pathol.2023.05.002. Epub 2023 May 26.

Ni Y, Watts CG, Scolyer RA, Madronio C, Armstrong BK, Morton RL, Menzies SW, Mann GJ, Thompson JF, Lo SN, Cust AE. Risk of developing a second primary melanoma after a first primary melanoma in a population-based Australian cohort. Br J Dermatol. 2023 May 24;188(6):814-816. doi: 10.1093/bjd/ljad076.

Odgers H, Anderson L, Kok PS, Farrell R. Dedifferentiated umbilical metastases from low grade endometrioid endometrial adenocarcinoma complicated by super-obesity: A case report. Int J Surg Case Rep. 2023 Jul;108:108449. doi: 10.1016/j.ijscr.2023.108449. Epub 2023 Jul 1.

Ong JS, Seviiri M, Dusingize JC, Wu Y, Han X, Shi J, Olsen CM, Neale RE, Thompson JF, Saw RPM, Shannon KF, Mann GJ, Martin NG, Medland SE, Gordon SD, Scolyer RA, Long GV, Iles MM, Landi MT, Whiteman DC, MacGregor S, Law MH. Uncovering the complex relationship between balding, testosterone and skin cancers in men. Nat Commun. 2023 Oct 3;14(1):5962. doi: 10.1038/s41467-023-41231-8.

Orlow I, Sadeghi KD, Edmiston SN, Kenney JM, Lezcano C, Wilmott JS, Cust AE, Scolyer RA, Mann GJ, Lee TK, Burke H, Jakrot V, Shang P, Ferguson PM, Boyce TW, Ko JS, Ngo P, Funchain P, Rees JR, O'Connell K, Hao H, Parrish E, Conway K, Googe PB, Ollila DW, Moschos SJ, Hernando E, Hanniford D, Argibay D, Amos CI, Lee JE, Osman I, Luo L, Kuan PF, Aurora A, Gould Rothberg BE, Bosenberg MW, Gerstenblith MR, Thompson C, Bogner PN, Gorlov IP, Holmen SL, Brunsgaard EK, Saenger YM, Shen R, Seshan V, Nagore E, Ernstoff MS, Busam KJ, Begg CB, Thomas NE, Berwick M; InterMEL Consortium. InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma. PLoS One. 2023 Apr 3;18(4):e0269324. doi: 10.1371/journal.pone.0269324.

Paver E, Aivazian K, Maclean F, Long GV, Spillane AJ, Wilmott JS, Scolyer RA. Utility of next generation sequencing for differentiating malignant PEComa from metastatic melanoma. Pathology. 2023 Jun;55(4):555-560. doi: 10.1016/j.pathol.2022.08.011. Epub 2022 Oct 29.

Paver EC, Ahmed T, Burke H, Saw RPM, Stretch JR, Spillane AJ, Shannon KF, Vergara IA, Elder DE, Lo SN, Thompson JF, Scolyer RA. Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma. JAMA Dermatol. 2023 Dec 1;159(12):1359-1367. doi: 10.1001/jamadermatol.2023.4193.

PCAWG Transcriptome Core Group; Calabrese C, Davidson NR, Demircioğlu D, Fonseca NA, He Y, Kahles A, Lehmann KV, Liu F, Shiraishi Y, Soulette CM, Urban L, Greger L, Li S, Liu D, Perry MD, Xiang Q, Zhang F, Zhang J, Bailey P, Erkek S, Hoadley KA, Hou Y, Huska MR, Kilpinen H, Korbel JO, Marin MG, Markowski J, Nandi T, Pan-Hammarström Q, Pedamallu CS, Siebert R, Stark SG, Su H, Tan P, Waszak SM, Yung C, Zhu S, Awadalla P, Creighton CJ, Meyerson M, Ouellette BFF, Wu K, Yang H; PCAWG Transcriptome Working Group; Brazma A, Brooks AN, Göke J, Rätsch G, Schwarz RF, Stegle O, Zhang Z; PCAWG Consortium. Author Correction: Genomic basis for RNA alterations in cancer. Nature. 2023 Feb;614(7948):E37. doi: 10.1038/s41586-022-05596-y. Erratum for: Nature. 2020 Feb;578(7793):129-136. doi: 10.1038/s41586-020-1970-0.

Pitiyarachchi O, Lee YC, Sim HW, Srirangan S, Mapagu C, Kirk J, Harnett PR, Balleine RL, Bowtell DDL, Samimi G, Brand AH, Marsh DJ, Beale P, Anderson L, Bouantoun N, Provan P; INOVATe Investigators; Ramus SJ, DeFazio A, Friedlander M. Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma. Transl Oncol. 2023 May;31:101638. doi: 10.1016/j.tranon.2023.101638. Epub 2023 Feb 18.

Reijers ILM, Rao D, Versluis JM, Menzies AM, Dimitriadis P, Wouters MW, Spillane AJ, Klop WMC, Broeks A, Bosch LJW, Lopez-Yurda M, van Houdt WJ, Rawson RV, Grijpink-Ongering LG, Gonzalez M, Cornelissen S, Bouwman J, Sanders J, Plasmeijer E, Elshot YS, Scolyer RA, van de Wiel BA, Peeper DS, van Akkooi ACJ, Long GV, Blank CU. IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma. J Exp Med. 2023 May 1;220(5):e20221952. doi: 10.1084/jem.20221952. Epub 2023 Mar 15.

Rheinbay E, Nielsen MM, Abascal F, Wala JA, Shapira O, Tiao G, Hornshøj H, Hess JM, Juul RI, Lin Z, Feuerbach L, Sabarinathan R, Madsen T, Kim J, Mularoni L, Shuai S, Lanzós A, Herrmann C, Maruvka YE, Shen C, Amin SB, Bandopadhayay P, Bertl J, Boroevich KA, Busanovich J, Carlevaro-Fita J, Chakravarty D, Chan CWY, Craft D, Dhingra P, Diamanti K, Fonseca NA, Gonzalez-Perez A, Guo Q, Hamilton MP, Haradhvala NJ, Hong C, Isaev K, Johnson TA, Juul M, Kahles A, Kahraman A, Kim Y, Komorowski J, Kumar K, Kumar S, Lee D, Lehmann KV, Li Y, Liu EM, Lochovsky L, Park K, Pich O, Roberts ND, Saksena G, Schumacher SE, Sidiropoulos N, Sieverling L, Sinnott-Armstrong N, Stewart C, Tamborero D, Tubio JMC, Umer HM, Uusküla-Reimand L, Wadelius C, Wadi L, Yao X, Zhang CZ, Zhang J, Haber JE, Hobolth A, Imielinski M, Kellis M, Lawrence MS, von Mering C, Nakagawa H, Raphael BJ, Rubin MA, Sander C, Stein LD, Stuart JM, Tsunoda T, Wheeler DA, Johnson R, Reimand J, Gerstein M, Khurana E, Campbell PJ, López-Bigas N; PCAWG Drivers and Functional Interpretation Working Group; PCAWG Structural Variation Working Group; Weischenfeldt J, Beroukhim R, Martincorena I, Pedersen JS, Getz G; PCAWG Consortium. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature. 2023 Feb;614(7948):E40. doi: 10.1038/s41586-022-05599-9. Erratum for: Nature. 2020 Feb;578(7793):102-111. doi: 10.1038/s41586-020-1965-x.

Risbey C, Fielder T, Steffens D, Shin JS, Solomon M. Patterns of DNA mismatch repair protein expression for primary and recurrent colorectal cancer at an advanced surgical unit: A retrospective audit. Colorectal Dis. 2023 Mar;25(3):369-374. doi: 10.1111/codi.16391. Epub 2022 Nov 21.

Roden AC, Judge M, den Bakker MA, Fang W, Jain D, Marx A, Moreira AL, Rajan A, Stroebel P, Szolkowska M, Cooper WA. Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2023 Dec;83(6):967-980. doi: 10.1111/his.15047. Epub 2023 Sep 18.

Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, Santamarina M, Ju YS, Temes J, Garcia-Souto D, Detering H, Li Y, Rodriguez-Castro J, Dueso-Barroso A, Bruzos AL, Dentro SC, Blanco MG, Contino G, Ardeljan D, Tojo M, Roberts ND, Zumalave S, Edwards PA, Weischenfeldt J, Puiggròs M, Chong Z, Chen K, Lee EA, Wala JA, Raine KM, Butler A, Waszak SM, Navarro FCP, Schumacher SE, Monlong J, Maura F, Bolli N, Bourque G, Gerstein M, Park PJ, Wedge DC, Beroukhim R, Torrents D, Korbel JO, Martincorena I, Fitzgerald RC, Van Loo P, Kazazian HH, Burns KH; PCAWG Structural Variation Working Group; Campbell PJ, Tubio JMC; PCAWG Consortium. Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nat Genet. 2023 Jun;55(6):1080. doi: 10.1038/s41588-023-01319-9. Erratum for: Nat Genet. 2020 Mar;52(3):306-319. doi: 10.1038/s41588-019-0562-0.

Russell PA, Farrall AL, Prabhakaran S, Asadi K, Barrett W, Cooper C, Cooper W, Cotton S, Duhig E, Egan M, Fox S, Godbolt D, Gupta S, Hassan A, Leslie C, Leong T, Moffat D, Qiu MR, Sivasubramaniam V, Skerman J, Snell C, Walsh M, Whale K, Klebe S. Real-world prevalence of PD-L1 expression in non-small cell lung cancer: an Australia-wide multi-centre retrospective observational study. Pathology. 2023 Dec;55(7):922-928. doi: 10.1016/j.pathol.2023.08.008. Epub 2023 Sep 27.

Sharouni ME, Lo SN, Varey AH, Elias SG, Witkamp AJ, Sigurdsson V, Suijkerbuijk KP, van Diest PJ, van Gils CH, Blokx WA, Scolyer RA, Thompson JF. Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publication. Future Oncol. 2023 Jan;19(2):97-102. doi: 10.2217/fon-2022-0525. Epub 2023 Feb 10.

Simpson RC, Shanahan ER, Scolyer RA, Long GV. Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors. Nat Rev Clin Oncol. 2023 Oct;20(10):697-715. doi: 10.1038/s41571-023-00803-9. Epub 2023 Jul 24.

Tadi S, Cheung VK, Lee CS, Nguyen K, Luk PP, Low TH, Palme C, Clark J, Gupta R. MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinoma. Pathology. 2023 Jun;55(4):456-465. doi: 10.1016/j.pathol.2023.01.007. Epub 2023 Mar 21.

Tanudisastro M, Chatterjee R, Anderson L, Smirnova S. Ruptured ectopic molar pregnancy and ruptured uterine fibroid: a challenging rare diagnosis. BMJ Case Rep. 2023 Jan 18;16(1):e251045. doi: 10.1136/bcr-2022-251045.

Thompson JF, Hyngstrom J, Caracò C, Zager JS, Jahkola T, Bowles TL, Pennacchioli E, Hoekstra HJ, Moncrieff M, Ingvar C, van Akkooi A, Sabel MS, Levine EA, Henderson M, Dummer R, Rossi CR, Kane JM 3rd, Trocha S, Wright F, Byrd DR, Matter M, MacKenzie-Ross A, Kelley MC, Terheyden P, Huston TL, Wayne JD, Neuman H, Smithers BM, Desai D, Gershenwald JE, Schneebaum S, Gesierich A, Jacobs LK, Lewis JM, O'Donoghue C, Sardi A, McKinnon JG, Slingluff CL, Farma JM, Schultz E, Scheri RP, Vidal-Sicart S, Testori AAE, Scolyer RA, Elashoff DE, Cochran AJ, Faries MB. Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma. Ann Surg Oncol. 2023 Jul;30(7):4359-4360. doi: 10.1245/s10434-023-13570-9. Epub 2023 May 6.

Tjahjono R, Low HT, Lee J, Sebaratnam DF, Gupta R, Veness MJ, Clark J, Palme CE. DANGER: what clinicians need to know about aggressive head and neck cutaneous squamous cell carcinoma. Med J Aust. 2023 Jan 16;218(1):11-15. doi: 10.5694/mja2.51786. Epub 2022 Dec 4.

Varey AHR, Williams GJ, Lo SN, Taing CY, Maurichi A, Santinami M, Scolyer RA, Thompson JF. Clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2023 May;37(5):859-870. doi: 10.1111/jdv.18665. Epub 2022 Nov 7.

Vergara IA, Aivazian K, Carlino MS, Guminski AD, Maher NG, Shannon KF, Ch'ng S, Saw RPM, Long GV, Wilmott JS, Scolyer RA. Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets. Mod Pathol. 2023 Apr;36(4):100099. doi: 10.1016/j.modpat.2023.100099. Epub 2023 Jan 10.

Wilmott JS, Tawbi H, Engh JA, Amankulor NM, Shivalingam B, Banerjee H, Vergara IA, Lee H, Johansson PA, Ferguson PM, Saiag P, Robert C, Grob JJ, Butterfield LH, Scolyer RA, Kirkwood JM, Long GV, Davies MA. Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases. Clin Cancer Res. 2023 Feb 1;29(3):521-531. doi: 10.1158/1078-0432.CCR-22-2581.

Xin H, Romanazzo S, Tomaskovic-Crook E, Mitchell TC, Hung JC, Wise SG, Cheng K, Al Maruf DSA, Stokan MJ, Manzie TGH, Parthasarathi K, Cheung VKY, Gupta R, Ly M, Pulitano C, Wise IK, Crook JM, Clark JR. Ex Vivo Preservation of Ovine Periosteum Using a Perfusion Bioreactor System. Cells. 2023 Jun 27;12(13):1724. doi: 10.3390/cells12131724.

Yakneen S, Waszak SM; PCAWG Technical Working Group; Gertz M, Korbel JO; PCAWG Consortium. Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes. Nat Biotechnol. 2023 Apr;41(4):577. doi: 10.1038/s41587-022-01554-1. Erratum for: Nat Biotechnol. 2020 Mar;38(3):288-292. doi: 10.1038/s41587-019-0360-3.

Yeo D, Kao S, Gupta R, Wahlroos S, Bastian A, Strauss H, Klemm V, Shrestha P, Ramirez AB, Costandy L, Huston R, Gardner BS, Grimison P, Clark JR, Rasko JEJ. Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging. Front Oncol. 2023 Mar 27;13:1141228. doi: 10.3389/fonc.2023.1141228.

Yuan Y, Ju YS, Kim Y, Li J, Wang Y, Yoon CJ, Yang Y, Martincorena I, Creighton CJ, Weinstein JN, Xu Y, Han L, Kim HL, Nakagawa H, Park K, Campbell PJ, Liang H; PCAWG Consortium. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers. Nat Genet. 2023 Jun;55(6):1078. doi: 10.1038/s41588-023-01317-x. Erratum for: Nat Genet. 2020 Mar;52(3):342-352. doi: 10.1038/s41588-019-0557-x.

Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M, Desai N, Sültmann H, Moch H; PCAWG Pathogens; Cooper CS, Eils R, Ferretti V, Lichter P; PCAWG Consortium. Author Correction: The landscape of viral associations in human cancers. Nat Genet. 2023 Jun;55(6):1077. doi: 10.1038/s41588-023-01316-y. Erratum for: Nat Genet. 2020 Mar;52(3):320-330. doi: 10.1038/s41588-019-0558-9.

Zhang M, Phung D, Gupta R, Wykes J, Wu R, Lee J, Elliott M, Palme CE, Clark J, Low TH. Persisting facial nerve palsy or trigeminal neuralgia - red flags for perineural spread of head and neck cutaneous squamous cell carcinoma (HNcSCC). ANZ J Surg. 2023 Oct;93(10):2394-2401. doi: 10.1111/ans.18625. Epub 2023 Jul 23.

Zilberg C, Lyons JG, Gupta R, Damian DL. The Immune Microenvironment in Basal Cell Carcinoma. Ann Dermatol. 2023 Aug;35(4):243-255. doi: 10.5021/ad.22.042.

Zilberg C, Lyons JG, Gupta R, Ferguson A, Damian DL. The Tumor Immune Microenvironment in Cutaneous Squamous Cell Carcinoma Arising in Organ Transplant Recipients. Ann Dermatol. 2023 Apr;35(2):91-99. doi: 10.5021/ad.22.175.

2022

Ahmadi N, Kelly G, Low TH, Clark J, Gupta R. Molecular factors governing perineural invasion in malignancy. Surg Oncol. 2022 Apr 14;42:101770. doi: 10.1016/j.suronc.2022.101770. Epub ahead of print. PMID: 35490532.

Attrill GH, Lee H, Tasker AT, Adegoke NA, Ferguson AL, da Silva IP, Saw RPM, Thompson JF, Palendira U, Long GV, Ferguson PM, Scolyer RA, Wilmott JS. Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome. Front Immunol. 2022 Aug 8;13:979993. doi: 10.3389/fimmu.2022.979993. eCollection 2022. PMID: 36003398

Attrill GH, Owen CN, Ahmed T, Vergara IA, Colebatch AJ, Conway JW, Nahar KJ, Thompson JF, Pires da Silva I, Carlino MS, Menzies AM, Lo S, Palendira U, Scolyer RA^, Long GV^, Wilmott JS^ (^ These authors contributed equally to this manuscript). Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy. J Immunother Cancer. 2022 Jun;10(6):e004771. doi: 10.1136/jitc-2022-004771. PMID: 35688560

Aung TN, Shafi S, Wilmott JS, Nourmohammadi S, Vathiotis I, Gavrielatou N, Fernandez A, Yaghoobi V, Sinnberg T, Amaral T, Ikenberg K, Khosrotehrani K, Osman I, Acs B, Bai Y, Martinez-Morilla S, Moutafi M, Thompson JF, Scolyer RA, Rimm DL. Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms. EBioMedicine. 2022 Aug;82:104143. doi: 10.1016/j.ebiom.2022.104143. Epub 2022 Jul 7. PMID: 35810563

Barnhill R, van Laere S, Vermeulen P, Roman-Roman S, Gardrat S, Alsafadi S, Tarin M, Champenois G, Nicolas A, Matet A, Cassoux N, Servois V, Rodrigues M, Scolyer R, Lazar A, Romano E, Piperno-Neumann S, Mariani P, Lugassy C. L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases. Lab Invest. 2022 Nov;102(11):1214-1224. doi: 10.1038/s41374-022-00803-w. Epub 2022 Jun 7. PMID: 35672380 & 36775447

Burton EM, Amaria RN, Cascone T, Chalabi M, Gross ND, Mittendorf EA, Scolyer RA, Sharma P, Ascierto PA. Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge-December 1st-2nd, 2021. J Transl Med. 2022 Jun 15;20(1):271. doi: 10.1186/s12967-022-03472-x. PMID: 35706041

Busam KJ, Judge MJ, Bichakjian CK, Coit D, Kutzner H, Requena L, Scolyer RA, Stefanato CM, Wood BA, Walsh NM. Dataset for the Reporting of Merkel Cell Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR). Am J Surg Pathol. 2022 Nov 1;46(11):1583-1591. doi: 10.1097/PAS.0000000000001959. Epub 2022 Aug 25. PMID: 36001458

Chetwood JD, Shin JS, Koorey D. Gastrointestinal: Esophageal nodularity in a 32-year-old female patient. Journal of Gastroenterology and Hepatology. First published: 20 March 2022 https://doi.org/10.1111/jgh.15807

Cheung VKY, Hulme K, Schifter M, Palme C, Low TH, Clark J, Gupta R. Oral Epithelial Dysplasia: A Review of Diagnostic Criteria for Anatomic Pathologists. Adv Anat Pathol. 2022 Jul 1;29(4):227-240.

Cho D, Lord S, Simes J, Cooper WA, Friedlander M, Bae S, Lee CK. Next Generation Sequencing, Should I Use anti-HER2 Therapy for HER2 Amplified Tumors Off-Label? Illustrating an Extrapolation Framework. Therapeutic Advances in Medical Oncology. 2022; 14: 17588359221112822.

Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh, N, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. Biomarker Signatures for Progressive Idiopathic Pulmonary Fibrosis. European Respiratory Journal 2022; 59: 2101181.

Cochran AJ, Wen DR, Huang RR, Abrishami P, Smart C, Binder S, Scolyer RA, Thompson JF, Stern S, Van Kreuningen L, Elashoff DE, Sim MS, Wang HJ, Faries MB; MSLT-I Study Group. Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Eur J Surg Oncol. 2022 Jun;48(6):1280-1287. doi: 10.1016/j.ejso.2022.01.021. Epub 2022 Feb 12. PMID: 35246348

Colebatch AJ*, Paver EC*, Vergara IA, Thompson JF, Long GV, Wilmott JS, Scolyer RA (*authors contributed equally to the work and are considered co-first authors). Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma. Pathology. 2022 Aug;54(5):533-540. doi: 10.1016/j.pathol.2021.12.289. Epub 2022 Mar 2. PMID: 35248370

Colebatch AJ, Adhikari C, Diefenbach RJ, Rawson RV, Ferguson PM, Rizos H, Long GV, McCarthy SW, Thompson JF, Wilmott JS, Scolyer RA. Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi. Am J Surg Pathol. 2022 Aug 1;46(8):1048-1059. doi: 10.1097/PAS.0000000000001902. Epub 2022 Apr 20. PMID: 35439782

Conway JW, Braden J, Wilmott JS, Scolyer RA†, Long GV†, Pires da Silva I†. (†These authors contributed equally to this work and share senior authorship). The effect of organ-specific tumor microenvironments on response patterns to immunotherapy. Front Immunol. 2022 Nov 17;13:1030147. doi: 10.3389/fimmu.2022.1030147. eCollection 2022. PMID: 36466910

Conway JW, Rawson RV, Lo S, Ahmed T, Vergara IA, Gide TN, Attrill GH, Carlino MS, Saw RPM, Thompson JF, Spillane AJ, Shannon KF, Shivalingam B, Menzies AM, Wilmott JS, Long GV^, Scolyer RA^, Pires da Silva I^ (^these authors contributed equally to this manuscript). Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites. J Immunother Cancer. 2022 Sep;10(9):e004884. doi: 10.1136/jitc-2022-004884. PMID: 36096531

Dennis C, Prince D, Moayed-Alaei L, Remash D, Bowen D, Strasser S, Crawford M, Pulitano C, Kench J, McCaughan GW, McKenzie C, Liu K. Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation. In press, Frontiers in Oncology, 2022.

Dhanji P, Chetwood JD, Shin JS, Tamilarasan AG. Metastatic Crohn's disease: treat-to-target approach and review of the literature. Journal of Gastroenterology and Hepatology 2022 Sep 1. Vol. 37:138-139.

Diefenbach RJ, Lee JH, Stewart A, Menzies AM, Carlino MS, Saw RPM, Stretch JR, Long GV, Scolyer RA, Rizos H. Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA. Front Oncol. 2022 Apr 12;12:820510. doi: 10.3389/fonc.2022.820510. eCollection 2022. PMID: 35494035

El Sharouni MA, Rawson RV, Sigurdsson V, Witkamp AJ, van Gils CH, Scolyer RA, Thompson JF*, van Diest PJ*, Lo SN*. (*Contributed equally). The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultra-thick melanomas (≥15mm in thickness). J Am Acad Dermatol. 2022 Aug;87(2):298-305. doi: 10.1016/j.jaad.2022.01.040. Epub 2022 Feb 1. PMID: 35121073

El Sharouni MA, Scolyer RA, van Gils CH, Ch'ng S, Nieweg OE, Pennington TE, Saw RP, Shannon K, Spillane A, Stretch J, Witkamp AJ, Sigurdsson V, Thompson JF, van Diest PJ*, Lo SN*. (*contributed equally). Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients. Eur J Cancer. 2022 May;167:133-141. doi: 10.1016/j.ejca.2021.12.036. Epub 2022 Feb 22. PMID: 335216870

Ferguson A, Sharman A, Allen R, Ye T, Lee JH, Low TH, Ch'ng S, Palme CE, Ashford B, Ranson M, Clark JR, Patrick E, Gupta R*, and Palendira U*. High-dimensional and spatial analysis reveals immune landscape dependent progression in cutaneous squamous cell carcinoma. Clin Cancer Res. 2022 Nov 1;28(21):4677-4688.

Fielder T, Butler J, Tierney G, Holmes M, Lam B, Satgunaseelan L, Colebatch A, Mahar A, Gupta R, O'Toole S, Cooper WA. ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1. Pathology. 2022; 54:399-403.

Fielder T, Watts F, Howden C, Gupta R, McKenzie C. Why Choose a Pathology Career? Arch Pathol Lab Med. 2022 Jul 1;146(7):903-910. doi: 10.5858/arpa.2021-0118-OA. PMID: 34637490.

Folmsbee J, Zhang L, Lu X, Rahman J, Gentry J, Conn B, Vered M, Roy P, Gupta R, Lin D, Samankan S, Dhorajiva P, Peter A, Wang M, Israel A, Brandwein-Weber M, Doyle S. Histology segmentation using active learning on regions of interest in oral cavity squamous cell carcinoma. J Pathol Inform. 2022 Sep 27;13:100146.

Gaetano L, Domenico B, Lo SN, Hamed T, Potter AJ, Thompson JF, Scolyer RA, Guitera P. Association between excision margins and local recurrence in 1407 patients with primary in situ melanomas. JAAD Int. 2022 Jun 16;8:102-108. doi: 10.1016/j.jdin.2022.06.001. eCollection 2022 Sep. PMID: 35875393

Ghosh YA, Gupta R, Al Maruf DA, Cheng K, Mukherjee P, Clark JR. "Surgical technique: A novel pedicled periosteal scapular flap to facilitate bone growth in an Ovine model". J Plast Reconstr Aesthet Surg. 2022 Apr;75(4):1497-1520. doi: 10.1016/j.bjps.2022.01.048. Epub 2022 Jan 31. PMID: 35140043.

Gu B, Liu K, McKenzie C, MacGregor D, Corte C. Gastrointestinal: Autoimmune enteropathy associated with thymoma. J Gastroenterol Hepatol. 2022 Apr;37(4):606. doi: 10.1111/jgh.15692. Epub 2021 Oct 10. PMID: 34632628.

Guitera P, Waddell A, Paton E, Fogarty GB, Hong A, Scolyer RA, Stretch JR, O'Donnell BA, Pellacani G. Re: Reply to letter to the editor re: 'A practical guide on the use of Imiquimod cream to treat Lentigo Maligna' (original PMID: 34529272). Australas J Dermatol. 2022 May;63(2):e198-e199. doi: 10.1111/ajd.13797. Epub 2022 Feb 2 PMID: 35107826.

Hanna S, Marinos E, Bryan D, Ahmed T, Lo SN, Carlino MS, Smith A, Cairns G, Shannon K, Long GV, Scolyer RA, Saw RPM. Effect of the SunSafe Training Program on the attitudes, knowledge, and behaviour of Australian high school students towards sun safety: a prospective study. Clin Exp Dermatol. 2022 Nov;47(11):1956-1967. doi: 10.1111/ced.15220. Epub 2022 Aug 24. PMID: 35434843

Heyneman S, Prosser N, Lee J, Mahar A, Anderson L, Kao SC, Cooper WA. Squamous Cell Carcinoma Differentiation at Progression as a Resistance Mechanism in Metastatic Non-Small Cell Lung carcinoma Harbouring a Targetable Mutation. Pathology 2022;54:935-938.

Ho G, Schwartz RJ, Regio Pereira A, Dimitrou F, Paver E, McKenzie C, Saw RPM, Scolyer RA, Long GV, Guitera P. Reflectance confocal microscopy - a non-invasive tool for monitoring systemic treatment response in stage III unresectable primary scalp melanoma. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e583-e585. doi: 10.1111/jdv.18076. Epub 2022 Mar 29. PMID: 35285090.

Hulme KR, Mahar A, Campbell RG, Clifton-Bligh R, Gill AJ, Palme CE, Gupta R. Phosphaturic Mesenchymal Tumors in the Head and Neck Demonstrate a Broad Clinical and Morphologic Spectrum. Head Neck Pathol. 2022 Feb 4. doi: 10.1007/s12105-022-01419-8. Epub ahead of print. PMID: 35119617.

Hurrell MJL, Heller GZ, Elliott MS, Gao K, Ebrahimi A, Clark JR, Shannon K, Palme CE, Wykes J, Gupta R, Ch'ng S, Nguyen KM, Low TH. Recursive Partitioning to Determine Order of Significance of Regional Metastasis Characteristics in Head and Neck Cutaneous Squamous Cell Carcinoma. Ann Surg Oncol. 2022 May 15. doi: 10.1245/s10434-022-11863-z. Epub ahead of print. PMID: 35569073.

Jain D, Nambirajan A, Chen G, Geisinger K et al for the IASLC Pathology Committee. NSCLC subtyping in conventional cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group survey to determine specific cytomorphological criteria for adenocarcinoma and squamous cell carcinoma. J Thorac Oncol. 2022; 17;6:793-805.

Jobson D, Roffey B, Arnold C, Azzi A, Button-Sloan A, Dawson T, Fernandez-Penas P, Fishburn P, Gyorki DE, Hiscutt EL, Jakrot V, Lilleyman A, Lochhead A, Long GV, Mailer S, Mann G, McCormack CJ, Muir J, Pratt GF, Scolyer RA, Shackelton M, Shumack S, Soyer HP, Tan CG, Webb A, Zalcberg J, Morton R, Mar V. Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (MelCOR): A modified Delphi study. Australas J Dermatol. 2022 Aug;63(3):344-351. doi: 10.1111/ajd.13848. Epub 2022 Apr 29. PMID: 35486539

Kynaston A, Liu K, Davis A, Kao S, McKenzie C. A case of steroid responsive nivolumab induced cholangitis. Pathology. 2022 Feb 10:S0031-3025(22)00031-9. doi: 10.1016/j.pathol.2021.11.009. Epub ahead of print. PMID: 35153072.

Lawless AK*, Coker DJ*, Lo SN, Ahmed T, Scolyer RA, Ch'ng S, Nieweg OE, Shannon K, Spillane A, Stretch JR, Thompson JF#, Saw RPM# (*These authors contributed equally to the work and are considered co-first authors. #These authors contributed equally to the work and are considered co-senior authors.) Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases. Ann Surg Oncol. 2022 Oct;29(11):7019-7028. doi: 10.1245/s10434-022-11997-0. Epub 2022 Jun 30. PMID: 35771368

Li AT, Miin Yip J, Choksi H, London K, Potter AJ, Lo SN, Saw RPM, Shannon KF, Pires da Silva I, Varey AHR, Menzies AM, Long GV, Shivalingam B, Scolyer RA, Thompson JF, Ch'ng S. Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread. Melanoma Res. 2022 Aug 1;32(4):260-268. doi: 10.1097/CMR.0000000000000827. Epub 2022 May 13. PMID: 35579680

Lô SN, Ma J, Manuguerra M, Moreno-Betancur M, Scolyer RA, Thompson JF. Competing risks analysis with missing cause-of-failure-penalized likelihood estimation of cause-specific Cox models. Stat Methods Med Res. 2022 May;31(5):978-994. doi: 10.1177/09622802211070254. Epub 2022 Jan 17. PMID: 35037794

Luke JJ, Rutkowski P, Queirolo P, Del Vecchio M, Mackiewicz J, Chiarion-Sileni V, de la Cruz Merino L, Khattak MA, Schadendorf D, Long GV, Ascierto PA, Mandala M, De Galitiis F, Haydon A, Dummer R, Grob JJ, Robert C, Carlino MS, Mohr P, Poklepovic A, Sondak VK, Scolyer RA, Kirkwood JM, Chen K, Diede SJ, Ahsan S, Ibrahim N, Eggermont AMM; KEYNOTE-716 Investigators.* (*A complete list of investigators who participated in the KEYNOTE-716 study is provided in Table 1 of the Supplementary Appendix, available at NEJM.org). Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial. Lancet. 2022 Apr 30;399(10336):1718-1729. doi: 10.1016/S0140-6736(22)00562-1. Epub 2022 Apr 1. PMID: 35367007

Luo L, Shen R, Arora A, Orlow I, Busam KJ, Lezcano C, Lee TK, Hernando E, Gorlov I, Amos C, Ernstoff MS, Seshan V, Cust AE, Wilmott J, Scolyer RA, Mann G, Nagore E, Funchain P, Ko J, Ngo P, Edmiston SN, Conway K, Googe PB, Ollila D, Lee JE, Fang S, Rees JR, Thompson CL, Gerstenblith M, Bosenberg M, Gould Rothberg B, Osman I, Saenger Y, Reynolds AZ, Schwartz M, Boyce T, Holmen S, Brunsgaard E, Bogner P, Kuan PF, Wiggins C, Thomas NE, Begg CB, Berwick M; For InterMEL. Landscape of Mutations in Early Stage Primary Cutaneous Melanoma - An InterMEL Study. Pigment Cell Melanoma Res. 2022 Nov;35(6):605-612. doi: 10.1111/pcmr.13058. Epub 2022 Aug 12. PMID: 35876628

Marsland M, Dowdell A, Jiang CC, Wilmott JS, Scolyer RA, Zhang XD, Hondermarck H#, Faulkner S.# (#contributed equally to the study). Expression of NGF/proNGF and Their Receptors TrkA, p75NTR and Sortilin in Melanoma. Int J Mol Sci. 2022 Apr 12;23(8):4260. doi: 10.3390/ijms23084260.. PMID: 35457078

McLean AEB, Kao SC, Barnes DJ, Wong KKH, Scolyer RA, Cooper WA*, Kohonen-Corish MRJ*. (*These authors contributed equally). The Emerging Role of the Lung Microbiome and its importance in Lung Cancer Diagnosis and Treatment. Lung Cancer. 2022 Jan 20;165:124-132. doi: 10.1016/j.lungcan.2022.01.011. Online ahead of print. PMID: 35123155 and PMID: 35279297 (Corrigendum)

Mino-Kenudson M, Schalper K, Cooper W, Dacic S, Hirsch F, Jain D, Lopez-Rios F, Tsao MS, Yatabe Y, Beasley MB, Yu H, Sholl LM, Brambilla E, Chou TY, Connolly C, Wistuba I, Kerr KM, Lantuejoul S, IASLC Pathology Committee. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective from the IASLC Pathology Committee. Journal of Thoracic Oncology. 2022; 17:1335-1354 https://doi.org/10.1016/j.jtho.2022.09.109

Moncrieff MD, Lo SN, Scolyer RA, Heaton MJ, Nobes JP, Snelling AP, Carr MJ, Nessim C, Wade R, Peach AH, Kisyova R, Mason J, Wilson ED, Nolan G, Jones RP, Sondak VK, Thompson JF, Zager JS. ASO Visual Abstract: Evaluation of Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International Multicenter Study. Ann Surg Oncol. 2022 May 25. doi: 10.1245/s10434-022-11822-8. Online ahead of print. PMID: 35612683

Moncrieff MD, Lo SN, Scolyer RA, Heaton MJ, Nobes JP, Snelling AP, Carr MJ, Nessim C, Wade R, Peach AH, Kisyova R, Mason J, Wilson ED, Nolan G, Pritchard Jones R, Johansson I, Olofsson Bagge R, Wright LJ, Patel NG, Sondak VK*, Thompson JF*, Zager JS* (*Joint senior authors with equal merit (alphabetical)). Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease. J Clin Oncol. 2022 Dec 1;40(34):3940-3951. doi: 10.1200/JCO.21.02488. Epub 2022 Jul 18. PMID: 35849790

Muir CA, Wood CCG, Clifton-Bligh RJ, Long GV, Scolyer RA, Carlino MS, Menzies AM*, Tsang VHM* (*contributed equally and are co-senior authors of this research article). Association of Antithyroid Antibodies in Checkpoint Inhibitor-Associated Thyroid Immune-Related Adverse Events. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e1843-e1849. doi: 10.1210/clinem/dgac059. PMID: 35104870 (nb: 14.5.2: this paper was one of the top 10 percent of articles published in the journal in 2020-2021, assessed by rate of citation)

Multicenter Selective Lymphadenectomy Trials Study Group, Crystal JS, Thompson JF, Hyngstrom J, Caracò C, Zager JS, Jahkola T, Bowles TL, Pennacchioli E, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, van Akkooi A, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Neves R, Rossi CR, Kane JM 3rd, Trocha S, Wright F, Byrd DR, Matter M, Hsueh EC, MacKenzie-Ross A, Kelley M, Terheyden P, Huston TL, Wayne JD, Neuman H, Smithers BM, Ariyan CE, Desai D, Gershenwald JE, Schneebaum S, Gesierich A, Jacobs LK, Lewis JM, McMasters KM, O'Donoghue C, van der Westhuizen A, Sardi A, Barth R, Barone R, McKinnon JG, Slingluff CL, Farma JM, Schultz E, Scheri RP, Vidal-Sicart S, Molina M, Testori AAE, Foshag LJ, Van Kreuningen L, Wang HJ, Sim MS, Scolyer RA, Elashoff DE, Cochran AJ, Faries MB. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial. JAMA Surg. 2022 Sep 1;157(9):835-842. doi: 10.1001/jamasurg.2022.2055. PMID: 35921122

Nahar KJ*, Marsh-Wakefield F*, Rawson RV, Gide TN, Ferguson AL, Allen RO, Quek C, Pires da Silva I, Tattersall S, Kiely CJ, Sandanayake N, Carlino MS, McCaughan G, Wilmott JS, Scolyer RA, Long GV, Menzies AM*, Palendira U* (* Equal contributions). Distinct pre-treatment innate immune landscape and post-treatment T cell responses underlie the development of combination therapy-induced colitis. JCI Insight. 2022 Nov 8;7(21):e157839. doi: 10.1172/jci.insight.157839. PMID: 36173679

Newell F#, Pires da Silva I#, Johansson PA#, Menzies AM#, Wilmott JS#, Addala V, Carlino MS, Rizos H, Nones K, Edwards JJ, Lakis V, Kazakoff SH, Mukhopadhyay P, Ferguson PM, Leonard C, Koufariotis LT, Wood S, Blank CU, Thompson JF, Spillane AJ, Saw RPM, Shannon KF, Pearson JV, Mann GJ, Hayward NK§, Scolyer RA§, Waddell N§, Long GV§. (#These authors contributed equally to this work. §These authors jointly supervised this work). Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance. Cancer Cell. 2022 Jan 10;40(1):88-102.e7. doi: 10.1016/j.ccell.2021.11.012. Epub 2021 Dec 23. PMID: 34951955

Newell F*, Johansson PA*, Wilmott JS, Nones K, Lakis V, Pritchard AL, Lo SN, Rawson RV, Kazakoff SH, Colebatch AJ, Koufariotis LT, Ferguson PM, Wood S, Leonard C, Law MH, Brooks KM, Broit N, Palmer JM, Couts KL, Vergara IA, Long GV, Barbour AP, Nieweg OE, Shivalingam B, Robinson WA, Stretch JR, Spillane AJ, Saw RPM, Shannon KF, Thompson JF, Mann GJ, Pearson JV, Scolyer RA#, Waddell N#, Hayward NK# (# These authors jointly supervised this work * These authors contributed equally). Comparative genomics provides etiological and biological insight into the melanoma subtypes. Cancer Discov. 2022 Dec 2;12(12):2856-2879. doi: 10.1158/2159-8290.CD-22-0603. PMID: 36098958

Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, Dacic S, Jain D, Kerr K, Lantuejoul S, Noguchi M, Papotti M, Rekhtman N, Scagliotti G, van Schil P, Sholl L, Yatabe Y, Yoshida A, Travis WD. The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015. Journal of Thoracic Oncology. 2022; 17:362-387.

Park JS, Ben-David M, McKenzie C, Sandroussi C. Cytomegalovirus adrenalitis mimicking adrenal metastasis in an immunocompetent patient. J Surg Case Rep. 2022 Mar 26;2022(3):rjac122. doi: 10.1093/jscr/rjac122. PMID: 35355581; PMCID: PMC8963155.

Parker A, Bowman E, Zingone A, Ryan BM, Cooper WA, Kohonen-Corish M, Harris CC, Cox TR. Extracellular matrix Profiles determine risk and prognosis of the Squamous Cell Carcinoma Subtype of Non-Small Cell Lung Carcinoma Extracellular matrix profiles determine squamous non-small cell lung cancer risk and prognosis. 2022. Genome Medicine. 2022; 14: 1-29.

Paver E, Aivazian K, Maclean F, Long GV, Spillane AJ, Wilmott JS, Scolyer RA. Utility of next generation sequencing for differentiating malignant PEComa from metastatic melanoma. Pathology. 2022 Oct 29:S0031-3025(22)00277-X. doi: 10.1016/j.pathol.2022.08.011. Online ahead of print. PMID: 36400594

Paver EC, Cooper WA, Colebatch AJ, Ferguson PM, Hill SK, Lum T, Shin JS, O'Toole S, Anderson L, Scolyer RA, Gupta R. Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation. Pathology. 2021 Feb;53(2):141-156

Pennington TE, Zhao CY, Colebatch AJ, Fernandez-Peñas P, Guitera P, Burke H, Scolyer RA, Menzies AM, Carlino MS, Lo S, Long GV, Saw RP. Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma. Australas J Dermatol. 2022 May;63(2):e133-e137. doi: 10.1111/ajd.13807. Epub 2022 Feb 21. PMID: 35188271

Pereira AR*, Corral-Forteza M*, Collgros H, El Sharouni MA, Ferguson PM, Scolyer RA, Guitera P (*contributed equally). Dermoscopic features and screening strategies for the detection of small-diameter melanomas. Clin Exp Dermatol. 2022 May;47(5):932-941. doi: 10.1111/ced.15094. Epub 2022 Feb 15. PMID: 34997617

Pires da Silva I#, Ahmed T#, McQuade JL, Nebhan CA, Park JJ, Versluis JM, Serra-Bellver P, Khan Y, Slattery T, Oberoi HK, Ugurel S, Haydu LE, Herbst R, Utikal J, Pföhler C, Terheyden P, Weichenthal M, Gutzmer R, Mohr P, Rai R, Smith JL, Scolyer RA, Arance AM, Pickering L, Larkin J, Lorigan P, Blank CU, Schadendorf D, Davies MA, Carlino MS, Johnson DB, Long GV§, Lo SN§, Menzies AM§ (# §These authors contributed equally). Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma. J Clin Oncol. 2022 Apr 1;40(10):1068-1080. doi: 10.1200/JCO.21.01701. Epub 2022 Feb 10. PMID: 35143285

Potter AJ, Colebatch AJ, Rawson RV, Ferguson PM, Cooper WA, Gupta R, O'Toole S, Saw RPM, Ch'ng S, Menzies AM, Long GV, Scolyer RA. Pathologist-initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centre. Pathology. 2022 Aug;54(5):526-532. doi: 10.1016/j.pathol.2021.12.290. Epub 2022 Mar 3. PMID: 35249747

Rawson RV, Shteinman ER, Ansar S, Vergara IA, Thompson JF, Long GV, Scolyer RA, Wilmott JS. Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics. Pathology. 2022 Dec;54(7):863-873. doi: 10.1016/j.pathol.2022.05.012. Epub 2022 Jul 31. PMID: 35987723

Reijers IL, Menzies AM, Van Akkooi AC, Versluis JM, Van Den Heuvel NM, Saw RP, Pennington TE, Kapiteijn E, Van Der Veldt AA, Suijkerbuijk KP, Hospers GA, et al. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial. Nature medicine. 2022 Jun;28(6):1178-88.

Reijers IL, Rawson RV, Colebatch AJ, Rozeman EA, Menzies AM, van Akkooi AC, Shannon KF, Wouters MW, Saw RP, van Houdt WJ, Zuur CL. Representativeness of the index lymph node for total nodal basin in pathologic response assessment after neoadjuvant checkpoint inhibitor therapy in patients with stage III melanoma. JAMA surgery. 2022 Apr 1;157(4):335-42.

Risbey C, Fielder T, Steffens D, Shin J-S, Solomon M. Patterns of DNA mismatch repair protein expression for primary and recurrent colorectal cancer at an advanced surgical unit: a retrospective audit. Colorectal Disease 2022; DOI: 10.1111/codi.16391

Satgunaseelan L, Porazinski S, Strbenac D, Istadi A, Willet C, Chew T, Sadsad R, Palme CE, Lee JH, Boyer M, Yang JYH, Clark JR, Pajic M, Gupta R. Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of EGFR Amplification: Implications for Novel Personalized Therapy. Front Oncol. 2021 Nov 29;11:750852.

Satgunaseelan L, Strbenac D, Cali Willet C, Chew T, Sadsad R, Wykes J, Low H, Cooper WA, Lee CS, Palme CE, Yang J, Clark JR Gupta R. Whole Genome Duplication in Oral Squamous Cell Carcinoma in Patients Younger Than 50 years: Implications for Prognosis and Adverse Clinicopathological Factors. Genes, Chromosomes and Cancer. 2022;61:561-571.

Satgunaseelan L, Strbenac D, Tadi S, Nguyen K, Wykes J, Palme CE, Low TH, Yang JYH, Clark JR, Gupta R. Viral Integration Plays a Minor Role in the Development and Prognostication of Oral Squamous Cell Carcinoma. Cancers (Basel). 2022 Oct 24;14(21):5213.

Satgunaseelan L, Strbenac D, Willet C, Chew T, Sadsad R, Wykes J, Low HTH, Cooper WA, Lee CS, Palme CE, Yang JYH, Clark JR, Gupta R. Whole Genome Duplication in Oral Squamous Cell Carcinoma in Patients Younger Than 50 years: Implications for Prognosis and Adverse Clinicopathological Factors. Genes Chromosomes Cancer. 2022 Sep;61(9):561-571.

Schwartz RJ, Ho G, Smith A, Collgros H, Regio Pereira A, Gouveia B, Long GV, Menzies AM, Potter AJ, Paver E, Star P, Scolyer RA, Martin LK.. Successful treatment of eruptive keratoacanthomas with actitretin for patients on checkpoint inhibitor immunotherapy. J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e445-e448. doi: 10.1111/jdv.17940. Epub 2022 Jan 28. PMID: 35043483

Scolyer RA, Atkinson V, Gyorki DE, Lambie D, O'Toole S, Saw RPM, Amanuel B, Angel CM, Button-Sloan AE, Carlino MS, Ch'ng S, Colebatch AJ, Daneshvar D, Pires da Silva I, Dawson T, Ferguson PM, Foster-Smith E, Fox SB, Gill AJ, Gupta R, Henderson MA, Hong AM, Howle JR, Jackett LA, James C, Lee CS, Lochhead A, Loh D, McArthur GA, McLean CA, Menzies AM, Nieweg OE, O'Brien BH, Pennington TE, Potter AJ, Prakash S, Rawson RV, Read RL, Rtshiladze MA, Shannon KF, Smithers BM, Spillane AJ, Stretch JR, Thompson JF, Tucker P, Varey AHR, Vilain RE, Wood BA, Long GV. BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: Practical guidance for the Australian setting. Pathology. 2022 Feb;54(1):6-19. doi: 10.1016/j.pathol.2021.11.002. Epub 2021 Dec 20. PMID: 34937664

Scolyer RA. Pathology: The Next Chapter. Editorial. Pathology. 2022 Feb;54(1):4-5. doi: 10.1016/j.pathol.2021.12.001. Epub 2022 Jan 10. PMID: 35022138

Semsarian CR, Ma T, Nickel B, Scolyer RA, Ferguson PM, Soyer HP, Parker L, Barratt A, Thompson JF, Bell KJL. Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? Br J Dermatol. 2022 Jan 10. doi: 10.1111/bjd.21010. Online ahead of print. PMID: 35007335

Semsarian CR, Ma T, Nickel B, Scolyer RA, Ferguson PM, Soyer HP, Parker L, Barratt A, Thompson JF, Bell KJL. Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? Br J Dermatol. 2022 Jun;186(6):1030-1032. doi: 10.1111/bjd.21010. Epub 2022 Apr 7. PMID: 35007335

Seviiri M, Scolyer RA, Bishop DT, Newton-Bishop JA, Iles MM, Lo SN, Stretch JR, Saw RPM, Nieweg OE, Shannon KF, Spillane AJ, Gordon SD, Olsen CM, Whiteman DC, Landi MT, Thompson JF, Long GV, MacGregor S, Law MH. Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting. J Transl Med. 2022 Sep 5;20(1):403. doi: 10.1186/s12967-022-03613-2. PMID: 36064556

Shklovskaya E, Pedersen B, Stewart A, Simpson JOG, Ming Z, Irvine M, Scolyer RA, Long GV, Rizos H. Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response Biomarkers.. Cancers (Basel). 2022 Oct 3;14(19):4830. doi: 10.3390/cancers14194830. PMID: 36230753

Shteinman ER, Wilmott JS, da Silva IP, Long GV*, Scolyer RA*, Vergara IA.* (*These authors contributed equally to this work). Causes, consequences and clinical significance of aneuploidy across melanoma subtypes. Front Oncol. 2022 Oct 6;12:988691. doi: 10.3389/fonc.2022.988691. eCollection 2022. PMID: 36276131

Simpson RC*, Shanahan ER*, Batten M*, Reijers ILM*, Read M#, Silva IP#, Versluis JM#, Ribeiro R, Angelatos AS, Tan J, Adhikari C, Menzies AM, Saw RPM, Gonzalez M, Shannon KF, Spillane AJ, Velickovic R, Lazar AJ, Damania AV, Mishra AK, Chelvanambi M, Banerjee A, Ajami NJ, Wargo JA, Macia L, Holmes AJ, Wilmott JS, Blank CU, Scolyer RA, Long GV (*#these authors have contributed equally). Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and gut microbiome. Nat Med. 2022 Nov;28(11):2344-2352. doi: 10.1038/s41591-022-01965-2. Epub 2022 Sep 22. PMID: 36138151

Smith AL, Watts CG, Henderson M, Long GV, Rapport F, Saw RPM, Scolyer RA, Spillane AJ, Thompson JF, Cust AE. Factors influencing acceptance, adoption and adherence to sentinel node biopsy recommendations in the Australian Melanoma Management Guidelines: a qualitative study using an implementation science framework. Implement Sci Commun. 2022 Oct 1;3(1):103. doi: 10.1186/s43058-022-00351-w. PMID: 36183121

Star P, Jackett LA, Cheung K, Wilmott JS, Ho G, Smith A, Long GV, Scolyer RA, Martin LK. Multiple eruptive squamoproliferative lesions during anti-PD1 immunotherapy for metastatic melanoma: pathogenesis, immunohistochemical analysis and treatment. Dermatol Ther. 2022 Jun;35(6):e15472. doi: 10.1111/dth.15472. Epub 2022 Apr 5. PMID: 35347815

Thomson A, Denis M, Totaro R, Cooper W, Dennis M. Fulminant Delta COVID-19 myocarditis: a fatal case of primary cardiac dysfunction. Eur Heart J Case Rep. 2022 Apr 13;6(4):ytac142. doi: 10.1093/ehjcr/ytac142

van Akkooi ACJ*, Hieken TJ*, Burton EM*, Ariyan C, Ascierto PA, Asero SVMA, Blank CU, Block MS, Boland GM, Caraco C, Chng S, Davidson BS, Duprat Neto JP, Faries MB, Gershenwald JE, Grunhagen DJ, Gyorki DE, Han D, Hayes AJ, van Houdt WJ, Karakousis GC, Klop WMC, Long GV, Lowe MC, Menzies AM, Bagge RO, Pennington TE, Rutkowski P, Saw RPM, Scolyer RA, Shannon KF, Sondak VK, Tawbi H, Testori AAE, Tetzlaff MT, Thompson JF, Zager JS, Zuur CL, Wargo JA, Spillane AJ#, Ross MI#, International Neoadjuvant Melanoma Consortium (INMC) (*shared first authorship, #Shared Senior Authorship). Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC). Ann Surg Oncol. 2022 Jun;29(6):3694-3708. doi: 10.1245/s10434-021-11236-y. Epub 2022 Jan 28. PMID: 35089452 & 35426590 (correction).

Varey AHR, Williams GJ, Lo SN, Taing CY, Maurichi A, Santinami M, Scolyer RA, Thompson JF. Clinical Management of Melanocytic Tumours of Uncertain Malignant Potential (MelTUMPs), including Melanocytomas: A Systematic Review and Meta-Analysis. J Eur Acad Dermatol Venereol. 2022 Oct 17. doi: 10.1111/jdv.18665. Online ahead of print. PMID: 36251355

Walsh SLF, Mackintosh, JA, Calandriello L, Silva M, Sverzellati N, Larici AR, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Deep learning-based outcome prediction in progressive fibrotic lung disease using high-resolution computed tomography. American Journal of Respiratory and Critical Care Medicine. 2022 Jun 13. doi: 10.1164/rccm.202112-2684OC. Online ahead of print

Wang KYX*, Pupo GM*, Tembe V*, Patrick E, Strbenac D, Schramm SJ, Thompson JF, Scolyer RA, Muller S, Tarr G, Mann GJ*, Yang JYH* (*equal contribution). Cross-Platform Omics Prediction procedure: a statistical machine learning framework for wider implementation of precision medicine. NPJ Digit Med. 2022 Jul 4;5(1):85. doi: 10.1038/s41746-022-00618-5. PMID: 35788693

Wang M†, Zadeh S†, Pizzolla A, Thia K, Gyorki DE, McArthur GA, Scolyer RA, Long G, Wilmott JS, Andrews MC, Au-Yeung G, Weppler A, Sandhu S, Trapani JA, Davis MJ, Neeson PJ (†contributed equally). Characterization of the treatment-naive immune microenvironment in melanoma with BRAF mutation. J Immunother Cancer. 2022 Apr;10(4):e004095. doi: 10.1136/jitc-2021-004095. PMID: 35383113

Watts C; Spillane A; Henderson MA; Cust, A; Braithwaite J; Gyorki DE; Hong AM; Kelly JW; Long GV; Mar VJ; Menzies AM; Morton, RL; Rapport, F; Saw RPM; Schmid H; Scolyer RA; Smith, AL; Winder A; Mann, GJ. Sentinel lymph node biopsy rates in Victoria, 2018 and 2019. Med J Aust 14 Mar 2022 doi: 10.5694/mja2.51424. PMID: TBC

Weiss JM, Hunter MV, Cruz NM, Baggiolini A, Tagore M, Ma Y, Misale S, Marasco M, Simon-Vermot T, Campbell NR, Newell F, Wilmott JS, Johansson PA, Thompson JF, Long GV, Pearson JV, Mann GJ, Scolyer RA, Waddell N, Montal ED, Huang TH, Jonsson P, Donoghue MTA, Harris CC, Taylor BS, Xu T, Chaligné R, Shliaha PV, Hendrickson R, Jungbluth AA, Lezcano C, Koche R, Studer L, Ariyan CE, Solit DB, Wolchok JD, Merghoub T, Rosen N, Hayward NK, White RM. Anatomic position determines oncogenic specificity in melanoma. Nature. 2022 Apr;604(7905):354-361. doi: 10.1038/s41586-022-04584-6. Epub 2022 Mar 30. PMID: 35355015

Wilson A, Goltsman D, Nankervis J, Clark J, Gupta R, Ashford B. Defining the incidence of cutaneous squamous cell carcinoma in coastal NSW Australia. Australas J Dermatol. 2022 May;63(2):213-216. doi: 10.1111/ajd.13830. Epub 2022 Apr 9. PMID: 35397123.

Woodford R, Zhou D, Lord SJ, Marschner I, Cooper WA, Lewis CR, John T, Yang JCH, Lee CK. PD-L1 expression as a prognostic biomarker for patients treated with chemotherapy for metastatic non-small cell lung cancer. Future Oncology. 2022; 18:14.

Yabe TE, King K, Russell S, Satgunaseelan L, Gupta R, Chen J, Ashford B. MYH9 mutation and squamous cell cancer of the tongue in a young adult: a novel case report. Diagn Pathol. 2022 Feb 6;17(1):23.

Yaseen Z, Gide TN, Conway JW, Potter AJ, Quek C, Hong AM, Long GV, Scolyer RA, Wilmott JS. Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-profiling Melanoma. Front Mol Biosci. 2022 May 19;9:810858. doi: 10.3389/fmolb.2022.810858. PMID: 35664673

Yu SL, Hsiao YJ, Cooper WA (equal 1st author),, Choi YL, Avilés-Salas A, Chou TY, Coudry R, Raskin GA, Fox SB, Huang CC, Jeon YK, Ko YH, Ku WH, Kwon GY, Leslie C, Lin MC, Lou PJ, Scapulatempo-Neto C, Mendoza Ramírez S, Savelov N, Shim HS, Lara Torres CO, Cunha IW, Zavalishina L, Chen YM. The Ring study: an international comparison of PD-L1 diagnostic assays and their interpretation in NSCLC, HNSCC and UC. Pathology. Available online 1 Oct 2022. https://doi.org/10.1016/j.pathol.2022.07.016

Yung AE, Crouch G, Varey AHR, Lo S, Elliott MS, Lee J, Rawson R, Gupta R, Hong AM, Clark JR, Ch'ng S. Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck. Ann Surg Oncol. 2022 Apr 13. doi: 10.1245/s10434-022-11669-z. Epub ahead of print. PMID: 35419758.

2021

Ackermann DM, Smit AK, Janda M, van Kemenade CH, Dieng M, Morton RL, Turner RM, Cust AE, Irwig L, Hersch JK, Guitera P, Soyer HP, Mar V, Saw RPM, Low D, Low C, Drabarek D, Espinoza D, Emery J, Murchie P, Thompson JF, Scolyer RA, Azzi A, Lilleyman A, Bell KJL. Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trialTrials. 2021 May 4;22(1):324. doi: 10.1186/s13063-021-05231-7.
Aggarwal C, Bubendorf L, Cooper WA, Illei P, Borralho Nunes P, Ong BH, Tsao MS, Yatabe Y, Kerr KM. Molecular testing in stage I-III non-small cell lung cancer: Approaches and challengesLung Cancer. 2021 Dec;162:42-53. doi: 10.1016/j.lungcan.2021.09.003. Epub 2021 Sep 15.
Aivazian K, Ahmed T, El Sharouni MA, Stretch JR, Saw RPM, Spillane AJ, Shannon KF, Ch'ng S, Nieweg OE, Thompson JF, Lo SN, Scolyer RA. Histological regression in melanoma: impact on sentinel lymph node status and survivalMod Pathol. 2021 Nov;34(11):1999-2008. doi: 10.1038/s41379-021-00870-2. Epub 2021 Jul 10.
Aivazian K, Mahar A, Jackett LA, Kimble RM, Scolyer RA. GLI activated epithelioid cell tumour: report of a case and proposed new terminologyPathology. 2021 Feb;53(2):267-270. doi: 10.1016/j.pathol.2020.07.013. Epub 2020 Oct 6.
Anderson MA, Ying T, Wyburn K, Ferguson PM, Strach MC, Grimison P, Chadban S, Gracey DM. Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case reportBMC Urol. 2021 Jun 7;21(1):87. doi: 10.1186/s12894-021-00855-y.
Attrill GH, Ferguson PM, Palendira U, Long GV, Wilmott JS, Scolyer RA. The tumour immune landscape and its implications in cutaneous melanomaPigment Cell Melanoma Res. 2021 May;34(3):529-549. doi: 10.1111/pcmr.12926. Epub 2020 Oct 1.
Benton S, Zhao J, Zhang B, Bahrami A, Barnhill RL, Busam K, Cerroni L, Cook MG, de la Fouchardière A, Elder DE, Johansson I, Landman G, Lazar A, LeBoit P, Lowe L, Massi D, Duncan LM, Messina J, Mihic-Probst D, Mihm MC Jr, Piepkorn MW, Schmidt B, Scolyer RA, Shea CR, Tetzlaff MT, Tron VA, Xu X, Yeh I, Yun SJ, Zembowicz A, Gerami P. Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid NeoplasmsAm J Surg Pathol. 2021 Dec 1;45(12):1597-1605. doi: 10.1097/PAS.0000000000001753.
Butler LM, Mah CY, Machiels J, Vincent AD, Irani S, Mutuku SM, Spotbeen X, Bagadi M, Waltregny D, Moldovan M, Dehairs J, Vanderhoydonc F, Bloch K, Das R, Stahl J, Kench JG, Gevaert T, Derua R, Waelkens E, Nassar ZD, Selth LA, Trim PJ, Snel MF, Lynn DJ, Tilley WD, Horvath LG, Centenera MM, Swinnen JV. Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid CompositionCancer Res. 2021 Oct 1;81(19):4981-4993. doi: 10.1158/0008-5472.CAN-20-3863. Epub 2021 Aug 6.
Chiam K, Carle C, Hughes S, Kench JG, Woo HH, Lord S, Smith DP. Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different biopsy scenariosProstate Cancer Prostatic Dis. 2021 Sep;24(3):662-673. doi: 10.1038/s41391-021-00320-9. Epub 2021 Mar 2.
Ch'ng S, Scolyer RA, Thompson JF. ASO Author Reflections: Surgical Resection May Improve the Outcome for Patients with Residual Metastatic Melanoma When Modern Systemic Therapies Have Not Achieved Complete Disease ControlAnn Surg Oncol. 2021 Oct;28(11):6124-6125. doi: 10.1245/s10434-021-10514-z. Epub 2021 Aug 9.
Ch'ng S, Uyulmaz S, Carlino MS, Pennington TE, Shannon KF, Rtshiladze M, Stretch JR, Nieweg OE, Varey AHR, Hsiao E, Kapoor R, Pires da Silva I, Lo SN, Spillane AJ, Scolyer RA, Long GV, Hong AM, Saw RPM, Thompson JF, Menzies AM. Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapiesEur J Cancer. 2021 Aug;153:8-15. doi: 10.1016/j.ejca.2021.04.037. Epub 2021 Jun 12.
Collgros H, Rodriguez-Lomba E, Regio Pereira A, Lo SN, Scolyer RA, Guitera P. Lentiginous melanoma (lentigo maligna and lentigo maligna melanoma) in Australia: clinicopathological characteristics, management and recurrence rates after 10-year follow-up at a tertiary centreJ Eur Acad Dermatol Venereol. 2021 Jun;35(6):1315-1322. doi: 10.1111/jdv.17135. Epub 2021 Mar 3.
Combes A, March B, Waugh R, Watson G, Eisinger D. Epithelioid sarcoma of the penis: A penile sparing approach, and long-term implicationsUrol Case Rep. 2021 Aug 12;39:101808. doi: 10.1016/j.eucr.2021.101808. eCollection 2021 Nov.
Cooper WA, Lantuejoul S, Mino-Kenudson M. Predicting Response to Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Blockade in NSCLC-Is Multiplex Immunohistochemistry or Immunofluorescence the Answer?J Thorac Oncol. 2021 Aug;16(8):1247-1249. doi: 10.1016/j.jtho.2021.06.007.
Cooper WA, Mahar A, Myers JL, Grainge C, Corte TJ, Williamson JP, Lau EMT, Raghu G, Troy LK. In ReplyArch Pathol Lab Med. 2021 Nov 1;145(11):1326-1327. doi: 10.5858/arpa.2021-0305-LE.
Cooper WA, Mahar A, Myers JL, Grainge C, Corte TJ, Williamson JP, Vallely MP, Lai S, Mulyadi E, Torzillo PJ, Phillips MJ, Lau EMT, Raghu G, Troy LK. Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features. Further Lessons from COLDICE, a Prospective Multicenter Clinical TrialAm J Respir Crit Care Med. 2021 May 15;203(10):1306-1313. doi: 10.1164/rccm.202009-3688OC.
Cree IA, Tan PH, Travis WD, Wesseling P, Yagi Y, White VA, Lokuhetty D, Scolyer RA. Counting mitoses: SI(ze) matters!Mod Pathol. 2021 Sep;34(9):1651-1657. doi: 10.1038/s41379-021-00825-7. Epub 2021 Jun 2.
Crouch G, Sinha S, Lo S, Saw RPM, Lee KK, Stretch J, Shannon K, Guitera P, Scolyer RA, Thompson JF, Ch'ng S. Clinical outcomes following surgical treatment of lentigo maligna of the head and neckEur J Surg Oncol. 2021 May;47(5):1145-1151. doi: 10.1016/j.ejso.2020.09.028. Epub 2020 Sep 23.
Däster S, Shin JS, Loizides S, Steffens D, Koh CE, Solomon MJ. Pathology reporting of pelvic exenteration specimens for locally recurrent rectal cancerEur J Surg Oncol. 2021 Aug;47(8):2100-2107. doi: 10.1016/j.ejso.2021.03.258. Epub 2021 Apr 17.
Davis AP, Cooper WA, Boyer M, Lee JH, Pavlakis N, Kao SC. Efficacy of immunotherapy in KRAS-mutant non-small-cell lung cancer with comutationsImmunotherapy. 2021 Aug;13(11):941-952. doi: 10.2217/imt-2021-0090. Epub 2021 Jun 11.
Delahunt B, Egevad L, Samaratunga H, Srigley JR, Cheng L, Clouston D, Furusato B, Kench J, Leite KRM, MacLennan GT, Moch H, Pan CC, Ro J, Tsuzuki T, van der Kwast T, Wheeler T, Yaxley JW. Intraductal carcinoma of the prostate is not a diagnostic entityHistopathology. 2021 Jan;78(2):342-344. doi: 10.1111/his.14260. Epub 2020 Dec 4.
Delahunt B, Neill B, Burnett JR, Scolyer RA. Publication metrics: it really is all about the numbersPathology. 2021 Jun;53(4):561-563. doi: 10.1016/j.pathol.2021.03.001. Epub 2021 Apr 23.
Dessinioti C, Geller AC, Stergiopoulou A, Dimou N, Lo S, Keim U, Gershenwald JE, Haydu LE, Dummer R, Mangana J, Hauschild A, Egberts F, Vieira R, Brinca A, Zalaudek I, Deinlein T, Evangelou E, Thompson JF, Scolyer RA, Peris K, Garbe C, Stratigos AJ. A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differencesBr J Dermatol. 2021 Jul;185(1):101-109. doi: 10.1111/bjd.19819. Epub 2021 Apr 1.
Dessinioti C, Geller AC, Whiteman DC, Garbe C, Grob JJ, Kelly JW, Scolyer RA, Rawson RV, Lallas A, Pellacani G, Stratigos AJ. Not all melanomas are created equal: a review and call for more research into nodular melanomaBr J Dermatol. 2021 Oct;185(4):700-710. doi: 10.1111/bjd.20388. Epub 2021 Jul 14.
Ebrahimi A, Luk PP, Low H, McDowell L, Magarey MJR, Smith PN, Perriman DM, Veness M, Gupta R, Clark JR. A critical analysis of the 8th edition TNM staging for head and neck cutaneous squamous cell carcinoma with lymph node metastases and comparison to N1S3 stage and ITEM risk score: A multicenter studyJ Surg Oncol. 2021 Jun;123(7):1531-1539. doi: 10.1002/jso.26410. Epub 2021 Mar 15.
Egevad L, Delahunt B, Bostwick DG, Cheng L, Evans AJ, Gianduzzo T, Graefen M, Hugosson J, Kench JG, Leite KRM, Oxley J, Sauter G, Srigley JR, Stattin P, Tsuzuki T, Yaxley J, Samaratunga H. Prostate cancer grading, time to go back to the futureBJU Int. 2021 Feb;127(2):165-168. doi: 10.1111/bju.15298. Epub 2020 Nov 27.
El Sharouni MA, Ahmed T, Varey AHR, Elias SG, Witkamp AJ, Sigurdsson V, Suijkerbuijk KPM, van Diest PJ, Scolyer RA, van Gils CH, Thompson JF, Blokx WAM, Lo SN. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) MelanomasJ Clin Oncol. 2021 Apr 10;39(11):1243-1252. doi: 10.1200/JCO.20.02446. Epub 2021 Feb 18.
El Sharouni MA, Ahmed T, Witkamp AJ, Sigurdsson V, van Gils CH, Nieweg OE, Scolyer RA, Thompson JF, van Diest PJ, Lo SN. Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based dataBr J Surg. 2021 May 27;108(5):550-553. doi: 10.1002/bjs.11946.
El Sharouni MA, Aivazian K, Witkamp AJ, Sigurdsson V, van Gils CH, Scolyer RA, Thompson JF, van Diest PJ, Lo SN. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous MelanomaJAMA Dermatol. 2021 Feb 1;157(2):166-173. doi: 10.1001/jamadermatol.2020.5032.
El Sharouni MA, Stodell MD, Ahmed T, Suijkerbuijk KPM, Cust AE, Witkamp AJ, Sigurdsson V, van Diest PJ, Scolyer RA, Thompson JF, van Gils CH, Lo SN. Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumorAnn Oncol. 2021 Mar;32(3):375-383. doi: 10.1016/j.annonc.2020.11.015. Epub 2020 Nov 28.
El Sharouni MA, Varey AHR, Witkamp AJ, Ahmed T, Sigurdsson V, van Diest PJ, Scolyer RA, Thompson JF, Lo SN, van Gils CH. Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohortBr J Dermatol. 2021 Aug;185(2):412-418. doi: 10.1111/bjd.19895. Epub 2021 May 9.
Eviston TJ, Minaei E, Mueller SA, Ahmadi N, Ashford B, Clark JR, West N, Zhang P, Gupta R, Ranson M. Gene expression profiling of perineural invasion in head and neck cutaneous squamous cell carcinomaSci Rep. 2021 Jun 23;11(1):13192. doi: 10.1038/s41598-021-92335-4.
Ferguson PM, Kench JG, Watson GF. Intranuclear inclusions are a distinguishing morphological feature of renal cell carcinoma with leiomyomatous stromaPathology. 2021 Jun;53(4):543-545. doi: 10.1016/j.pathol.2020.08.026. Epub 2020 Dec 4.
Fielder T, Butler J, Tierney G, Holmes M, Lam KY, Satgunaseelan L, Colebatch AJ, Mahar A, Gupta R, O'Toole S, Cooper WA. ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1Pathology. 2021 Oct 23:S0031-3025(21)00477-3. doi: 10.1016/j.pathol.2021.07.012. Online ahead of print.
Fielder T, Watts F, Howden C, Gupta R, McKenzie C. Why Choose a Pathology Career?Arch Pathol Lab Med. 2021 Oct 12. doi: 10.5858/arpa.2021-0118-OA. Online ahead of print.
Flora A, Gibson M, Toon C, Rawson R, Lowe P. Primary cutaneous CD8+ aggressive epidermotropic T-cell lymphoma mimicking pyoderma gangrenosumIndian J Dermatol Venereol Leprol. 2021 Jan-Feb;88(1):90-92. doi: 10.25259/IJDVL_296_2021.
Friedman EB, Scolyer RA, Williams GJ, Thompson JF. Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin RecommendationsAdv Ther. 2021 Jul;38(7):3506-3530. doi: 10.1007/s12325-021-01783-x. Epub 2021 May 28.
Gallagher SJ, Bailey T, Rawson RV, Mahar AM, Thompson JF, Long GV, Wilmott JS, Scolyer RA. Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysisPathology. 2021 Dec;53(7):830-835. doi: 10.1016/j.pathol.2021.02.012. Epub 2021 Jun 2.
Garg M, Couturier DL, Nsengimana J, Fonseca NA, Wongchenko M, Yan Y, Lauss M, Jönsson GB, Newton-Bishop J, Parkinson C, Middleton MR, Bishop DT, McDonald S, Stefanos N, Tadross J, Vergara IA, Lo S, Newell F, Wilmott JS, Thompson JF, Long GV, Scolyer RA, Corrie P, Adams DJ, Brazma A, Rabbie R. Tumour gene expression signature in primary melanoma predicts long-term outcomesNat Commun. 2021 Feb 18;12(1):1137. doi: 10.1038/s41467-021-21207-2.
Georgevsky D, Li Y, Pather S, Tejada-Berges T, Robinson D, Laurence J, Campbell N, Wyburn K, Liyanagama K, Narayan R, Lutz T, Chan A, Heaney SA, Kitzing YX, Anderson L, Testa G, Johannesson L, Marren A. Uterus transplantation and pregnancy induction: Approved protocol at the Royal Prince Alfred HospitalAust N Z J Obstet Gynaecol. 2021 Aug;61(4):621-624. doi: 10.1111/ajo.13364. Epub 2021 May 6.
Gherardin NA, Waldeck K, Caneborg A, Martelotto LG, Balachander S, Zethoven M, Petrone PM, Pattison A, Wilmott JS, Quiñones-Parra SM, Rossello F, Posner A, Wong A, Weppler AM, Shannon KF, Hong A, Ferguson PM, Jakrot V, Raleigh J, Hatzimihalis A, Neeson PJ, Deleso P, Johnston M, Chua M, Becker JC, Sandhu S, McArthur GA, Gill AJ, Scolyer RA, Hicks RJ, Godfrey DI, Tothill RW. γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient SurvivalCancer Immunol Res. 2021 Jun;9(6):612-623. doi: 10.1158/2326-6066.CIR-20-0817. Epub 2021 Mar 5.
Ghosh YA, Gupta R, Clark JR. Recreating Human Eyelid Anatomy in a Modified Ovine ModelOphthalmic Plast Reconstr Surg. 2021 Nov-Dec 01;37(6):602-603. doi: 10.1097/IOP.0000000000002054.
Giblin W, Bringman-Rodenbarger L, Guo AH, Kumar S, Monovich AC, Mostafa AM, Skinner ME, Azar M, Mady AS, Chung CH, Kadambi N, Melong KA, Lee HJ, Zhang L, Sajjakulnukit P, Trefely S, Varner EL, Iyer S, Wang M, Wilmott JS, Soyer HP, Sturm RA, Pritchard AL, Andea AA, Scolyer RA, Stark MS, Scott DA, Fullen DR, Bosenberg MW, Chandrasekaran S, Nikolovska-Coleska Z, Verhaegen ME, Snyder NW, Rivera MN, Osterman AL, Lyssiotis CA, Lombard DB. The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamicsJ Clin Invest. 2021 Jun 15;131(12):e138926. doi: 10.1172/JCI138926.
Gibson M, Scolyer RA, Soyer HP, Ferguson P, McGeechan K, Irwig L, Bell KJL. Estimating the potential impact of interventions to reduce over-calling and under-calling of melanomaJ Eur Acad Dermatol Venereol. 2021 Jul;35(7):1519-1527. doi: 10.1111/jdv.17189. Epub 2021 Apr 4.
Gide TN, Pires da Silva I, Quek C, Ferguson PM, Batten M, Shang P, Ahmed T, Menzies AM, Carlino MS, Saw RPM, Thompson JF, Scolyer RA, Long GV, Wilmott JS. Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/- Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic TargetsCancers (Basel). 2021 Jun 25;13(13):3186. doi: 10.3390/cancers13133186.
Gu B, Liu K, McKenzie C, MacGregor D, Corte C. Gastrointestinal: Autoimmune enteropathy associated with thymomaJ Gastroenterol Hepatol. 2022 Apr;37(4):606. doi: 10.1111/jgh.15692. Epub 2021 Oct 10.
Guitera P, Waddell A, Paton E, Fogarty GB, Hong A, Scolyer RA, Stretch JR, O'Donnell BA, Pellacani G. A practical guide on the use of imiquimod cream to treat lentigo malignaAustralas J Dermatol. 2021 Nov;62(4):478-485. doi: 10.1111/ajd.13720. Epub 2021 Sep 16.
Güvenç C, Antoranz A, Szumera-Cie?kiewicz A, Teterycz PP, Rutkowski PR, Rawson RV, Scolyer RA, Thompson JF, Newton-Bishop J, Stas M, Boecxstaens V, Bechter O, Vercauteren J, Garmyn M, van den Oord J, Bosisio FM. Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick MelanomasInt J Mol Sci. 2021 Sep 29;22(19):10568. doi: 10.3390/ijms221910568.
Haas L, Elewaut A, Gerard CL, Umkehrer C, Leiendecker L, Pedersen M, Krecioch I, Hoffmann D, Novatchkova M, Kuttke M, Neumann T, da Silva IP, Witthock H, Cuendet MA, Carotta S, Harrington KJ, Zuber J, Scolyer RA, Long GV, Wilmott JS, Michielin O, Vanharanta S, Wiesner T, Obenauf AC. Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanomaNat Cancer. 2021 Jul;2(7):693-708. doi: 10.1038/s43018-021-00221-9. Epub 2021 Jul 15.
Haefliger S, Guitera P, Melhoranse Gouveia B, Colebatch AJ, Scolyer RA, Rtshiladze M, Martin LK. Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in childrenPediatr Dermatol. 2021 Nov;38(6):1549-1552. doi: 10.1111/pde.14846. Epub 2021 Nov 4.
Henderson JM, Xiang MSW, Huang JC, Wetzel S, Jiang L, Lai JH, Wu W, Kench JG, Bachovchin WW, Roediger B, McCaughan GW, Zhang HE, Gorrell MD. Dipeptidyl Peptidase Inhibition Enhances CD8 T Cell Recruitment and Activates Intrahepatic Inflammasome in a Murine Model of Hepatocellular CarcinomaCancers (Basel). 2021 Nov 1;13(21):5495. doi: 10.3390/cancers13215495.
Holmes M, Mahar A, Lum T, Kao S, Cooper WA. Real-world programmed death-ligand 1 prevalence rates in non-small cell lung cancer: correlation with clinicopathological features and tumour mutation statusJ Clin Pathol. 2021 Feb;74(2):123-128. doi: 10.1136/jclinpath-2020-206709. Epub 2020 Jun 23.
Hughes TM, Williams GJ, Gyorki DE, Kelly JW, Stretch JR, Varey AHR, Hong AM, Scolyer RA, Thompson JF. Desmoplastic melanoma: a review of its pathology and clinical behaviour, and of management recommendations in published guidelinesJ Eur Acad Dermatol Venereol. 2021 Jun;35(6):1290-1298. doi: 10.1111/jdv.17154. Epub 2021 Mar 3.
Hulme KR, Mahar A, Cao C, McCaughan B, Cooper WA. Micronodular thymoma with lymphoid stroma: a clinicopathological study of five casesPathology. 2021 Dec;53(7):930-933. doi: 10.1016/j.pathol.2021.01.016. Epub 2021 May 1.
Hulme KR, Robbins E, Crawford M, Mahar A, McKenzie CA. Giant porta hepatis schwannoma: a rare cause of a cystic hepatic neoplasmPathology. 2022 Feb;54(1):140-143. doi: 10.1016/j.pathol.2021.03.008. Epub 2021 Jun 30.
Jackett LA, Satgunaseelan L, Roper E, Lo SN, Thompson JF, Scolyer RA. Residual melanoma in wide local excision specimens after 'complete' excision of primary cutaneous in situ and invasive melanomasPathology. 2022 Feb;54(1):71-78. doi: 10.1016/j.pathol.2021.05.094. Epub 2021 Aug 13.
Ke H, Gill AJ, McKenzie C, Kench JG, Chan RCF, Pavlakis N, Fulham M, Koh C, Kao S. Malignant Peritoneal Mesothelioma With EWSR1-ATF1 Fusion: A Case ReportJTO Clin Res Rep. 2021 Oct 11;2(11):100236. doi: 10.1016/j.jtocrr.2021.100236. eCollection 2021 Nov.
Kelly GM, Al-Ejeh F, McCuaig R, Casciello F, Ahmad Kamal N, Ferguson B, Pritchard AL, Ali S, Silva IP, Wilmott JS, Long GV, Scolyer RA, Rao S, Hayward NK, Gannon F, Lee JS. G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in MelanomaClin Cancer Res. 2021 May 1;27(9):2624-2635. doi: 10.1158/1078-0432.CCR-20-3463. Epub 2021 Feb 15.
Krishnamurthy S, Gilot D, Ahn SB, Lam V, Shin JS, Guillemin GJ, Heng B. Involvement of Kynurenine Pathway in Hepatocellular CarcinomaCancers (Basel). 2021 Oct 15;13(20):5180. doi: 10.3390/cancers13205180.
Larkin M, Hicks H, Palmieri D, Binks M, Anderson L. Malignant sex cord tumour of the ovary in Peutz-Jeghers syndromeANZ J Surg. 2021 Nov;91(11):2542-2544. doi: 10.1111/ans.16865. Epub 2021 Apr 12.
Lau NS, Ly M, Jacques A, Ewenson K, Mestrovic N, Almoflihi A, Koutalistras N, Liu K, Kench J, McCaughan G, Crawford M, Pulitano C. Prolonged Ex Vivo Normothermic Perfusion of a Split Liver: An Innovative Approach to Increase the Number of Available GraftsTransplant Direct. 2021 Sep 7;7(10):e763. doi: 10.1097/TXD.0000000000001216. eCollection 2021 Oct.
Lee H, Da Silva IP, Palendira U, Scolyer RA, Long GV, Wilmott JS. Targeting NK Cells to Enhance Melanoma Response to ImmunotherapiesCancers (Basel). 2021 Mar 17;13(6):1363. doi: 10.3390/cancers13061363.
Li AT, Vakharia K, Lo SN, Varey AHR, Carlino MS, Saw RPM, Shannon KF, Howle JR, Pennington TE, Stretch JR, Nieweg OE, Spillane AJ, Long GV, Menzies AM, Scolyer RA, Thompson JF, Ch'ng S. Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for MelanomaAnn Surg Oncol. 2021 Oct;28(11):6109-6123. doi: 10.1245/s10434-021-10489-x. Epub 2021 Aug 4.
Liu D, Sharbeen G, Phillips P; Australian Pancreatic Cancer Genome Initiative, Ford CE. ROR1 and ROR2 expression in pancreatic cancerBMC Cancer. 2021 Nov 11;21(1):1199. doi: 10.1186/s12885-021-08952-9.
Liu J, Itchins M, Nagrial A, Cooper WA, De Silva M, Barnet M, Varikatt W, Sivasubramaniam V, Davis A, Gill AJ, Blinman P, Lee K, Hui R, Gao B, Pavlakis N, Clarke S, Lee J, Boyer M, Kao S. Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitorsLung Cancer. 2021 May;155:28-33. doi: 10.1016/j.lungcan.2021.03.004. Epub 2021 Mar 9.
Liyanage UE, MacGregor S, Bishop DT, Shi J, An J, Ong JS, Han X, Scolyer RA, Martin NG, Medland SE, Byrne EM, Green AC, Saw RPM, Thompson JF, Stretch J, Spillane A, Jiang Y, Tian C; 23andMe Research Team, Gordon SG, Duffy DL, Olsen CM, Whiteman DC, Long GV, Iles MM, Landi MT, Law MH. Multi-Trait Genetic Analysis Identifies Autoimmune Loci Associated with Cutaneous MelanomaJ Invest Dermatol. 2022 Jun;142(6):1607-1616. doi: 10.1016/j.jid.2021.08.449. Epub 2021 Nov 20.
Luk PP, Ebrahimi A, Veness MJ, McDowell L, Magarey M, Gao K, Palme CE, Clark JR, Gupta R. Prognostic value of the 8th edition American Joint Commission Cancer nodal staging system for patients with head and neck cutaneous squamous cell carcinoma: A multi-institutional studyHead Neck. 2021 Feb;43(2):558-567. doi: 10.1002/hed.26512. Epub 2020 Oct 29.
Maharaj AD, Evans SM, Ioannou LJ, Croagh D, Earnest A, Holland JF, Pilgrim CHC, Neale RE, Goldstein D, Kench JG, Merrett ND, White K, Burmeister EA, Evans PM, Hayes TM, Houli N, Knowles B, Leong T, Nikfarjam M, Philip J, Quinn M, Shapiro J, Smith MD, Spillane JB, Wong R, Zalcberg JR. The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancerHPB (Oxford). 2021 Nov 16:S1365-182X(21)01700-7. doi: 10.1016/j.hpb.2021.11.005. Online ahead of print.
Maharaj AD, Evans SM, Zalcberg JR, Ioannou LJ, Graco M, Croagh D, Pilgrim CHC, Dodson T, Goldstein D, Philip J, Kench JG, Merrett ND, Neale RE, White K, Evans P, Leong T, Green SE. Barriers and enablers to the implementation of multidisciplinary team meetings: a qualitative study using the theoretical domains frameworkBMJ Qual Saf. 2021 Oct;30(10):792-803. doi: 10.1136/bmjqs-2020-011793. Epub 2020 Nov 27.
Majewska H, Gorczy?ski A, Czapiewski P, Menon R, Mueller J, Lakis S, Heuckmann JM, Laco J, Gupta R, Andreasen S, Stodulski D, Iliszko M, Dziadziuszko R, Jassem J, Heukamp LC, Biernat W. ALK alterations in salivary gland carcinomasVirchows Arch. 2021 May;478(5):933-941. doi: 10.1007/s00428-020-02971-w. Epub 2020 Nov 25.
Mangantig E, MacGregor S, Iles MM, Scolyer RA, Cust AE, Hayward NK, Montgomery GW, Duffy DL, Thompson JF, Henders A, Bowdler L, Rowe C, Cadby G, Mann GJ, Whiteman DC, Long GV, Ward SV, Khosrotehrani K, Barrett JH, Law MH. Germline variants are associated with increased primary melanoma tumor thickness at diagnosisHum Mol Genet. 2021 Jan 6;29(21):3578-3587. doi: 10.1093/hmg/ddaa222.
McCarthy RE, Bowen DG, Strasser SI, McKenzie C. The dangers of herbal weight loss supplements: a case report of drug-induced liver injury secondary to Garcinia cambogia ingestionPathology. 2021 Jun;53(4):545-547. doi: 10.1016/j.pathol.2020.08.021. Epub 2020 Nov 27.
Menzies AM, Amaria RN, Rozeman EA, Huang AC, Tetzlaff MT, van de Wiel BA, Lo S, Tarhini AA, Burton EM, Pennington TE, Saw RPM, Xu X, Karakousis GC, Ascierto PA, Spillane AJ, van Akkooi ACJ, Davies MA, Mitchell TC, Tawbi HA, Scolyer RA, Wargo JA, Blank CU, Long GV. Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)Nat Med. 2021 Feb;27(2):301-309. doi: 10.1038/s41591-020-01188-3. Epub 2021 Feb 8.
Menzies AM, Scolyer RA, Long GV. Neoadjuvant Immunotherapy in Melanoma - The New FrontierClin Cancer Res. 2021 Aug 1;27(15):4133-4135. doi: 10.1158/1078-0432.CCR-21-1236. Epub 2021 Jun 3.
Mino-Kenudson M, Le Stang N, Daigneault JB, Nicholson AG, Cooper WA, Roden AC, Moreira AL, Thunnissen E, Papotti M, Pelosi G, Motoi N, Poleri C, Brambilla E, Redman M, Jain D, Dacic S, Yatabe Y, Tsao MS, Lopez-Rios F, Botling J, Chen G, Chou TY, Hirsch FR, Beasley MB, Borczuk A, Bubendorf L, Chung JH, Hwang D, Lin D, Longshore J, Noguchi M, Rekhtman N, Sholl L, Travis W, Yoshida A, Wynes MW, Wistuba II, Kerr KM, Lantuejoul S. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLCJ Thorac Oncol. 2021 Apr;16(4):686-696. doi: 10.1016/j.jtho.2020.12.026. Epub 2021 Mar 2.
Mooney CP, Clark JR, Shannon K, Palme CE, Ebrahimi A, Gao K, Ch'ng S, Elliott M, Gupta R, Low TH. The significance of regional metastasis location in head and neck cutaneous squamous cell carcinomaHead Neck. 2021 Sep;43(9):2705-2711. doi: 10.1002/hed.26744. Epub 2021 May 21.
Mooney CP, Gao K, Clark JR, Gupta R, Shannon K, Palme CE, Ebrahimi A, Ch'ng S, Low TH. Soft Tissue Metastases in Head and Neck Cutaneous Squamous Cell CarcinomaLaryngoscope. 2021 Apr;131(4):E1209-E1213. doi: 10.1002/lary.29064. Epub 2020 Sep 14.
Muir CA, Clifton-Bligh RJ, Long GV, Scolyer RA, Lo SN, Carlino MS, Tsang VHM, Menzies AM. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor TreatmentJ Clin Endocrinol Metab. 2021 Aug 18;106(9):e3704-e3713. doi: 10.1210/clinem/dgab263.
Mukherjee P, Chung J, Cheng K, Gupta R, Haag H, Williams Z, Wallace G. Invitro and Invivo Study of PCL-Hydrogel Scaffold to Advance Bioprinting Translation in Microtia ReconstructionJ Craniofac Surg. 2021 Jul-Aug 01;32(5):1931-1936. doi: 10.1097/SCS.0000000000007173.
Newell F, Pires da Silva I, Johansson PA, Menzies AM, Wilmott JS, Addala V, Carlino MS, Rizos H, Nones K, Edwards JJ, Lakis V, Kazakoff SH, Mukhopadhyay P, Ferguson PM, Leonard C, Koufariotis LT, Wood S, Blank CU, Thompson JF, Spillane AJ, Saw RPM, Shannon KF, Pearson JV, Mann GJ, Hayward NK, Scolyer RA, Waddell N, Long GV. Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordanceCancer Cell. 2022 Jan 10;40(1):88-102.e7. doi: 10.1016/j.ccell.2021.11.012. Epub 2021 Dec 23.
Oh LJ, Asher R, Veness M, Smee R, Goldstein D, Gopalakrishna Iyer N, Balasubramanian D, Low TH, Palme CE, Gupta R, Clark J. Effect of age and gender in non-smokers with oral squamous cell carcinoma: Multi-institutional studyOral Oncol. 2021 May;116:105210. doi: 10.1016/j.oraloncology.2021.105210. Epub 2021 Feb 19.
Oh LJ, Satgunaseelan L, Asher R, Veness M, Smee R, Goldstein D, Gopalakrishna Iyer N, Balasubramanian D, Low H, Palme CE, Gupta R, Clark JR. Young age is not a predictor of disease specific survival in oral cancer: A multi-institutional studyOral Oncol. 2021 Apr;115:105162. doi: 10.1016/j.oraloncology.2020.105162. Epub 2021 Feb 3.
Pang JB, Castles B, Byrne DJ, Button P, Hendry S, Lakhani SR, Sivasubramaniam V, Cooper WA, Armes J, Millar EKA, Raymond W, Roberts-Thomson S, Kumar B, Burr M, Selinger C, Harvey K, Chan C, Beith J, Clouston D, O'Toole SA, Fox SB; kConFab. SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3Am J Surg Pathol. 2021 Aug 1;45(8):1108-1117. doi: 10.1097/PAS.0000000000001701.
Parakh S, Musafer A, Paessler S, Witkowski T, Suen CSNLW, Tutuka CSA, Carlino MS, Menzies AM, Scolyer RA, Cebon J, Dobrovic A, Long GV, Klein O, Behren A. PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic MelanomaFront Immunol. 2021 Jun 9;12:672521. doi: 10.3389/fimmu.2021.672521. eCollection 2021.
Park JJ, Diefenbach RJ, Byrne N, Long GV, Scolyer RA, Gray ES, Carlino MS, Rizos H. Circulating Tumor DNA Reflects Uveal Melanoma Responses to Protein Kinase C InhibitionCancers (Basel). 2021 Apr 6;13(7):1740. doi: 10.3390/cancers13071740.
Paver E, O'Toole S, Cheng XM, Mahar A, Cooper WA. Updates in the molecular pathology of non-small cell lung cancerSemin Diagn Pathol. 2021 Sep;38(5):54-61. doi: 10.1053/j.semdp.2021.04.001. Epub 2021 Apr 25.
Paver EC, Cooper WA, Colebatch AJ, Ferguson PM, Hill SK, Lum T, Shin JS, O'Toole S, Anderson L, Scolyer RA, Gupta R. Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretationPathology. 2021 Feb;53(2):141-156. doi: 10.1016/j.pathol.2020.10.007. Epub 2020 Dec 30.
Peri A, Greenstein E, Alon M, Pai JA, Dingjan T, Reich-Zeliger S, Barnea E, Barbolin C, Levy R, Arnedo-Pac C, Kalaora S, Dassa B, Feldmesser E, Shang P, Greenberg P, Levin Y, Benedek G, Levesque MP, Adams DJ, Lotem M, Wilmott JS, Scolyer RA, Jönsson GB, Admon A, Rosenberg SA, Cohen CJ, Niv MY, Lopez-Bigas N, Satpathy AT, Friedman N, Samuels Y. Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaJ Clin Invest. 2021 Oct 15;131(20):e129466. doi: 10.1172/JCI129466.
Pham TT, Liney G, Wong K, Henderson C, Rai R, Graham PL, Borok N, Truong MX, Lee M, Shin JS, Hudson M, Barton MB. Multi-parametric magnetic resonance imaging assessment of whole tumour heterogeneity for chemoradiotherapy response prediction in rectal cancerPhys Imaging Radiat Oncol. 2021 Apr 13;18:26-33. doi: 10.1016/j.phro.2021.03.003. eCollection 2021 Apr.
Potter AJ, Dimitriou F, Karim RZ, Mahar A, Chan C, Long GV, Scolyer RA. Cutaneous clear cell sarcoma with an epidermal component mimicking melanomaPathology. 2022 Apr;54(3):369-371. doi: 10.1016/j.pathol.2021.05.097. Epub 2021 Aug 19.
Quek C, Bai X, Long GV, Scolyer RA, Wilmott JS. High-Dimensional Single-Cell Transcriptomics in Melanoma and Cancer ImmunotherapyGenes (Basel). 2021 Oct 16;12(10):1629. doi: 10.3390/genes12101629.
Rabbie R, Ferguson P, Wong K, Couturier DL, Moran U, Turner C, Emanuel P, Haas K, Saunus JM, Davidson MR, Lakhani SR, Shivalingam B, Long GV, Parkinson C, Osman I, Scolyer RA, Corrie P, Adams DJ. The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrenceBr J Cancer. 2021 Jan;124(1):156-160. doi: 10.1038/s41416-020-01090-2. Epub 2020 Oct 7.
Ramanayake N, Vargas AC, Talbot J, Bonar F, Wong DD, Wong D, Mahar A, Karim R, Luk PP, Selinger C, Sioson L, Gill AJ, Maclean F. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian populationPathology. 2021 Oct;53(6):705-712. doi: 10.1016/j.pathol.2020.11.007. Epub 2021 Feb 25.
Rawson RV, Adhikari C, Bierman C, Lo SN, Shklovskaya E, Rozeman EA, Menzies AM, van Akkooi ACJ, Shannon KF, Gonzalez M, Guminski AD, Tetzlaff MT, Stretch JR, Eriksson H, van Thienen JV, Wouters MW, Haanen JBAG, Klop WMC, Zuur CL, van Houdt WJ, Nieweg OE, Ch'ng S, Rizos H, Saw RPM, Spillane AJ, Wilmott JS, Blank CU, Long GV, van de Wiel BA, Scolyer RA. Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanomaAnn Oncol. 2021 Jun;32(6):766-777. doi: 10.1016/j.annonc.2021.03.006. Epub 2021 Mar 17.
Rawson RV, Wilmott JS, Scolyer RA. Mucosal Melanoma: A Review Emphasizing the Molecular Landscape and Implications for Diagnosis and ManagementSurg Pathol Clin. 2021 Jun;14(2):293-307. doi: 10.1016/j.path.2021.01.005. Epub 2021 Apr 28.
Remash D, Prince DS, McKenzie C, Strasser SI, Kao S, Liu K. Immune checkpoint inhibitor-related hepatotoxicity: A reviewWorld J Gastroenterol. 2021 Aug 28;27(32):5376-5391. doi: 10.3748/wjg.v27.i32.5376.
Robertson SJ, Orme L, Teixeira R, Shamassi M, Newell F, Patch AM, Yeh I, Gard G, Wilmott J, Jackett L, LeBoit P, Fellowes A, MacArthur G, Fox S, Hayward NK, Bastian B, Scolyer R, Waddell N, Penington A, Shackleton M. Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz NeviJAMA Dermatol. 2021 Jul 1;157(7):836-841. doi: 10.1001/jamadermatol.2021.0025.
Rocha LKFL, Vilain RE, Scolyer RA, Lo SN, Drummond M, Star P, Fogarty GB, Hong AM, Guitera P. Confocal microscopy, dermoscopy, and histopathology features of atypical intraepidermal melanocytic proliferations associated with evolution to melanoma in situInt J Dermatol. 2022 Feb;61(2):167-174. doi: 10.1111/ijd.15815. Epub 2021 Aug 5.
Rowan DJ, Allende DS, Bellizzi AM, Gill RM, Liu X, McKenzie CA, Moreira RK, Mounajjed T, Said S, Westerhoff M, Jenkins SM, Batts KP, Burgart LJ, Lamps LW, Graham RP. Diagnostic challenges of focal nodular hyperplasia: interobserver variability, accuracy, and the utility of glutamine synthetase immunohistochemistryHistopathology. 2021 Nov;79(5):791-800. doi: 10.1111/his.14424. Epub 2021 Aug 6.
Rozeman EA, Hoefsmit EP, Reijers ILM, Saw RPM, Versluis JM, Krijgsman O, Dimitriadis P, Sikorska K, van de Wiel BA, Eriksson H, Gonzalez M, Torres Acosta A, Grijpink-Ongering LG, Shannon K, Haanen JBAG, Stretch J, Ch'ng S, Nieweg OE, Mallo HA, Adriaansz S, Kerkhoven RM, Cornelissen S, Broeks A, Klop WMC, Zuur CL, van Houdt WJ, Peeper DS, Spillane AJ, van Akkooi ACJ, Scolyer RA, Schumacher TNM, Menzies AM, Long GV, Blank CU. Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanomaNat Med. 2021 Feb;27(2):256-263. doi: 10.1038/s41591-020-01211-7. Epub 2021 Feb 8.
Satgunaseelan L, Porazinski S, Strbenac D, Istadi A, Willet C, Chew T, Sadsad R, Palme CE, Lee JH, Boyer M, Yang JYH, Clark JR, Pajic M, Gupta R. Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of EGFR Amplification: Implications for Novel Personalized TherapyFront Oncol. 2021 Nov 29;11:750852. doi: 10.3389/fonc.2021.750852. eCollection 2021.
Scheinberg T, Lomax A, Tattersall M, Thomas D, McCowage G, Sullivan M, Karim R, Luk PP, Mahar A, Bonar F, Bhadri VA. PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcomaCancer Rep (Hoboken). 2021 Apr;4(2):e1327. doi: 10.1002/cnr2.1327. Epub 2020 Dec 13.
Scolyer RA, Atkinson V, Gyorki DE, Lambie D, O'Toole S, Saw RPM, Amanuel B, Angel CM, Button-Sloan AE, Carlino MS, Ch'ng S, Colebatch AJ, Daneshvar D, Pires da Silva I, Dawson T, Ferguson PM, Foster-Smith E, Fox SB, Gill AJ, Gupta R, Henderson MA, Hong AM, Howle JR, Jackett LA, James C, Lee CS, Lochhead A, Loh D, McArthur GA, McLean CA, Menzies AM, Nieweg OE, O'Brien BH, Pennington TE, Potter AJ, Prakash S, Rawson RV, Read RL, Rtshiladze MA, Shannon KF, Smithers BM, Spillane AJ, Stretch JR, Thompson JF, Tucker P, Varey AHR, Vilain RE, Wood BA, Long GV. BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian settingPathology. 2022 Feb;54(1):6-19. doi: 10.1016/j.pathol.2021.11.002. Epub 2021 Dec 20.
Scolyer RA, El Sharouni MA, Thompson JF. Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently Applied-ReplyJAMA Dermatol. 2021 Aug 1;157(8):1006-1007. doi: 10.1001/jamadermatol.2021.1497.
Simpson RC, Shanahan E, Scolyer RA, Long GV. Targeting the Microbiome to Overcome ResistanceCancer Cell. 2021 Feb 8;39(2):151-153. doi: 10.1016/j.ccell.2021.01.016.
Singh J, Thachil T, Eapen MS, Lim A, Sufyan W, Rawson R, Duncan H, De Ieso P, Sohal SS. Immunohistochemical investigation of cytokine expression levels as biomarkers in transrectal ultrasound-guided needle biopsy specimens of prostate adenocarcinomaMol Clin Oncol. 2021 Sep;15(3):191. doi: 10.3892/mco.2021.2353. Epub 2021 Jul 16.
Smithers FAE, Haymerle G, Palme CE, Low TH, Froggatt C, Gupta R, Clark JR. A prospective study of intraoperative assessment of mucosal squamous cell carcinoma margins in the head and neckHead Neck. 2021 Feb;43(2):590-600. doi: 10.1002/hed.26517. Epub 2020 Oct 23.
Star P, Rawson RV, Drummond M, Lo S, Scolyer RA, Guitera P. Lentigo maligna: defining margins and predictors of recurrence utilizing clinical, dermoscopic, confocal microscopy and histopathology featuresJ Eur Acad Dermatol Venereol. 2021 Sep;35(9):1811-1820. doi: 10.1111/jdv.17349. Epub 2021 Jun 17.
Than NN, Chin S, Kench JG, McCaughan G, Majumdar A. Steroid-refractory T-cell mediated rejection after human metapneumovirus infection in a liver transplant recipientPathology. 2021 Oct;53(6):793-794. doi: 10.1016/j.pathol.2020.11.008. Epub 2021 Mar 6.
Verbeke C, Webster F, Brosens L, Campbell F, Del Chiaro M, Esposito I, Feakins RM, Fukushima N, Gill AJ, Kakar S, Kench JG, Krasinskas AM, van Laethem JL, Schaeffer DF, Washington K. Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the International Collaboration on Cancer Reporting (ICCR)Histopathology. 2021 Dec;79(6):902-912. doi: 10.1111/his.14540. Epub 2021 Sep 22.
Vergara IA, Mintoff CP, Sandhu S, McIntosh L, Young RJ, Wong SQ, Colebatch A, Cameron DL, Kwon JL, Wolfe R, Peng A, Ellul J, Dou X, Fedele C, Boyle S, Arnau GM, Raleigh J, Hatzimihalis A, Szeto P, Mooi J, Widmer DS, Cheng PF, Amann V, Dummer R, Hayward N, Wilmott J, Scolyer RA, Cho RJ, Bowtell D, Thorne H, Alsop K, Cordner S, Woodford N, Leditschke J, O'Brien P, Dawson SJ, McArthur GA, Mann GJ, Levesque MP, Papenfuss AT, Shackleton M. Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doublingNat Commun. 2021 Mar 4;12(1):1434. doi: 10.1038/s41467-021-21576-8.
Vergara IA, Wilmott JS, Long GV, Scolyer RA. Genetic drivers of non-cutaneous melanomas: Challenges and opportunities in a heterogeneous landscapeExp Dermatol. 2022 Jan;31(1):13-30. doi: 10.1111/exd.14287. Epub 2021 Feb 1.
Versluis JM, Reijers ILM, Rozeman EA, Menzies AM, van Akkooi ACJ, Wouters MW, Ch'ng S, Saw RPM, Scolyer RA, van de Wiel BA, Schilling B, Long GV, Blank CU. Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanomaEur J Cancer. 2021 May;148:51-57. doi: 10.1016/j.ejca.2021.02.012. Epub 2021 Mar 15.
Watts CG, McLoughlin K, Goumas C, van Kemenade CH, Aitken JF, Soyer HP, Fernandez Peñas P, Guitera P, Scolyer RA, Morton RL, Menzies SW, Caruana M, Kang YJ, Mann GJ, Chakera AH, Madronio CM, Armstrong BK, Thompson JF, Cust AE. Association Between Melanoma Detected During Routine Skin Checks and MortalityJAMA Dermatol. 2021 Dec 1;157(12):1425-1436. doi: 10.1001/jamadermatol.2021.3884.
Watts F, Palme CE, Porceddu S, Sundaresan P, Clark JR, Gupta R. Clinician perspectives on the factors influencing prognostic stratification by the American Joint Commission on Cancer Head and Neck Cutaneous Squamous Cell Carcinoma StagingSurgery. 2021 Nov;170(5):1467-1473. doi: 10.1016/j.surg.2021.04.019. Epub 2021 Jun 12.
Williams MD, DeLellis RA, Erickson LA, Gupta R, Johnson SJ, Kameyama K, Natu S, Ng T, Perren A, Perrier ND, Seethala RR, Gill AJ. Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer ReportingHum Pathol. 2021 Apr;110:73-82. doi: 10.1016/j.humpath.2020.07.008. Epub 2020 Jul 17.
Wong A, Rawson RV, Templeton DJ. Herpes simplex virus-2 (HSV-2) pseudotumour as the initial presentation of human immunodeficiency virus infectionIntern Med J. 2021 Jun;51(6):1001-1002. doi: 10.1111/imj.15364.
Wu SZ, Roden DL, Al-Eryani G, Bartonicek N, Harvey K, Cazet AS, Chan CL, Junankar S, Hui MN, Millar EA, Beretov J, Horvath L, Joshua AM, Stricker P, Wilmott JS, Quek C, Long GV, Scolyer RA, Yeung BZ, Segara D, Mak C, Warrier S, Powell JE, O'Toole S, Lim E, Swarbrick A. Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysisGenome Med. 2021 May 10;13(1):81. doi: 10.1186/s13073-021-00885-z.
Xie H, Morton R, Balendran J, Philp S, Saidi S, Farrell R, Anderson L, Pather S. The impact of primary human papillomavirus screening on negative loop excision histology following biopsy-proven high-grade cervical intra-epithelial lesions: A review from a large tertiary colposcopy unitAust N Z J Obstet Gynaecol. 2021 Dec;61(6):941-948. doi: 10.1111/ajo.13426. Epub 2021 Sep 10.
Yung AE, Que MS, Lo S, Aggarwal S, Hong AM, Tin MM, Clark JR, Gupta R, Ch'ng S. Validation of the American Joint Committee on Cancer Staging in Squamous Cell Carcinoma of the Vermilion LipAnn Surg Oncol. 2021 Jun;28(6):3092-3099. doi: 10.1245/s10434-020-09431-4. Epub 2021 Jan 2.

2020

Ahmadzada T, Cooper WA, Holmes M, Mahar A, Westman H, Gill AJ, Nordman I, Yip PY, Pal A, Zielinski R, Pavlakis N, Nagrial A, Daneshvar D, Brungs D, Karikios D, Aleksova V, Burn J, Asher R, Grau GE, Hosseini-Beheshti E, Reid G, Clarke S, Kao S. Retrospective evaluation of the use of pembrolizumab in malignant mesothelioma in a real-world Australian population. JTO Clinical and Research Reports, 2020 epub 16 July.

Aivazian K, Mahar A, Jackett LA, Kimble RM, Scolyer RA. GLI activated epithelioid cell tumour: report of a case and proposed new terminology. Pathology. 2020 Oct 5:S0031-3025(20)30921-1. doi: 10.1016/j.pathol.2020.07.013. Epub ahead of print. PMID: 33032812.

Ansar S, Tran K, Pinner J, Majumdar A, McKenzie C. A rare cause of ductopenia: adult onset Alagille syndrome. Pathology. 2020 Aug;52(5):610-612. doi: 10.1016/j.pathol.2020.04.015. Epub 2020 Jul 2. PMID: 32622471.

Attrill GH, Ferguson PM, Palendira U, Long GV, Wilmott JS, Scolyer RA. The tumour immune landscape and its implications in cutaneous melanoma. Pigment Cell Melanoma Res. 2020 Sep 16. doi: 10.1111/pcmr.12926. Epub ahead of print. PMID: 32939993.

Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Li Y, Kelso S; MC3 Working Group; PCAWG novel somatic mutation calling methods working group, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L; PCAWG Consortium. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nat Commun. 2020 Sep 21;11(1):4748. doi: 10.1038/s41467-020-18151-y. Erratum in: Nat Commun. 2020 Nov 30;11(1):6232. PMID: 32958763; PMCID: PMC7505971.

Baker LA, Holliday H, Roden D, Krisp C, Wu SZ, Junankar S, Serandour AA, Mohammed H, Nair R, Sankaranarayanan G, Law AMK, McFarland A, Simpson PT, Lakhani S, Dodson E, Selinger C, Anderson L, Samimi G, Hacker NF, Lim E, Ormandy CJ, Naylor MJ, Simpson K, Nikolic I, O'Toole S, Kaplan W, Cowley MJ, Carroll JS, Molloy M, Swarbrick A. Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer. Breast Cancer Res. 2020 Jun 11;22(1):63. doi: 10.1186/s13058-020-01306-6. PMID: 32527287; PMCID: PMC7291584.

Barbour AP, Samra JS, Haghighi KS, Donoghoe MW, Burge M, Harris MT, Chua YJ, Mitchell J, O'Rourke N, Chan H, Gebski VJ, Gananadha S, Croagh DG, Kench JG, Goldstein D; Australasian Gastro-Intestinal Trials Group (AGITG) GAP investigators. The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer. Ann Surg Oncol. 2020 Jul;27(7):2506-2515. doi: 10.1245/s10434-020-08205-2. Epub 2020 Jan 29. PMID: 31997125.

Barnhill R, van Dam PJ, Vermeulen P, Champenois G, Nicolas A, Rawson RV, Wilmott JS, Thompson JF, Long GV, Cassoux N, Roman-Roman S, Busam KJ, Scolyer RA, Lazar AJ, Lugassy C. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value. J Pathol Clin Res. 2020 Jul;6(3):195-206. doi: 10.1002/cjp2.161. Epub 2020 Apr 18. PMID: 32304183; PMCID: PMC7339161.

Braun M, Aguilera AR, Sundarrajan A, Corvino D, Stannard K, Krumeich S, Das I, Lima LG, Meza Guzman LG, Li K, Li R, Salim N, Jorge MV, Ham S, Kelly G, Vari F, Lepletier A, Raghavendra A, Pearson S, Madore J, Jacquelin S, Effern M, Quine B, Koufariotis LT, Casey M, Nakamura K, Seo EY, Hölzel M, Geyer M, Kristiansen G, Taheri T, Ahern E, Hughes BGM, Wilmott JS, Long GV, Scolyer RA, Batstone MD, Landsberg J, Dietrich D, Pop OT, Flatz L, Dougall WC, Veillette A, Nicholson SE, Möller A, Johnston RJ, Martinet L, Smyth MJ, Bald T. CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells. Immunity. 2020 Oct 13;53(4):805-823.e15. doi: 10.1016/j.immuni.2020.09.010. PMID: 33053330.

Cantor DI, Cheruku HR, Westacott J, Shin JS, Mohamedali A, Ahn SB. Proteomic investigations into resistance in colorectal cancer. Expert Rev Proteomics. 2020 Jan;17(1):49-65. doi: 10.1080/14789450.2020.1713103. Epub 2020 Jan 17. PMID: 31914823.

Chetwood JD, Mudaliar S, Staudenmann D, Shin JS, Liu K, Majumdar A, Kaffes A, Strasser S, McCaughan GW, Saxena P. Emerging role of endoscopic ultrasound- guided liver biopsy. Gut. 2020 Sep 18:gutjnl-2020-322704. doi: 10.1136/gutjnl-2020-322704. Epub ahead of print. PMID: 32948619.

Clynick B, Jo HE, Corte TJ, Glaspole IN, Grainge C, Hopkins PMA, Reynolds PN, Chapman S, Walters EH, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, Baltic S, Ryan M, Tan DBA, Moodley YP. Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosis. Eur Respir J. 2020 Sep 10;56(3):1902058. doi: 10.1183/13993003.02058-2019. PMID: 32381494.

Cohen PA, Leung Y, Anderson L, van der Griend R, Chivers P, Bilic S, Bittinger S, Brand A, Bulsara MK, Codde J, Eva L, Farrell L, Harker D, Herbst U, Jeffares S, Loh D, McNally O, Mohan GR, Nicholson T, Powell A, Salfinger SG, Simcock B, Stewart C, Silvers J, Stockler MR, Sykes P, Stoyles P, Tan A, Tan AL, Wrede CDH. Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy. Gynecol Oncol. 2020 Dec;159(3):623-629. doi: 10.1016/j.ygyno.2020.09.053. Epub 2020 Oct 5.

Cooper WA, Mahar A, Myers JL, Grainge C, Corte TJ, Williamson JP, Vallely MP, Lai S, Mulyadi E, Torzillo PJ, Phillips MJ, Lau EMT, Raghu G, Troy LK. Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features: Further Lessons from COLDICE, a Prospective Multi-Center Study. Am J Respir Crit Care Med. 2020 Dec 7. doi: 10.1164/rccm.202009-3688OC. Epub ahead of print. PMID: 33285079.

Crouch G, Sinha S, Lo S, Saw RPM, Lee KK, Stretch J, Shannon K, Guitera P, Scolyer RA, Thompson JF, Ch'ng S. Clinical outcomes following surgical treatment of lentigo maligna of the head and neck. Eur J Surg Oncol. 2020 Sep 23:S0748-7983(20)30800-3. doi: 10.1016/j.ejso.2020.09.028. Epub ahead of print. PMID: 33023795.

Davis A, Mahar A, Wong K, Barnet M, Kao S. Prolonged Disease Control on Nivolumab for Primary Pulmonary NUT Carcinoma. Clin Lung Cancer. 2020 Nov 17:S1525-7304(20)30326-0. doi: 10.1016/j.cllc.2020.10.016. Epub ahead of print. PMID: 33349572.

Delahunt B, Egevad L, Samaratunga H, Srigley JR, Cheng L, Clouston D, Furusato B, Kench J, Leite KRM, MacLennan GT, Moch H, Pan CC, Ro J, Tsuzuki T, van der Kwast T, Wheeler T, Yaxley JW. Intraductal carcinoma of the prostate is not a diagnostic entity. Histopathology. 2021 Jan;78(2):342-344. doi: 10.1111/his.14260. Epub 2020 Dec 4. PMID: 32970871.

Delahunt B, Neill B, Burnett JR, Scolyer RA. Publication metrics: what do they mean? Pathology. 2020 Oct;52(6):619-620. doi: 10.1016/j.pathol.2020.07.002. Epub 2020 Aug 16. PMID: 32814621.

Diefenbach RJ, Lee JH, Menzies AM, Carlino MS, Long GV, Saw RPM, Howle JR, Spillane AJ, Scolyer RA, Kefford RF, Rizos H. Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA. Cancers (Basel). 2020 Aug 10;12(8):2228. doi: 10.3390/cancers12082228. PMID: 32785074; PMCID: PMC7465941.

Dreyer SB, Pinese M, Jamieson NB, Scarlett CJ, Colvin EK, Pajic M, Johns AL, Humphris JL, Wu J, Cowley MJ, Chou A, Nagrial AM, Chantrill L, Chin VT, Jones MD, Moran-Jones K, Carter CR, Dickson EJ, Samra JS, Merrett ND, Gill AJ, Kench JG, Duthie F, Miller DK, Cooke S, Aust D, Knösel T, Rümmele P, Grützmann R, Pilarsky C, Nguyen NQ, Musgrove EA, Bailey PJ, McKay CJ, Biankin AV, Chang DK; Australian Pancreatic Cancer Genome Initiative; Glasgow Precision Oncology Laboratory. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer. Ann Surg. 2020 Aug;272(2):366-376. doi: 10.1097/SLA.0000000000003143. PMID: 32675551; PMCID: PMC7373491.

Ebrahimi A, Gupta R, Luk P, Low TH, McDowell L, Magarey MJR, Smith PN, Perriman DM, Schulte KM, Veness M, Porceddu SV, Clark JR. Number of nodal metastases and the American Joint Committee on cancer staging of head and neck cutaneous squamous cell carcinoma: A multicenter study. Oral Oncol. 2020 Dec;111:104855. doi: 10.1016/j.oraloncology.2020.104855. Epub 2020 Aug 21. PMID: 32835932.

Ebrahimi A, Luk PP, Low H, McDowell L, Magarey MJR, Smith PN, Perriman DM, Shadbolt B, Veness M, Gupta R, Clark JR. The American Joint Committee on Cancer staging for metastatic head and neck cutaneous squamous cell carcinoma: A multi- institutional study of within-stage heterogeneity and impact on prognostic performance. Head Neck. 2020 Nov;42(11):3235-3242. doi: 10.1002/hed.26369. Epub 2020 Aug 25. PMID: 32840938.

Edwards J, Ferguson PM, Lo SN, Pires da Silva I, Colebatch AJ, Lee H, Saw RPM, Thompson JF, Menzies AM, Long GV, Newell F, Pearson JV, Waddell N, Hayward NK, Johansson PA, Mann GJ, Scolyer RA, Palendira U, Wilmott JS. Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas. Cancer Immunol Res. 2020 Nov;8(11):1346-1353. doi: 10.1158/2326-6066.CIR-19-0835. Epub 2020 Sep 11. PMID: 32917657.

Egevad L, Delahunt B, Bostwick DG, Cheng L, Evans AJ, Gianduzzo T, Graefen M, Hugosson J, Kench JG, Leite KRM, Oxley J, Sauter G, Srigley JR, Stattin P, Tsuzuki T, Yaxley J, Samaratunga H. Prostate cancer grading, time to go back to the future. BJU Int. 2020 Nov 18. doi: 10.1111/bju.15298. Epub ahead of print. PMID: 33206437.

Egevad L, Swanberg D, Delahunt B, Ström P, Kartasalo K, Olsson H, Berney DM, Bostwick DG, Evans AJ, Humphrey PA, Iczkowski KA, Kench JG, Kristiansen G, Leite KRM, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, Tsuzuki T, van der Kwast T, Varma M, Zhou M, Clements M, Eklund M. Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading. Virchows Arch. 2020 Dec;477(6):777-786. doi: 10.1007/s00428-020-02858-w. Epub 2020 Jun 15. PMID: 32542445; PMCID: PMC7683442.

El Sharouni MA, Ahmed T, Witkamp AJ, Sigurdsson V, van Gils CH, Nieweg OE, Scolyer RA, Thompson JF, van Diest PJ, Lo SN. Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data. Br J Surg. 2020 Aug 26. doi: 10.1002/bjs.11946. Epub ahead of print. PMID: 32846017.

El Sharouni MA, Aivazian K, Witkamp AJ, Sigurdsson V, van Gils CH, Scolyer RA, Thompson JF, van Diest PJ, Lo SN. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma. JAMA Dermatol. 2020 Dec 23:e205032. doi: 10.1001/jamadermatol.2020.5032. Epub ahead of print. PMID: 33355600; PMCID: PMC7758823.

El Sharouni MA, Stodell MD, Ahmed T, Suijkerbuijk KPM, Cust AE, Witkamp AJ, Sigurdsson V, van Diest PJ, Scolyer RA, Thompson JF, van Gils CH, Lo SN. Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor. Ann Oncol. 2020 Nov 28:S0923-7534(20)43170-9. doi: 10.1016/j.annonc.2020.11.015. Epub ahead of print. PMID: 33253862.

Elder DE, Bastian BC, Cree IA, Massi D, Scolyer RA. The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. Arch Pathol Lab Med. 2020 Apr;144(4):500-522. doi: 10.5858/arpa.2019-0561-RA. Epub 2020 Feb 14. PMID: 32057276.

Elder DE, Karakousis G, Scolyer RA. Staging for Melanoma - Toward a New Paradigm? J Natl Cancer Inst. 2020 Sep 1;112(9):873-874. doi: 10.1093/jnci/djaa009. PMID: 31977050; PMCID: PMC7492757.

Feletto E, Lew JB, Worthington J, He E, Caruana M, Butler K, Hui H, Taylor N, Banks E, Barclay K, Broun K, Butt A, Carter R, Cuff J, Dessaix A, Ee H, Emery J, Frayling IM, Grogan P, Holden C, Horn C, Jenkins MA, Kench JG, Laaksonen MA, Leggett B, Mitchell G, Morris S, Parkinson B, St John DJ, Taoube L, Tucker K, Wakefield MA, Ward RL, Win AK, Worthley DL, Armstrong BK, Macrae FA, Canfell K. Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia. BMJ Open. 2020 Jun 21;10(6):e036475. doi: 10.1136/bmjopen-2019-036475. PMID: 32565470; PMCID: PMC7307542.

Ferguson PM, Kench JG, Watson GF. Intranuclear inclusions are a distinguishing morphological feature of renal cell carcinoma with leiomyomatous stroma. Pathology. 2020 Nov 30:S0031-3025(20)30987-9. doi: 10.1016/j.pathol.2020.08.026. Epub ahead of print. PMID: 33272694.

Fischer GM, Carapeto FCL, Joon AY, Haydu LE, Chen H, Wang F, Van Arnam JS, McQuade JL, Wani K, Kirkwood JM, Thompson JF, Tetzlaff MT, Lazar AJ, Tawbi HA, Gershenwald JE, Scolyer RA, Long GV, Davies MA. Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker. Cancer Med. 2020 Nov;9(22):8650-8661. doi: 10.1002/cam4.3474. Epub 2020 Oct 5. PMID: 33016647; PMCID: PMC7666738.

Gandhi JS, Smith SC, Paner GP, McKenney JK, Sekhri R, Osunkoya AO, Baras AS, DeMarzo AM, Cheville JC, Jimenez RE, Trpkov K, Colecchia M, Ro JY, Montironi R, Menon S, Hes O, Williamson SR, Hirsch MS, Netto GJ, Fine SW, Sirohi D, Kaushal S, Sangoi A, Robinson BD, Kweldam CF, Humphrey PA, Hansel DE, Schultz L, Magi- Galluzzi C, Przybycin CG, Shah RB, Mehra R, Kunju LP, Aron M, Kryvenko ON, Kench JG, Kuroda N, Tavora F, van der Kwast T, Grignon DJ, Epstein JI, Reuter VE, Amin MB. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. Am J Surg Pathol. 2020 May;44(5):673-680. doi: 10.1097/PAS.0000000000001417. PMID: 31876580.

Gómez-Martín I, Collgros H, Ferguson PM, Barreiro A, Guitera P, Andrades- López E, Puig S, Pujol RM, Barranco C, Alòs L, Segura S. Diagnostic accuracy of pigmented labial macules by in vivo reflectance confocal microscopy and correlation among techniques. J Am Acad Dermatol. 2020 Mar 5:S0190-9622(20)30313-3. doi: 10.1016/j.jaad.2020.02.067. Epub ahead of print. PMID: 32147389.

Grasso C, Field CS, Tang CW, Ferguson PM, J Compton B, Anderson RJ, Painter GF, Weinkove R, F Hermans I, Berridge MV. Vaccines adjuvanted with an NKT cell agonist induce effective T-cell responses in models of CNS lymphoma. Immunotherapy. 2020 Apr;12(6):395-406. doi: 10.2217/imt-2019-0134. Epub 2020 Apr 22. PMID: 32316797.

Grossman D, Okwundu N, Bartlett EK, Marchetti MA, Othus M, Coit DG, Hartman RI, Leachman SA, Berry EG, Korde L, Lee SJ, Bar-Eli M, Berwick M, Bowles T, Buchbinder EI, Burton EM, Chu EY, Curiel-Lewandrowski C, Curtis JA, Daud A, Deacon DC, Ferris LK, Gershenwald JE, Grossmann KF, Hu-Lieskovan S, Hyngstrom J, Jeter JM, Judson-Torres RL, Kendra KL, Kim CC, Kirkwood JM, Lawson DH, Leming PD, Long GV, Marghoob AA, Mehnert JM, Ming ME, Nelson KC, Polsky D, Scolyer RA, Smith EA, Sondak VK, Stark MS, Stein JA, Thompson JA, Thompson JF, Venna SS, Wei ML, Swetter SM. Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. JAMA Dermatol. 2020 Sep 1;156(9):1004-1011. doi: 10.1001/jamadermatol.2020.1729. PMID: 32725204.

Harris CG, Lo S, Ahmed T, Scolyer RA, Ferguson PM, Karim RZ, Lam TK, Lee KK, Shannon KF, Spillane AJ, Stretch JR, Thompson JF, Saw RP. Primary dermal melanoma: clinical behaviour, prognosis and treatment. Eur J Surg Oncol. 2020 Nov;46(11):2131-2139. doi: 10.1016/j.ejso.2020.04.043. Epub 2020 May 1. PMID: 32417156.

Haydu LE, Lo SN, McQuade JL, Amaria RN, Wargo J, Ross MI, Cormier JN, Lucci A, Lee JE, Ferguson SD, Saw RPM, Spillane AJ, Shannon KF, Stretch JR, Hwu P, Patel SP, Diab A, Wong MKK, Glitza Oliva IC, Tawbi H, Carlino MS, Menzies AM, Long GV, Lazar AJ, Tetzlaff MT, Scolyer RA, Gershenwald JE, Thompson JF, Davies MA. Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma. J Clin Oncol. 2020 May 1;38(13):1429-1441. doi: 10.1200/JCO.19.01508. Epub 2020 Jan 28. PMID: 31990608; PMCID: PMC7193747.

Hendry S, Byrne DJ, Christie M, Steinfort DP, Irving LB, Wagner CA, Ellwood T, Cooper WA, Fox SB. Adequate tumour cellularity is essential for accurate PD-L1 immunohistochemistry assessment on cytology cell-block specimens. Cytopathology. 2020 Mar;31(2):90-95. doi: 10.1111/cyt.12795. Epub 2020 Jan 11. PMID: 31808243.

Hoefsmit EP, Rozeman EA, Van TM, Dimitriadis P, Krijgsman O, Conway JW, Pires da Silva I, van der Wal JE, Ketelaars SLC, Bresser K, Broeks A, Kerkhoven RM, Reeves JW, Warren S, Kvistborg P, Scolyer RA, Kapiteijn EW, Peeper DS, Long GV, Schumacher TNM, Blank CU. Comprehensive analysis of cutaneous and uveal melanoma liver metastases. J Immunother Cancer. 2020 Dec;8(2):e001501. doi: 10.1136/jitc-2020-001501. PMID: 33262254; PMCID: PMC7713183.

Holmes M, Mahar A, Lum T, Kao S, Cooper WA. Real-world programmed death- ligand 1 prevalence rates in non-small cell lung cancer: correlation with clinicopathological features and tumour mutation status. J Clin Pathol. 2020 Jun 23:jclinpath-2020-206709. doi: 10.1136/jclinpath-2020-206709. Epub ahead of print. PMID: 32576631.

House IG, Savas P, Lai J, Chen AXY, Oliver AJ, Teo ZL, Todd KL, Henderson MA, Giuffrida L, Petley EV, Sek K, Mardiana S, Gide TN, Quek C, Scolyer RA, Long GV, Wilmott JS, Loi S, Darcy PK, Beavis PA. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. Clin Cancer Res. 2020 Jan 15;26(2):487-504. doi: 10.1158/1078-0432.CCR-19-1868. Epub 2019 Oct 21. PMID: 31636098.

Ipenburg NA, Lo SN, Vilain RE, Holtkamp LHJ, Wilmott JS, Nieweg OE, Thompson JF, Scolyer RA. The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study. J Am Acad Dermatol. 2020 Apr;82(4):910-919. doi: 10.1016/j.jaad.2019.10.065. Epub 2019 Nov 2. PMID: 31682859.

Itchins M, Lau B, Hudson AL, Westman H, Xia CY, Hayes SA, Howell VM, Rodriguez M, Cooper WA, Wei H, Buckland M, Li BT, Li M, Rathi V, Fox SB, Gill AJ, Clarke SJ, Boyer MJ, Pavlakis N. ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling. Oncologist. 2020 Aug;25(8):641-649. doi: 10.1634/theoncologist.2020-0075. Epub 2020 Jul 2. PMID: 32558067; PMCID: PMC7418351.

Jackett LA, Colebatch AJ, Rawson RV, Ferguson PM, Thompson JF, McCarthy SW, Wilmott JS, Scolyer RA. Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy. Am J Surg Pathol. 2020 Mar;44(3):357-367. doi: 10.1097/PAS.0000000000001406. PMID: 31743128.

Jerman LF, Anderson L, Markham R, Hey-Cunningham AJ. The Lymphatic System in Endometriosis: a Pilot Study of Endometrial-Like Cells and Immune Cell Populations in Lymph Nodes Associated with Deep Infiltrating Bowel Lesions. Reprod Sci. 2020 Apr;27(4):977-987. doi: 10.1007/s43032-020-00171-0. Epub 2020 Feb 19. PMID: 32077078.

Johansson PA, Brooks K, Newell F, Palmer JM, Wilmott JS, Pritchard AL, Broit N, Wood S, Carlino MS, Leonard C, Koufariotis LT, Nathan V, Beasley AB, Howlie M, Dawson R, Rizos H, Schmidt CW, Long GV, Hamilton H, Kiilgaard JF, Isaacs T, Gray ES, Rolfe OJ, Park JJ, Stark A, Mann GJ, Scolyer RA, Pearson JV, van Baren N, Waddell N, Wadt KW, McGrath LA, Warrier SK, Glasson W, Hayward NK. Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours. Nat Commun. 2020 May 15;11(1):2408. doi: 10.1038/s41467-020-16276-8. PMID: 32415113; PMCID: PMC7229209.

John T, Cooper WA, Wright G, Siva S, Solomon B, Marshall HM, Fong KM. Lung Cancer in Australia. J Thorac Oncol. 2020 Dec;15(12):1809-1814. doi: 10.1016/j.jtho.2020.09.005. PMID: 33246594.

Kalaw E, Lim M, Kutasovic JR, Sokolova A, Taege L, Johnstone K, Bennett J, Saunus JM, Niland C, Ferguson K, Gresshoff I, Bettington M, Pathmanathan N, Tse GM, Papadimos D, Pathmanathan R, Harris G, Yamaguchi R, Tan PH, Fox S, O'Toole SA, Simpson PT, Lakhani SR, McCart Reed AE. Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1. Br J Cancer. 2020 Nov;123(11):1665-1672. doi: 10.1038/s41416-020-01065-3. Epub 2020 Sep 17. PMID: 32939056; PMCID: PMC7686342.

Kashani-Sabet M, Miller JR 3rd, Lo S, Nosrati M, Stretch JR, Shannon KF, Spillane AJ, Saw RPM, Cleaver JE, Kim KB, Leong SP, Thompson JF, Scolyer RA. Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system. Cancer. 2020 Nov 1;126(21):4717-4725. doi: 10.1002/cncr.33088. Epub 2020 Aug 11. PMID: 32780467.

Khandkar C, Vaidya K, Penglase R, Cai K, Shin JS, Hunyor I, Keech A, McGill N. Rare case of infiltrative cardiomyopathy secondary to scleromyxoedema. Intern Med J. 2020 Jan;50(1):127-128. doi: 10.1111/imj.14695. PMID: 31943623.

Lai C, Anderson M, Davis R, Anderson L, Wyburn K, Chadban S, Gracey D. Strongyloides hyperinfection in an HIV-positive kidney transplant recipient: a case report. BMC Infect Dis. 2020 Aug 18;20(1):613. doi: 10.1186/s12879-020-05333-8. PMID: 32811453; PMCID: PMC7436945.

Lai C, Bleasel J, McGrath J, Majumdar A, Kirwan P, Anderson L, Strasser S, Gracey D. BK Nephropathy as a Cause of Renal Dysfunction in an ABO-incompatible Liver Transplant Patient. Transplantation. 2020 Mar;104(3):e83-e84. doi: 10.1097/TP.0000000000003044. PMID: 31688666.

Landi MT, Bishop DT, MacGregor S, Machiela MJ, Stratigos AJ, Ghiorzo P, Brossard M, Calista D, Choi J, Fargnoli MC, Zhang T, Rodolfo M, Trower AJ, Menin C, Martinez J, Hadjisavvas A, Song L, Stefanaki I, Scolyer R, Yang R, Goldstein AM, Potrony M, Kypreou KP, Pastorino L, Queirolo P, Pellegrini C, Cattaneo L, Zawistowski M, Gimenez-Xavier P, Rodriguez A, Elefanti L, Manoukian S, Rivoltini L, Smith BH, Loizidou MA, Del Regno L, Massi D, Mandala M, Khosrotehrani K, Akslen LA, Amos CI, Andresen PA, Avril MF, Azizi E, Soyer HP, Bataille V, Dalmasso B, Bowdler LM, Burdon KP, Chen WV, Codd V, Craig JE, Dębniak T, Falchi M, Fang S, Friedman E, Simi S, Galan P, Garcia-Casado Z, Gillanders EM, Gordon S, Green A, Gruis NA, Hansson J, Harland M, Harris J, Helsing P, Henders A, Hočevar M, Höiom V, Hunter D, Ingvar C, Kumar R, Lang J, Lathrop GM, Lee JE, Li X, Lubiński J, Mackie RM, Malt M, Malvehy J, McAloney K, Mohamdi H, Molven A, Moses EK, Neale RE, Novaković S, Nyholt DR, Olsson H, Orr N, Fritsche LG, Puig- Butille JA, Qureshi AA, Radford-Smith GL, Randerson-Moor J, Requena C, Rowe C, Samani NJ, Sanna M, Schadendorf D, Schulze HJ, Simms LA, Smithers M, Song F, Swerdlow AJ, van der Stoep N, Kukutsch NA, Visconti A, Wallace L, Ward SV, Wheeler L, Sturm RA, Hutchinson A, Jones K, Malasky M, Vogt A, Zhou W, Pooley KA, Elder DE, Han J, Hicks B, Hayward NK, Kanetsky PA, Brummett C, Montgomery GW, Olsen CM, Hayward C, Dunning AM, Martin NG, Evangelou E, Mann GJ, Long G, Pharoah PDP, Easton DF, Barrett JH, Cust AE, Abecasis G, Duffy DL, Whiteman DC, Gogas H, De Nicolo A, Tucker MA, Newton-Bishop JA; GenoMEL Consortium; Q-MEGA and QTWIN Investigators; ATHENS Melanoma Study Group; 23andMe; SDH Study Group; IBD Investigators; Essen-Heidelberg Investigators; AMFS Investigators; MelaNostrum Consortium, Peris K, Chanock SJ, Demenais F, Brown KM, Puig S, Nagore E, Shi J, Iles MM, Law MH. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nat Genet. 2020 May;52(5):494-504. doi: 10.1038/s41588-020-0611-8. Epub 2020 Apr 27. PMID: 32341527; PMCID: PMC7255059.

Lantuejoul S, Sound-Tsao M, Cooper WA, Girard N, Hirsch FR, Roden AC, Lopez- Rios F, Jain D, Chou TY, Motoi N, Kerr KM, Yatabe Y, Brambilla E, Longshore J, Papotti M, Sholl LM, Thunnissen E, Rekhtman N, Borczuk A, Bubendorf L, Minami Y, Beasley MB, Botling J, Chen G, Chung JH, Dacic S, Hwang D, Lin D, Moreira A, Nicholson AG, Noguchi M, Pelosi G, Poleri C, Travis W, Yoshida A, Daigneault JB, Wistuba II, Mino-Kenudson M. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee. J Thorac Oncol. 2020 Apr;15(4):499-519. doi: 10.1016/j.jtho.2019.12.107. Epub 2019 Dec 20. PMID: 31870882.

Lau EMT, Grainge C, Williamson JP, Corte TJ, Cooper WA, Phillips MJ, Torzillo PJ, Vallely MP, Raghu G, Troy LK. Methodologies of COLDICE and Cryo-PID studies: details make the difference. Ann Transl Med. 2020 Jun;8(12):781. doi: 10.21037/atm-20-3769.

Law MH, Aoude LG, Duffy DL, Long GV, Johansson PA, Pritchard AL, Khosrotehrani K, Mann GJ, Montgomery GW, Iles MM, Cust AE, Palmer JM; Melanoma GWAS Consortium, Shannon KF, Spillane AJ, Stretch JR, Thompson JF, Saw RPM, Scolyer RA, Martin NG, Hayward NK, MacGregor S. Multiplex melanoma families are enriched for polygenic risk. Hum Mol Genet. 2020 Oct 10;29(17):2976-2985. doi: 10.1093/hmg/ddaa156. PMID: 32716505; PMCID: PMC7566496.

Lee JH, Menzies AM, Carlino MS, McEvoy AC, Sandhu S, Weppler AM, Diefenbach RJ, Dawson SJ, Kefford RF, Millward MJ, Al-Ogaili Z, Tra T, Gray ES, Wong SQ, Scolyer RA, Long GV, Rizos H. Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors. Clin Cancer Res. 2020 Aug 1;26(15):4064-4071. doi: 10.1158/1078-0432.CCR-19-3926. Epub 2020 Apr 22. PMID: 32321716.

Lee JH, Shklovskaya E, Lim SY, Carlino MS, Menzies AM, Stewart A, Pedersen B, Irvine M, Alavi S, Yang JYH, Strbenac D, Saw RPM, Thompson JF, Wilmott JS, Scolyer RA, Long GV, Kefford RF, Rizos H. Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition. Nat Commun. 2020 Apr 20;11(1):1897. doi: 10.1038/s41467-020-15726-7. PMID: 32312968; PMCID: PMC7171183.

Lepletier A, Madore J, O'Donnell JS, Johnston RL, Li XY, McDonald E, Ahern E, Kuchel A, Eastgate M, Pearson SA, Mallardo D, Ascierto PA, Massi D, Merelli B, Mandala M, Wilmott JS, Menzies AM, Leduc C, Stagg J, Routy B, Long GV, Scolyer RA, Bald T, Waddell N, Dougall WC, Teng MWL, Smyth MJ. Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma. Clin Cancer Res. 2020 Jul 15;26(14):3671-3681. doi: 10.1158/1078-0432.CCR-19-3925. Epub 2020 Apr 28. PMID: 32345648.

Li Z, Abadir E, Lee K, Clarke C, Bryant C, Cooper W, Pietersz G, Silveira P, Hart D, Ju X, Clark G. Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody. Clinical & Translational Immunology. 15 July 2020 https://doi.org/10.1002/cti2.1156  PMID:32685149

Lo SN, Ma J, Scolyer RA, Haydu LE, Stretch JR, Saw RPM, Nieweg OE, Shannon KF, Spillane AJ, Ch'ng S, Mann GJ, Gershenwald JE, Thompson JF, Varey AHR. Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram. J Clin Oncol. 2020 Aug 20;38(24):2719-2727. doi: 10.1200/JCO.19.02362. Epub 2020 Jun 12. PMID: 32530761; PMCID: PMC7430218.

López-Sánchez C, Ferguson P, Collgros H. Basal cell carcinoma of the palm: An unusual presentation of a common tumour. Australas J Dermatol. 2020 Feb;61(1):69-70. doi: 10.1111/ajd.13129. Epub 2019 Aug 6. PMID: 31386170.

Luk PP, Ebrahimi A, Veness MJ, McDowell L, Magarey M, Gao K, Palme CE, Clark JR, Gupta R. Prognostic value of the 8th edition American Joint Commission Cancer nodal staging system for patients with head and neck cutaneous squamous cell carcinoma: A multi-institutional study. Head Neck. 2020 Oct 29. doi: 10.1002/hed.26512. Epub ahead of print. PMID: 33118253.

Luke JJ, Ascierto PA, Carlino MS, Gershenwald JE, Grob JJ, Hauschild A, Kirkwood JM, Long GV, Mohr P, Robert C, Ross M, Scolyer RA, Yoon CH, Poklepovic A, Rutkowski P, Anderson JR, Ahsan S, Ibrahim N, M Eggermont AM. KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma. Future Oncol. 2020 Jan;16(3):4429-4438. doi: 10.2217/fon-2019-0666. Epub 2019 Dec 24. PMID: 31870188.

Maharaj AD, Evans SM, Zalcberg JR, Ioannou LJ, Graco M, Croagh D, Pilgrim CHC, Dodson T, Goldstein D, Philip J, Kench JG, Merrett ND, Neale RE, White K, Evans P, Leong T, Green SE. Barriers and enablers to the implementation of multidisciplinary team meetings: a qualitative study using the theoretical domains framework. BMJ Qual Saf. 2020 Nov 27:bmjqs-2020-011793. doi: 10.1136/bmjqs-2020-011793. Epub ahead of print. PMID: 33247002.

Maharaj AD, Evans SM, Zalcberg JR, Ioannou LJ, Graco M, Croagh D, Pilgrim CHC, Dodson T, Goldstein D, Philip J, Kench JG, Merrett ND, Neale RE, White K, Evans P, Leong T, Green SE. Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework. PLoS One. 2020 Dec 17;15(12):e0243312. doi: 10.1371/journal.pone.0243312. PMID: 33332372; PMCID: PMC7746147.

Majewska H, Gorczyński A, Czapiewski P, Menon R, Mueller J, Lakis S, Heuckmann JM, Laco J, Gupta R, Andreasen S, Stodulski D, Iliszko M, Dziadziuszko R, Jassem J, Heukamp LC, Biernat W. ALK alterations in salivary gland carcinomas. Virchows Arch. 2020 Nov 25. doi: 10.1007/s00428-020-02971-w. Epub ahead of print. PMID: 33237469.

Malesu R , Martin AJ , Lyons JG , Scolyer RA , Chen AC , McKenzie CA , Madore J , Halliday GM , Damian DL . Nicotinamide for skin cancer chemoprevention: effects of nicotinamide on melanoma in vitro and in vivo. Photochem Photobiol Sci. 2020 Feb 19;19(2):171-179. doi: 10.1039/c9pp00388f. PMID: 31942903.

Marsavela G, Lee J, Calapre L, Wong SQ, Pereira MR, McEvoy AC, Reid AL, Robinson C, Warburton L, Abed A, Khattak MA, Meniawy TM, Dawson SJ, Sandhu S, Carlino MS, Menzies AM, Scolyer RA, Long GV, Amanuel B, Millward M, Ziman MR, Rizos H, Gray ES. Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy. Clin Cancer Res. 2020 Nov 15;26(22):5926-5933. doi: 10.1158/1078-0432.CCR-20-2251. Epub 2020 Oct 16. PMID: 33067256.

McCarthy RE, Bowen DG, Strasser SI, McKenzie C. The dangers of herbal weight loss supplements: a case report of drug-induced liver injury secondary to Garcinia cambogia ingestion. Pathology. 2020 Nov 26:S0031-3025(20)30982-X. doi: 10.1016/j.pathol.2020.08.021. Epub ahead of print. PMID: 33250192.

McKelvey KJ, Hudson AL, Prasanna Kumar R, Wilmott JS, Attrill GH, Long GV, Scolyer RA, Clarke SJ, Wheeler HR, Diakos CI, Howell VM. Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model. PLoS One. 2020 Apr 2;15(4):e0226444. doi: 10.1371/journal.pone.0226444. PMID: 32240177; PMCID: PMC7117758.

Mermod M, Jourdan EF, Gupta R, Bongiovanni M, Tolstonog G, Simon C, Clark J, Monnier Y. Development and validation of a multivariable prediction model for the identification of occult lymph node metastasis in oral squamous cell carcinoma. Head Neck. 2020 Aug;42(8):1811-1820. doi: 10.1002/hed.26105. Epub 2020 Feb 14. PMID: 32057148.

Millar E, Browne L, Slapetova I, Shang F, Ren Y, Bradshaw R, Ann Brauer H, O'Toole S, Beretov J, Whan R, Graham PH. TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-Up. Cancers (Basel). 2020 Aug 21;12(9):2365. doi: 10.3390/cancers12092365. PMID: 32825588; PMCID: PMC7563743.

Mooney CP, Gao K, Clark JR, Gupta R, Shannon K, Palme CE, Ebrahimi A, Ch'ng S, Low TH. Soft Tissue Metastases in Head and Neck Cutaneous Squamous Cell Carcinoma. Laryngoscope. 2020 Sep 14. doi: 10.1002/lary.29064. Epub ahead of print. PMID: 32926433.

Moreira AL, Ocampo PSS, Xia Y, Zhong H, Russell PA, Minami Y, Cooper WA, Yoshida A, Bubendorf L, Papotti M, Pelosi G, Lopez-Rios F, Kunitoki K, Ferrari- Light D, Sholl LM, Beasley MB, Borczuk A, Botling J, Brambilla E, Chen G, Chou TY, Chung JH, Dacic S, Jain D, Hirsch FR, Hwang D, Lantuejoul S, Lin D, Longshore JW, Motoi N, Noguchi M, Poleri C, Rekhtman N, Tsao MS, Thunnissen E, Travis WD, Yatabe Y, Roden AC, Daigneault JB, Wistuba II, Kerr KM, Pass H, Nicholson AG, Mino-Kenudson M. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee. J Thorac Oncol. 2020 Oct;15(10):1599-1610. doi: 10.1016/j.jtho.2020.06.001. Epub 2020 Jun 17. PMID: 32562873.

Morton R, Mylvaganam G, Anderson L, Farrell R, Carter J, Pather S, Saidi S. Follow-up after treatment of high-grade cervical dysplasia: The utility of six- month colposcopy and cytology and routine 12-month colposcopy. Aust N Z J Obstet Gynaecol. 2020 Dec;60(6):959-964. doi: 10.1111/ajo.13248. Epub 2020 Sep 15. PMID: 32935336.

Mueller SA, Gauthier MA, Blackburn J, Grady JP, Kraitsek S, Hajdu E, Dettmer MS, Dahlstrom JE, Lee CS, Luk PP, Yu B, Giger R, Kummerfeld S, Clark JR, Gupta R, Cowley MJ. Molecular patterns in salivary duct carcinoma identify prognostic subgroups. Mod Pathol. 2020 Oct;33(10):1896-1909. doi: 10.1038/s41379-020-0576-2. Epub 2020 May 26. PMID: 32457410.

Mylvaganam G, Morton R, Anderson L, Tejada-Berges T. Endometrial adenocarcinoma arising in a pelvic implant following uterine morcellation: A case report. Case Rep Womens Health. 2020 Jan 18;26:e00174. doi: 10.1016/j.crwh.2020.e00174. PMID: 32195127; PMCID: PMC7075787.

Nahar KJ, Rawson RV, Ahmed T, Tattersall S, Sandanayake N, Kiely CJ, Lo S, Carlino M, Palendira U, Scolyer RA, Long GV, Menzies AM. Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab. J Immunother Cancer. 2020 Nov;8(2):e001488. doi: 10.1136/jitc-2020-001488. PMID: 33234603; PMCID: PMC7689081.

Newell F, Wilmott JS, Johansson PA, Nones K, Addala V, Mukhopadhyay P, Broit N, Amato CM, Van Gulick R, Kazakoff SH, Patch AM, Koufariotis LT, Lakis V, Leonard C, Wood S, Holmes O, Xu Q, Lewis K, Medina T, Gonzalez R, Saw RPM, Spillane AJ, Stretch JR, Rawson RV, Ferguson PM, Dodds TJ, Thompson JF, Long GV, Levesque MP, Robinson WA, Pearson JV, Mann GJ, Scolyer RA, Waddell N, Hayward NK. Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity. Nat Commun. 2020 Oct 16;11(1):5259. doi: 10.1038/s41467-020-18988-3. PMID: 33067454; PMCID: PMC7567804.

Niebling MG, Haydu LE, Lo SN, Rawson RV, Lamboo LGE, Stollman JT, Karim RZ, Thompson JF, Scolyer RA. The prognostic significance of microsatellites in cutaneous melanoma. Mod Pathol. 2020 Jul;33(7):1369-1379. doi: 10.1038/s41379-020-0500-9. Epub 2020 Feb 13. PMID: 32055007.

Ofri A, Dona E, O'Toole S. Squamous metaplasia of lactiferous ducts (SMOLD): an under-recognised entity. BMJ Case Rep. 2020 Dec 9;13(12):e237568. doi: 10.1136/bcr-2020-237568. PMID: 33298489; PMCID: PMC7733088.

Ofri A, Noushi F, O'Toole S. Invasive breast carcinoma with osteoclast-like giant cells (OLGC): A rare entity causing diagnostic confusion. Breast J. 2020 Sep;26(9):1831-1832. doi: 10.1111/tbj.13890. Epub 2020 May 18. PMID: 32419289.

Pamphlett R, Colebatch AJ, Doble PA, Bishop DP. Mercury in Pancreatic Cells of People with and without Pancreatic Cancer. Int J Environ Res Public Health. 2020 Dec 2;17(23):8990. doi: 10.3390/ijerph17238990. PMID: 33276658; PMCID: PMC7731371.

Paver EC, Currie AM, Gupta R, Dahlstrom JE. Human papilloma virus related squamous cell carcinomas of the head and neck: diagnosis, clinical implications and detection of HPV. Pathology. 2020 Feb;52(2):179-191. doi: 10.1016/j.pathol.2019.10.008. Epub 2019 Dec 27. PMID: 31889547.

Perry J, Ashford B, Thind AS, Gauthier ME, Minaei E, Major G, Iyer NG, Gupta R, Clark J, Ranson M. Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities. Int J Mol Sci. 2020 Dec 15;21(24):9536. doi: 10.3390/ijms21249536. PMID: 33333825; PMCID: PMC7765308.

Pirozyan MR, McGuire HM, Emran AA, Tseng HY, Tiffen JC, Lee JH, Carlino MS, Menzies AM, Long GV, Scolyer RA, Fazekas de St Groth B, Hersey P. Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients. Front Immunol. 2020 Mar 10;11:372. doi: 10.3389/fimmu.2020.00372. PMID: 32210968; PMCID: PMC7076153.

Pruessmann W, Rytlewski J, Wilmott J, Mihm MC Jr, Attrill GH, Dyring-Andersen B, Fields P, Zhan Q, Colebatch AJ, Ferguson PM, Thompson JF, Kallenbach K, Yusko E, Clark RA, Robins H, Scolyer RA, Kupper TS. Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence. Nat Cancer. 2020 Feb;1(2):197-209. doi: 10.1038/s43018-019-0019-5. Epub 2020 Jan 20. PMID: 33305293; PMCID: PMC7725220.

Quininir L, Luk PP, McGuire MA. Catheter entrapment in the Chiari network during catheter ablation. HeartRhythm Case Rep. 2020 Aug 21;6(12):896-898. doi: 10.1016/j.hrcr.2020.08.016. PMID: 33365233; PMCID: PMC7749197.

Rabbie R, Ferguson P, Wong K, Couturier DL, Moran U, Turner C, Emanuel P, Haas K, Saunus JM, Davidson MR, Lakhani SR, Shivalingam B, Long GV, Parkinson C, Osman I, Scolyer RA, Corrie P, Adams DJ. The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence. Br J Cancer. 2021 Jan;124(1):156-160. doi: 10.1038/s41416-020-01090-2. Epub 2020 Oct 7. PMID: 33024263; PMCID: PMC7782512.

Rapport F, Smith AL, Cust AE, Mann GJ, Watts CG, Gyorki DE, Henderson M, Hong AM, Kelly JW, Long GV, Mar VJ, Morton RL, Saw RP, Scolyer RA, Spillane AJ, Thompson JF, Braithwaite J. Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods study. BMJ Open. 2020 Feb 27;10(2):e032636. doi: 10.1136/bmjopen-2019-032636. PMID: 32111612; PMCID: PMC7050375.

Rawson RV, Scolyer RA. From Breslow to BRAF and immunotherapy: evolving concepts in melanoma pathogenesis and disease progression and their implications for changing management over the last 50 years. Hum Pathol. 2020 Jan;95:149-160. doi: 10.1016/j.humpath.2019.09.017. Epub 2019 Nov 6. PMID: 31704364.

Robinson M, Primiero C, Guitera P, Hong A, Scolyer RA, Stretch JR, Strutton G, Thompson JF, Soyer HP. Evidence-Based Clinical Practice Guidelines for the Management of Patients with Lentigo Maligna. Dermatology. 2020;236(2):111-116. doi: 10.1159/000502470. Epub 2019 Oct 22. PMID: 31639788.

Samaratunga H, Delahunt B, Egevad L, Srigley JR, Billis A, Bostwick DG, Camparo P, Cheng L, Clouston D, Denham J, Furusato B, Hartmann A, Jufe L, Kench J, Kenwright DN, Kristiansen G, Leite KRM, MacLennan GT, Merrimen J, Moch H, Oxley J, Pan CC, Paner G, Ro J, Sesterhenn IAM, Shanks J, Thunders M, Tsuzuki T, Wheeler T, Yaxley JW, Varma M. Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. Pathology. 2020 Feb;52(2):192-196. doi: 10.1016/j.pathol.2019.11.001. Epub 2019 Dec 14. PMID: 31843189.

Sasson SC, Zaunders JJ, Nahar K, Munier CML, Fairfax BP, Olsson-Brown A, Jolly C, Read SA, Ahlenstiel G, Palendira U, Scolyer RA, Carlino MS, Payne MJ, Cheung VTF, Gupta T, Klenerman P, Long GV, Brain O, Menzies AM, Kelleher AD. Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis. Clin Exp Immunol. 2020 Dec;202(3):335-352. doi: 10.1111/cei.13502. Epub 2020 Aug 19. PMID: 32734627; PMCID: PMC7670140.

Satgunaseelan L, Allanson BM, Asher R, Reddy R, Low HTH, Veness M, Gopal Iyer N, Smee RI, Palme CE, Gupta R, Clark JR. The incidence of squamous cell carcinoma of the oral tongue is rising in young non-smoking women: An international multi-institutional analysis. Oral Oncol. 2020 Nov;110:104875. doi: 10.1016/j.oraloncology.2020.104875. Epub 2020 Jul 1. PMID: 32622292.

Scheinberg T, Kench J, Stockler M, Mahon KL, Sebastian L, Stricker P, Joshua AM, Woo H, Thanigasalam R, Ahmadi N, Centenera MM, Butler LM, Horvath LG. Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer). BMJ Open. 2020 Jan 26;10(1):e033667. doi: 10.1136/bmjopen-2019-033667. PMID: 31988233; PMCID: PMC7045211.

Scheinberg T, Lomax A, Tattersall M, Thomas D, McCowage G, Sullivan M, Karim R, Luk PP, Mahar A, Bonar F, Bhadri VA. PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma. Cancer Rep (Hoboken). 2020 Dec 13:e1327. doi: 10.1002/cnr2.1327. Epub ahead of print. PMID: 33314769.

Scolyer RA, Rawson RV, Gershenwald JE, Ferguson PM, Prieto VG. Melanoma pathology reporting and staging. Mod Pathol. 2020 Jan;33(Suppl 1):15-24. doi: 10.1038/s41379-019-0402-x. Epub 2019 Nov 22. PMID: 31758078.

Shklovskaya E, Lee JH, Lim SY, Stewart A, Pedersen B, Ferguson P, Saw RP, Thompson JF, Shivalingam B, Carlino MS, Scolyer RA, Menzies AM, Long GV, Kefford RF, Rizos H. Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma. Cancers (Basel). 2020 Nov 14;12(11):3374. doi: 10.3390/cancers12113374. PMID: 33202676; PMCID: PMC7696726.

Sholl LM, Hirsch FR, Hwang D, Botling J, Lopez-Rios F, Bubendorf L, Mino- Kenudson M, Roden AC, Beasley MB, Borczuk A, Brambilla E, Chen G, Chou TY, Chung JH, Cooper WA, Dacic S, Lantuejoul S, Jain D, Lin D, Minami Y, Moreira A, Nicholson AG, Noguchi M, Papotti M, Pelosi G, Poleri C, Rekhtman N, Tsao MS, Thunnissen E, Travis W, Yatabe Y, Yoshida A, Daigneault JB, Zehir A, Peters S, Wistuba II, Kerr KM, Longshore JW. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee. J Thorac Oncol. 2020 Sep;15(9):1409-1424. doi: 10.1016/j.jtho.2020.05.019. Epub 2020 Jun 6. PMID: 32522712.

Smith AL, Watts CG, Robinson S, Schmid H, Goumas C, Mar VJ, Thompson JF, Rapport F; Australian Melanoma Centre of Research Excellence Study Group, Cust AE. Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study. Australas J Dermatol. 2020 Dec 5. doi: 10.1111/ajd.13518. Epub ahead of print. PMID: 33277693.

Smith ML, Hariri LP, Mino-Kenudson M, Dacic S, Attanoos R, Borczuk A, Colby TV, Cooper W, Jones K, Leslie KO, Mahar A, Larsen B, Cavazza A, Fukuoka J, Roden AC, Sholl LM, Mukhopadhyay S, Tazelaar H, Curg A, Beasley MB. Histopathologic Assessment of Idiopathic Pulmonary Fibrosis: Where we are and where we need to go. Arch Pathol Lab Med, 2020. Jul 2 Epub. PMID: 32614648

Smithers FAE, Haymerle G, Palme CE, Low TH, Froggatt C, Gupta R, Clark JR. A prospective study of intraoperative assessment of mucosal squamous cell carcinoma margins in the head and neck. Head Neck. 2020 Oct 23. doi: 10.1002/hed.26517. Epub ahead of print. PMID: 33098251.

Ström P, Kartasalo K, Olsson H, Solorzano L, Delahunt B, Berney DM, Bostwick DG, Evans AJ, Grignon DJ, Humphrey PA, Iczkowski KA, Kench JG, Kristiansen G, van der Kwast TH, Leite KRM, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, Tsuzuki T, Varma M, Zhou M, Lindberg J, Lindskog C, Ruusuvuori P, Wählby C, Grönberg H, Rantalainen M, Egevad L, Eklund M. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol. 2020 Feb;21(2):222-232. doi: 10.1016/S1470-2045(19)30738-7. Epub 2020 Jan 8. Erratum in: Lancet Oncol. 2020 Feb;21(2):e70. PMID: 31926806.

Subramaniam N, Gao K, Gupta R, Clark JR, Low TH. Trends in parotidectomy over 30 years in an Australian tertiary care center. Head Neck. 2020 Oct;42(10):2905-2911. doi: 10.1002/hed.26335. Epub 2020 Jul 3. PMID: 32618071.

Teo WS, Holliday H, Karthikeyan N, Cazet AS, Roden DL, Harvey K, Konrad CV, Murali R, Varghese BA, Thankamony AP, Chan CL, McFarland A, Junankar S, Ye S, Yang J, Nikolic I, Shah JS, Baker LA, Millar EKA, Naylor MJ, Ormandy CJ, Lakhani SR, Kaplan W, Mellick AS, O'Toole SA, Swarbrick A, Nair R. Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1. Front Cell Dev Biol. 2020 Jul 17;8:552. doi: 10.3389/fcell.2020.00552. PMID: 32766238; PMCID: PMC7380117.

Teoh A, Jo H, Chambers D, Symons K, Walters H, Goh N, Glaspole I, Cooper W, Reynolds PN, Moodley Y, Corte T. Blood monocyte counts as a potential prognostic marker for IPF: Analysis from the Australian IPF registry. European Respiratory Journal. 2020 55: 1901855; DOI: 10.1183/13993003.01855-2019 PMID: 31949112

Tetzlaff MT, Adhikari C, Lo S, Rawson RV, Amaria RN, Menzies AM, Wilmott JS, Ferguson PM, Ross MI, Spillane AJ, Vu KA, Ma J, Ning J, Haydu LE, Saw RPM, Wargo JA, Tawbi HA, Gershenwald JE, Long GV, Davies MA, Scolyer RA. Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma. Ann Oncol. 2020 Nov;31(11):1569-1579. doi: 10.1016/j.annonc.2020.07.016. Epub 2020 Jul 31. PMID: 32739408.

Tjahjono R, Phung D, Gurney H, Gupta R, Riffat F, Palme CE. Thyroid gland metastasis from renal cell carcinoma: a case series and literature review. ANZ J Surg. 2020 Dec 14. doi: 10.1111/ans.16482. Epub ahead of print. PMID: 33319504.

Travis WD, Dacic S, Wistuba I, Sholl L, Adusumilli P, Bubendorf L, Bunn P, Cascone T, Chaft J, Chen G, Chou TY, Cooper W, Erasmus JJ, Gerreira CG, Goo JM, Heymach J, Hirsch FR, Horinouchi H, Kerr K, Kris M, Jain D, Kim YT, Lope-Rios F, Lu S, Mitsudomi T, Moreira A, Motoi N, Nicholson AG, Oliveira R, Papotti M, Pastorino U, Paz-Ares L, Pelosi G, Poleri C, Provencio M, Roden AC, Scagliotti G, Swisher SG, Thunnissen E, Tsao MS, Vansteenkiste J, Weder W, Yatabe Y. IASLC Path committee. IASLC Multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens following neoadjuvant therapy. J Thoracic Oncol, 2020; 709-740. PMID: 32004713

Troy LK, Grainge C, Corte TJ, Williamson JP, Vallely MP, Cooper WA, Mahar A, Myers JL, Lai S, Mulyadi E, Torzillo PJ, Phillips MJ, Jo HE, Webster SE, Lin QT, Rhodes JE, Salamonsen M, Wrobel JP, Harris B, Don G, Wu PJC, Ng BJ, Oldmeadow C, Raghu G, Lau EMT; Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease alliance (COLDICE) Investigators. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. Lancet Respir Med. 2020 Feb;8(2):171-181. doi: 10.1016/S2213-2600(19)30342-X. Epub 2019 Sep 29. PMID: 31578168.

Tsang VHM, McGrath RT, Clifton-Bligh RJ, Scolyer RA, Jakrot V, Guminski AD, Long GV, Menzies AM. Response to Letter to the Editor: "Checkpoint Inhibitor- Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes". J Clin Endocrinol Metab. 2020 Jun 1;105(6):e2317-8. doi: 10.1210/clinem/dgaa144. PMID: 32188993; PMCID: PMC7170215.

Vargas AC, Maclean FM, Sioson L, Tran D, Bonar F, Mahar A, Cheah AL, Russell P, Grimison P, Richardson L, Gill AJ. Prevalence of PD-L1 expression in matched recurrent and/or metastatic sarcoma samples and in a range of selected sarcomas subtypes. PLoS One. 2020 Apr 15;15(4):e0222551. doi: 10.1371/journal.pone.0222551. PMID: 32294103; PMCID: PMC7159201.

Vasan K, Anand S, Satgunaseelan L, Asher R, Low H, Palme CE, Lee JH, Clark JR, Gupta R. Mismatch repair protein loss in cutaneous head and neck squamous cell carcinoma. J Surg Oncol. 2020 Dec;122(8):1755-1760. doi: 10.1002/jso.26218. Epub 2020 Sep 14. PMID: 32926758.

Watts CG, Smith AL, Robinson S, Chang CS, Goumas C, Schmid H, Kelly JW, Hong AM, Scolyer RA, Long GV, Spillane AJ, Henderson M, Gyorki DE, Mar VJ, Morton RL, Saw RP, Varey AH, Mann GJ, Thompson JF, Cust AE. Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management. Aust J Gen Pract. 2020 Jun;49(6):355-362. doi: 10.31128/AJGP-10-19-5138. PMID: 32464734.

Wu SZ, Roden DL, Wang C, Holliday H, Harvey K, Cazet AS, Murphy KJ, Pereira B, Al-Eryani G, Bartonicek N, Hou R, Torpy JR, Junankar S, Chan CL, Lam CE, Hui MN, Gluch L, Beith J, Parker A, Robbins E, Segara D, Mak C, Cooper C, Warrier S, Forrest A, Powell J, O'Toole S, Cox TR, Timpson P, Lim E, Liu XS, Swarbrick A. Stromal cell diversity associated with immune evasion in human triple-negative breast cancer. EMBO J. 2020 Oct 1;39(19):e104063. doi: 10.15252/embj.2019104063. Epub 2020 Aug 13. PMID: 32790115; PMCID: PMC7527929.

Xie H, Ansar S, Anderson L, Saidi S, Kitzing YX, Anand S. Glomangiomyoma of the clitoris: A case report and literature review. Case Rep Womens Health. 2020 Nov 10;29:e00269. doi: 10.1016/j.crwh.2020.e00269. PMID: 33294388; PMCID: PMC7691537.

Xie H, Pather S, Yeo D, Mylvaganam G, Venclovas R, Anderson L. Precaval recurrent endometrial cancer treated with en-bloc resection of the inferior vena cava and reconstruction using bovine pericardium. A case report and review of the literature. Gynecol Oncol Rep. 2020 Nov 28;34:100679. doi: 10.1016/j.gore.2020.100679. PMID: 33304980; PMCID: PMC7718161.

Yung AE, Que MS, Lo S, Aggarwal S, Hong AM, Tin MM, Clark JR, Gupta R, Ch'ng S. Validation of the American Joint Committee on Cancer Staging in Squamous Cell Carcinoma of the Vermilion Lip. Ann Surg Oncol. 2021 Jan 2. doi: 10.1245/s10434-020-09431-4. Epub ahead of print. PMID: 33389299.

Ziemys A, Kim M, Menzies AM, Wilmott JS, Long GV, Scolyer RA, Kwong L, Holder A, Boland G. Integration of Digital Pathologic and Transcriptomic Analyses Connects Tumor-Infiltrating Lymphocyte Spatial Density With Clinical Response to BRAF Inhibitors. Front Oncol. 2020 May 14;10:757. doi: 10.3389/fonc.2020.00757. PMID: 32528881; PMCID: PMC7247820.

2019

Ahmadi N, Gao K, Chia N, Kwon MS, Palme CE, Gupta R, Clark J. Association of PD-L1 expression in oral squamous cell carcinoma with smoking, sex, and p53 expression.Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Dec;128(6):631-638. doi: 10.1016/j.oooo.2019.07.008. Epub 2019 Aug 1.

Ahmadzada T, Lee K, Clarke C, Cooper WA, Linton A, McCaughan B, Asher R, Clarke S, Reid G, Kao S. High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes.Lung Cancer. 2019 Apr;130:35-41. doi: 10.1016/j.lungcan.2019.02.005. Epub 2019 Feb 7.

Amaria RN, Menzies AM, Burton EM, Scolyer RA, Tetzlaff MT, Antdbacka R, Ariyan C, Bassett R, Carter B, Daud A, Faries M, Fecher LA, Flaherty KT, Gershenwald JE, Hamid O, Hong A, Kirkwood JM, Lo S, Margolin K, Messina J, Postow MA, Rizos H, et al. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.Lancet Oncol. 2019 Jul;20(7):e378-e389. doi: 10.1016/S1470-2045(19)30332-8.

Arianayagam R, Kench JG, Elder GJ, Thanigasalam R. Laparoscopic partial nephrectomy for Juxtaglomerular apparatus tumour: A rare cause of hypertension.Urol Case Rep. 2019 May 29;26:100910. doi: 10.1016/j.eucr.2019.100910. eCollection 2019 Sep.

Bergamin S, Eade T, Kneebone A, Kench JG, Sved P, Biset JF, Hruby G. Ductal Carcinoma of the Prostate: An Uncommon Entity With Atypical Behaviour.Clin Oncol (R Coll Radiol). 2019 Feb;31(2):108-114. doi: 10.1016/j.clon.2018.10.011. Epub 2018 Nov 22.

Chakera AH, Quinn MJ, Lo S, Drummond M, Haydu LE, Bond JS, Stretch JR, Saw RPM, Lee KJ, McCarthy WH, Scolyer RA, Thompson JF. Subungual Melanoma of the Hand.Ann Surg Oncol. 2019 Apr;26(4):1035-1043. doi: 10.1245/s10434-018-07094-w. Epub 2018 Dec 18.

Clark JR, Low H, Gupta R. Cancer staging for rare cancers: should the American Joint Committee on Cancer have a separate staging classification for external auditory canal cancer?Ann Transl Med. 2019 Mar;7(Suppl 1):S12. doi: 10.21037/atm.2019.01.33.

Cohen PA, Anderson L, Eva L, Scurry J. Clinical and molecular classification of vulvar squamous pre-cancers.Int J Gynecol Cancer. 2019 May;29(4):821-828. doi: 10.1136/ijgc-2018-000135. Epub 2019 Feb 7.

Colebatch AJ, Dobrovic A, Cooper WA. TERT gene: its function and dysregulation in cancer.J Clin Pathol. 2019 Apr;72(4):281-284. doi: 10.1136/jclinpath-2018-205653. Epub 2019 Jan 29.

Colebatch AJ, Ferguson P, Newell F, Kazakoff SH, Witkowski T, Dobrovic A, Johansson PA, Saw RPM, Stretch JR, McArthur GA, Long GV, Thompson JF, Pearson JV, Mann GJ, Hayward NK, Waddell N, Scolyer RA, Wilmott JS. Molecular Genomic Profiling of MelanocyticÂ Nevi.J Invest Dermatol. 2019 Aug;139(8):1762-1768. doi: 10.1016/j.jid.2018.12.033. Epub 2019 Feb 14.

Compton BJ, Farrand KJ, Tang CW, Osmond TL, Speir M, Authier-Hall A, Wang J, Ferguson PM, Chan STS, Anderson RJ, Cooney TR, Hayman CM, Williams GM, Brimble MA, Brooks CR, Yong LK, Metelitsa LS, Zajonc DM, Godfrey DI, Gasser O, Weinkove R, Painter GF, et al. Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist.Org Biomol Chem. 2019 Jan 31;17(5):1225-1237. doi: 10.1039/c8ob02982b.

d'Avigdor WMH, Budzinska MA, Lee M, Lam R, Kench J, Stapelberg M, McLennan SV, Farrell G, George J, McCaughan GW, Tu T, Shackel NA. Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver.Sci Rep. 2019 Jul 22;9(1):10596. doi: 10.1038/s41598-019-46664-0.

Den Hondt M, Starr MW, Millett MC, Smyth J, Scolyer RA, Shannon KF, Thompson JF, Ch'ng S. Surgical management of the neck in patients with metastatic melanoma in parotid lymph nodes.J Surg Oncol. 2019 Dec;120(8):1462-1469. doi: 10.1002/jso.25732. Epub 2019 Oct 25.

Dessinioti C, Dimou N, Geller AC, Stergiopoulou A, Lo S, Keim U, Gershenwald JE, Haydu LE, Ribero S, Quaglino P, Puig S, Malvehy J, Kandolf-Sekulovic L, Radevic T, Kaufmann R, Meister L, Nagore E, Traves V, Champsas GG, Plaka M, Dreno B, Varey E, Scolyer RA, et al. Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.J Natl Cancer Inst. 2019 Dec 1;111(12):1314-1322. doi: 10.1093/jnci/djz034.

Diefenbach RJ, Lee JH, Strbenac D, Yang JYH, Menzies AM, Carlino MS, Long GV, Spillane AJ, Stretch JR, Saw RPM, Thompson JF, Ch'ng S, Scolyer RA, Kefford RF, Rizos H. Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma.Cancers (Basel). 2019 Nov 29;11(12). pii: E1905. doi: 10.3390/cancers11121905.

Ding LW, Sun QY, Edwards JJ, FernÃ¡ndez LT, Ran XB, Zhou SQ, Scolyer RA, Wilmott JS, Thompson JF, Doan N, Said JW, Venkatachalam N, Xiao JF, Loh XY, Pein M, Xu L, Mullins DW, Yang H, Lin DC, Koeffler HP. LNK suppresses interferon signaling in melanoma.Nat Commun. 2019 May 20;10(1):2230. doi: 10.1038/s41467-019-09711-y.

Dodds TJ, Wilmott JS, Jackett LA, Lo SN, Long GV, Thompson JF, Scolyer RA. Primary anorectal melanoma: clinical, immunohistology and DNA analysis of 43 cases.Pathology. 2019 Jan;51(1):39-45. doi: 10.1016/j.pathol.2018.09.060. Epub 2018 Nov 26.

Edwards J, Batten M, Ferguson A, Palendira U, Wilmott JS, Long GV, Scolyer RA. Novel Immune Targets in Melanoma-Response.Clin Cancer Res. 2019 Sep 1;25(17):5424-5425. doi: 10.1158/1078-0432.CCR-19-1866.

Edwards J, Tasker A, Pires da Silva I, Quek C, Batten M, Ferguson A, Allen R, Allanson B, Saw RPM, Thompson JF, Menzies AM, Palendira U, Wilmott JS, Long GV, Scolyer RA. Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naÃ¯ve Melanoma Patients: Implications for Clinical Trials.Clin Cancer Res. 2019 Jun 1;25(11):3247-3258. doi: 10.1158/1078-0432.CCR-18-4011. Epub 2019 Feb 18.

Egevad L, Judge M, Delahunt B, Humphrey PA, Kristiansen G, Oxley J, Rasiah K, Takahashi H, Trpkov K, Varma M, Wheeler TM, Zhou M, Srigley JR, Kench JG. Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).Pathology. 2019 Jan;51(1):11-20. doi: 10.1016/j.pathol.2018.10.003. Epub 2018 Nov 23.

Friedman EB, Dodds TJ, Lo S, Ferguson PM, Beck M, Saw RPM, Stretch JR, Lee KK, Nieweg OE, Spillane AJ, Scolyer RA, Thompson JF. Correlation Between Surgical and Histologic Margins in Melanoma Wide Excision Specimens.Ann Surg Oncol. 2019 Jan;26(1):25-32. doi: 10.1245/s10434-018-6858-y. Epub 2018 Oct 16.

Friedman EB, Moncrieff MD, Lo S, Scolyer RA, Thompson JF. Sentinel lymph node biopsy remains the most accurate method of obtaining staging and prognostic information for patients with primary cutaneous melanomas.Australas J Dermatol. 2019 Feb;60(1):75-76. doi: 10.1111/ajd.12942. Epub 2018 Oct 7.

Friedman EB, Scolyer RA, Thompson JF. Management of pigmented skin lesions during pregnancy.Aust J Gen Pract. 2019 Sep;48(9):621-624. doi: 10.31128/AJGP-04-19-48952.

Friedman EB, Scolyer RA, Thompson JF. Management of pigmented skin lesions in childhood and adolescence.Aust J Gen Pract. 2019 Aug;48(8):539-544. doi: 10.31128/AJGP-04-19-48951.

Gandhi JS, Smith SC, Paner GP, McKenney JK, Sekhri R, Osunkoya AO, Baras AS, DeMarzo AM, Cheville JC, Rafael JE, Trpkov K, Colecchia M, Ro JY, Montironi R, Menon S, Hes O, Williamson SR, Hirsch MS, Netto GJ, Fine SW, Sirohi D, Kaushal S, ..., Kench JG, et al. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.Am J Surg Pathol. 2019 Dec 23. doi: 10.1097/PAS.0000000000001417. [Epub ahead of print]

Gide TN, Allanson BM, Menzies AM, Ferguson PM, Madore J, Saw RPM, Thompson JF, Long GV, Wilmott JS, Scolyer RA. Inter- and intrapatient heterogeneity of indoleamine 2,3-dioxygenase expression in primary and metastatic melanoma cells and the tumour microenvironment.Histopathology. 2019 May;74(6):817-828. doi: 10.1111/his.13814.

Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, Madore J, Lim SY, Velickovic R, Wongchenko M, Yan Y, Lo S, Carlino MS, Guminski A, Saw RPM, Pang A, McGuire HM, Palendira U, Thompson JF, Rizos H, Silva IPD, Batten M, Scolyer RA, Long GV, Wilmott JS. Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy.Cancer Cell. 2019 Feb 11;35(2):238-255.e6. doi: 10.1016/j.ccell.2019.01.003.

Guitera P, Collgros H, Madronio CM, Goumas C, Mann GJ, Watts CG, Pereira AR, Armstrong BK, Drummond M, Morton RL, Scolyer RA, Menzies SW, Thompson JF, Cust AE. The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.Australas J Dermatol. 2019 May;60(2):118-125. doi: 10.1111/ajd.12928. Epub 2018 Oct 9.

Guo D, Lui GYL, Lai SL, Wilmott JS, Tikoo S, Jackett LA, Quek C, Brown DL, Sharp DM, Kwan RYQ, Chacon D, Wong JH, Beck D, van Geldermalsen M, Holst J, Thompson JF, Mann GJ, Scolyer RA, Stow JL, Weninger W, Haass NK, Beaumont KA. RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes.Int J Cancer. 2019 Jun 15;144(12):3070-3085. doi: 10.1002/ijc.32064. Epub 2019 Jan 3.

Gupta R, Sandison A, Wenig BM, Thompson LDR. Data Set for the Reporting of Ear and Temporal Bone Tumors: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.Arch Pathol Lab Med. 2019 May;143(5):593-602. doi: 10.5858/arpa.2018-0415-SA. Epub 2018 Nov 30.

Hasmat S, Ebrahimi A, Gao K, Low TH, Palme C, Gupta R, Clark J. Multifocal perineural invasion is a better prognosticator than depth of invasion in oral squamous cell carcinoma.Head Neck. 2019 Nov;41(11):3992-3999. doi: 10.1002/hed.25940. Epub 2019 Sep 5.

Hasmat S, Ebrahimi A, Luk PP, Low TH, McDowell L, Magarey MJR, Veness M, Gupta R, Clark J. Positive survival trend in metastatic head and neck cutaneous squamous cell carcinoma over four-decades: Multicenter study.Head Neck. 2019 Nov;41(11):3826-3832. doi: 10.1002/hed.25912. Epub 2019 Aug 12.

Haydu LE, Thompson JF, Scolyer RA, Gershenwald JE. Embracing changes to the American Joint Committee on Cancer 8th edition melanoma staging system.Eur J Cancer. 2019 May;112:9-11. doi: 10.1016/j.ejca.2019.01.103. Epub 2019 Mar 15.

Henderson MA, Gyorki D, Burmeister BH, Ainslie J, Fisher R, Di Iulio J, Smithers BM, Hong A, Shannon K, Scolyer RA, Carruthers S, Coventry BJ, Babington S, Duprat J, Hoekstra HJ, Thompson JF. Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life.Ann Surg Oncol. 2019 Dec;26(13):4663-4672. doi: 10.1245/s10434-019-07810-0. Epub 2019 Sep 12.

Heyer EE, Deveson IW, Wooi D, Selinger CI, Lyons RJ, Hayes VM, O'Toole SA, Ballinger ML, Gill D, Thomas DM, Mercer TR, Blackburn J. Diagnosis of fusion genes using targeted RNA sequencing.Nat Commun. 2019 Mar 27;10(1):1388. doi: 10.1038/s41467-019-09374-9.

Hong AM, Ferguson P, Dodds T, Jones D, Li M, Yang J, Scolyer RA. Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer.Oral Oncol. 2019 May;92:33-39. doi: 10.1016/j.oraloncology.2019.03.012. Epub 2019 Mar 18.

Hong AM, Fogarty GB, Dolven-Jacobsen K, Burmeister BH, Lo SN, Haydu LE, Vardy JL, Nowak AK, Dhillon HM, Ahmed T, Shivalingam B, Long GV, Menzies AM, Hruby G, Drummond KJ, Mandel C, Middleton MR, Reisse CH, Paton EJ, Steel V, Williams NC, Scolyer RA, et al. Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial.J Clin Oncol. 2019 Nov 20;37(33):3132-3141. doi: 10.1200/JCO.19.01414. Epub 2019 Sep 25.

Hu X, Aivazian K, McKenzie C, Wong M, Kaffes A, Saxena P. A Rare Case of Duodenal Adenocarcinoma Presenting as a Subepithelial Lesion in a Patient Undergoing Investigation for Iron Deficiency Anaemia.Case Rep Gastrointest Med. 2019 Oct 7;2019:3434620. doi: 10.1155/2019/3434620. eCollection 2019.

Ipenburg NA, Lo SN, Vilain RE, Holtkamp LHJ, Wilmott JS, Nieweg OE, Thompson JF, Scolyer RA. The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study.J Am Acad Dermatol. 2019 Nov 2. pii: S0190-9622(19)32989-5. doi: 10.1016/j.jaad.2019.10.065. [Epub ahead of print]

Ipenburg NA, Nieweg OE, Ahmed T, van Doorn R, Scolyer RA, Long GV, Thompson JF, Lo S. External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma.Br J Surg. 2019 Sep;106(10):1319-1326. doi: 10.1002/bjs.11262. Epub 2019 Jul 16.

Jackett LA, Scolyer RA. A Review of Key Biological and Molecular Events Underpinning Transformation of Melanocytes to Primary and Metastatic Melanoma.Cancers (Basel). 2019 Dec 17;11(12). pii: E2041. doi: 10.3390/cancers11122041.

Jo HE, Corte TJ, Glaspole I, Grainge C, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Keir GJ, Cooper WA, Mahar AM, Ellis S, Macansh S, Goh NS. Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry.BMC Pulm Med. 2019 May 3;19(1):84. doi: 10.1186/s12890-019-0846-2.

Jo HE, Glaspole I, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Macansh S, Grainge C, Keir GJ, Hayen A, Henderson D, Klebe S, Heinze SB, Miller A, Rouse HC, Duhig E, Cooper WA, Mahar AM, et al. Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.Respirology. 2019 Apr;24(4):361-368. doi: 10.1111/resp.13427. Epub 2018 Oct 17.

Kench JG, Judge M, Delahunt B, Humphrey PA, Kristiansen G, Oxley J, Rasiah K, Takahashi H, Trpkov K, Varma M, Wheeler TM, Zhou M, Srigley JR, Egevad L. Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting.Virchows Arch. 2019 Sep;475(3):263-277. doi: 10.1007/s00428-019-02574-0. Epub 2019 May 16.

Lantuejoul S, Sound-Tsao M, Cooper WA, Girard N, Hirsch FR, Roden AC, Lopez-Rios F, Jain D, Chou TY, Motoi N, Kerr KM, Yatabe Y, Brambilla E, Longshore J, Papotti M, Sholl LM, Thunnissen E, Rekhtman N, Borczuk A, Bubendorf L, Minami Y, Beasley MB, et al. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee.J Thorac Oncol. 2019 Dec 20. pii: S1556-0864(19)33847-X. doi: 10.1016/j.jtho.2019.12.107. [Epub ahead of print]

Lee H, Quek C, Silva I, Tasker A, Batten M, Rizos H, Lim SY, Nur Gide T, Shang P, Attrill GH, Madore J, Edwards J, Carlino MS, Guminski A, Saw RPM, Thompson JF, Ferguson PM, Palendira U, Menzies AM, Long GV, Scolyer RA, Wilmott JS. Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients.Oncoimmunology. 2018 Oct 31;8(2):e1537581. doi: 10.1080/2162402X.2018.1537581. eCollection 2019.

Lee JH, Saw RP, Thompson JF, Lo S, Spillane AJ, Shannon KF, Stretch JR, Howle J, Menzies AM, Carlino MS, Kefford RF, Long GV, Scolyer RA, Rizos H. Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients.Ann Oncol. 2019 May 1;30(5):815-822. doi: 10.1093/annonc/mdz075.

Lim SY, Lee JH, Gide TN, Menzies AM, Guminski A, Carlino MS, Breen EJ, Yang JYH, Ghazanfar S, Kefford RF, Scolyer RA, Long GV, Rizos H. Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1-Based Immunotherapy.Clin Cancer Res. 2019 Mar 1;25(5):1557-1563. doi: 10.1158/1078-0432.CCR-18-2795. Epub 2018 Nov 8.

Lo SN, Hong AM, Haydu LE, Ahmed T, Paton EJ, Steel V, Hruby G, Tran A, Morton RL, Nowak AK, Vardy JL, Drummond KJ, Dhillon HM, Mandel C, Scolyer RA, Middleton MR, Burmeister BH, Thompson JF, Fogarty GB. Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan.Trials. 2019 Aug 5;20(1):477. doi: 10.1186/s13063-019-3555-5.

Lo SN, Stodell MD, Scolyer RA, Thompson JF. Comment on "Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma".J Am Acad Dermatol. 2019 Jan;80(1):e21-e22. doi: 10.1016/j.jaad.2018.07.068. Epub 2018 Sep 15.

Long GV, Saw RPM, Lo S, Nieweg OE, Shannon KF, Gonzalez M, Guminski A, Lee JH, Lee H, Ferguson PM, Rawson RV, Wilmott JS, Thompson JF, Kefford RF, Ch'ng S, Stretch JR, Emmett L, Kapoor R, Rizos H, Spillane AJ, Scolyer RA, Menzies AM. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF(V600) mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.Lancet Oncol. 2019 Jul;20(7):961-971. doi: 10.1016/S1470-2045(19)30331-6. Epub 2019 Jun 3.

Luk PP, Junaid M, Mahar A, Clark JR, Gupta R. Mammary-type myofibroblastoma in the head and neck region.Pathology. 2019 Aug;51(5):544-547. doi: 10.1016/j.pathol.2019.01.015. Epub 2019 Jun 17.

Luk PP, Selinger CI, Cooper WA, Mahar A, Palme CE, O'Toole SA, Clark JR, Gupta R. Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms.Head Neck Pathol. 2019 Sep;13(3):397-414. doi: 10.1007/s12105-018-0988-1. Epub 2018 Nov 22.

Ly MMG, De Robles MS, Mckenzie C, Young CJ. Colonic lymphangioma presenting with intermittent pain and intussusception.J Surg Case Rep. 2019 Jan 11;2019(1):rjy336. doi: 10.1093/jscr/rjy336. eCollection 2019 Jan.

Maharaj AD, Holland JF, Scarborough RO, Evans SM, Ioannou LJ, Brown W, Croagh DG, Pilgrim CHC, Kench JG, Lipton LR, Leong T, McNeil JJ, Nikfarjam M, Aly A, Burton PR, Cashin PA, Chu J, Duong CP, Evans P, Goldstein D, Haydon A, Hii MW, et al. The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers.BMJ Open. 2019 Sep 30;9(9):e031434. doi: 10.1136/bmjopen-2019-031434.

Maharaj AD, Ioannou L, Croagh D, Zalcberg J, Neale RE, Goldstein D, Merrett N, Kench JG, White K, Pilgrim CHC, Chantrill L, Cosman P, Kneebone A, Lipton L, Nikfarjam M, Philip J, Sandroussi C, Tagkalidis P, Chye R, Haghighi KS, Samra J, Evans SM. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus.HPB (Oxford). 2019 Apr;21(4):444-455. doi: 10.1016/j.hpb.2018.08.016. Epub 2018 Oct 11.

Mazzola F, Gupta R, Luk PP, Palme C, Clark JR, Low TH. The Milan System for Reporting Salivary Gland Cytopathology-Proposed modifications to improve clinical utility.Head Neck. 2019 Aug;41(8):2566-2573. doi: 10.1002/hed.25732. Epub 2019 Mar 5.

McCabe MJ, Gauthier MA, Chan CL, Thompson TJ, De Sousa SMC, Puttick C, Grady JP, Gayevskiy V, Tao J, Ying K, Cipponi A, Deng N, Swarbrick A, Thomas ML, Lord RV, Johns AL, Kohonen-Corish M, O'Toole SA, Clark J, Mueller SA, Gupta R, McCormack AI, et al. Development and validation of a targeted gene sequencing panel for application to disparate cancers.Sci Rep. 2019 Nov 19;9(1):17052. doi: 10.1038/s41598-019-52000-3.

Menzies SW, Liyanarachchi S, Coates E, Smith A, Cooke-Yarborough C, Lo S, Armstrong B, Scolyer RA, Guitera P. Estimated risk of progression of lentigo maligna to lentigo maligna melanoma.Melanoma Res. 2019 May 14. doi: 10.1097/CMR.0000000000000619. [Epub ahead of print]

Minocha R, Martin AJ, Chen AC, Scolyer RA, Lyons JG, McKenzie CA, Madore J, Halliday GM, Damian DL. A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by Nicotinamide.J Invest Dermatol. 2019 Feb;139(2):467-469. doi: 10.1016/j.jid.2018.08.018. Epub 2018 Sep 20.

Mittal D, Lepletier A, Madore J, Aguilera AR, Stannard K, Blake SJ, Whitehall VLJ, Liu C, Bettington ML, Takeda K, Long GV, Scolyer RA, Lan R, Siemers N, Korman A, Teng MWL, Johnston RJ, Dougall WC, Smyth MJ. CD96 Is an Immune Checkpoint That Regulates CD8(+) T-cell Antitumor Function.Cancer Immunol Res. 2019 Apr;7(4):559-571. doi: 10.1158/2326-6066.CIR-18-0637. Epub 2019 Mar 20.

Mooney CP, Martin RCW, Dirven R, Ashford BG, Shannon K, Palme CE, Ngo Q, Wykes J, Davies S, Gao K, Ch'ng S, Low TH, Gupta R, Clark JR. Sentinel Node Biopsy in 105 High-Risk Cutaneous SCCs of the Head and Neck: Results of a Multicenter Prospective Study.Ann Surg Oncol. 2019 Dec;26(13):4481-4488. doi: 10.1245/s10434-019-07865-z. Epub 2019 Oct 3.

Morris PD, Lee D, Chung KK, Shin JS, Byrne C. Fulminant amoebic colitis and septic shock in a returning traveller.ANZ J Surg. 2019 Jan;89(1-2):E50. doi: 10.1111/ans.14975.

Morrow A, Hogden E, Kang YJ, Steinberg J, Canfell K, Solomon MJ, Kench JG, Gill AJ, Shaw T, Pachter N, Parkinson B, Wolfenden L, Mitchell G, Macrae F, Tucker K, Taylor N. Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol.Trials. 2019 Jun 20;20(1):373. doi: 10.1186/s13063-019-3457-6.

Mudaliar S, Liu K, Pavendranathan G, Kench JG, Strasser SI. Hepatobiliary and Pancreatic: Kasabach-Merritt syndrome in adult.J Gastroenterol Hepatol. 2019 Oct;34(10):1675. doi: 10.1111/jgh.14676. Epub 2019 May 28.

Mueller SA, Gauthier MA, Ashford B, Gupta R, Gayevskiy V, Ch'ng S, Palme CE, Shannon K, Clark JR, Ranson M, Cowley MJ. Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma.J Invest Dermatol. 2019 Jul;139(7):1449-1458.e1. doi: 10.1016/j.jid.2019.01.008. Epub 2019 Jan 23.

Newell F, Kong Y, Wilmott JS, Johansson PA, Ferguson PM, Cui C, Li Z, Kazakoff SH, Burke H, Dodds TJ, Patch AM, Nones K, Tembe V, Shang P, van der Weyden L, Wong K, Holmes O, Lo S, Leonard C, Wood S, Xu Q, Rawson RV, et al. Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.Nat Commun. 2019 Jul 18;10(1):3163. doi: 10.1038/s41467-019-11107-x.

Nijkang NP, Anderson L, Markham R, Manconi F. Endometrial polyps: Pathogenesis, sequelae and treatment.SAGE Open Med. 2019 May 2;7:2050312119848247. doi: 10.1177/2050312119848247. eCollection 2019. Review.

Park SL, Buzzai A, Rautela J, Hor JL, Hochheiser K, Effern M, McBain N, Wagner T, Edwards J, McConville R, Wilmott JS, Scolyer RA, TÃ¼ting T, Palendira U, Gyorki D, Mueller SN, Huntington ND, Bedoui S, HÃ¶lzel M, Mackay LK, Waithman J, Gebhardt T. Tissue-resident memory CD8(+) T cells promote melanoma-immune equilibrium in skin.Nature. 2019 Jan;565(7739):366-371. doi: 10.1038/s41586-018-0812-9. Epub 2018 Dec 31. Erratum in: Nature. 2019 Feb;566(7745):E10.

Pavlakis N, Cooper C, John T, Kao S, Klebe S, Lee CK, Leong T, Millward M, O'Byrne K, Russell PA, Solomon B, Cooper WA, Fox S. Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancer.Pathology. 2019 Dec;51(7):673-680. doi: 10.1016/j.pathol.2019.08.006. Epub 2019 Oct 24.

Pires da Silva I, Wang KYX, Wilmott JS, Holst J, Carlino MS, Park JJ, Quek C, Wongchenko M, Yan Y, Mann G, Johnson DB, McQuade JL, Rai R, Kefford RF, Rizos H, Scolyer RA, Yang JYH, Long GV, Menzies AM. Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma.Clin Cancer Res. 2019 Feb 15;25(4):1272-1279. doi: 10.1158/1078-0432.CCR-18-1680. Epub 2019 Jan 10.

Prince DS, Liu K, McCaughan GW, Kench J, Strasser SI. Heterozygosity for the Alpha-1-Antitrypsin Z Allele in Cirrhosis Is Associated With More Advanced Disease.Liver Transpl. 2019 Aug;25(8):1285-1286. doi: 10.1002/lt.25487. Epub 2019 Jun 25.

Quek C, Rawson RV, Ferguson PM, Shang P, Silva I, Saw RPM, Shannon K, Thompson JF, Hayward NK, Long GV, Mann GJ, Scolyer RA, Wilmott JS. Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas.Oncotarget. 2019 Jan 29;10(9):930-941. doi: 10.18632/oncotarget.26584. eCollection 2019 Jan 29.

Quinn DI, Stricker PD, Kench JG, Grogan J, Haynes AM, Henshall SM, Grygiel JJ, Delprado W, Turner JJ, Horvath LG, Mahon KL. p53 nuclear accumulation as an early indicator of lethal prostate cancer.Br J Cancer. 2019 Oct;121(7):578-583. doi: 10.1038/s41416-019-0549-8. Epub 2019 Aug 14.

Raj D, Yang MH, Rodgers D, Hampton EN, Begum J, Mustafa A, Lorizio D, Garces I, Propper D, Kench JG, Kocher HM, Young TS, Aicher A, Heeschen C. Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma.Gut. 2019 Jun;68(6):1052-1064. doi: 10.1136/gutjnl-2018-316595. Epub 2018 Aug 18.

Rawson RV, Bailey T, Colebatch AJ, Ferguson P. Journal Watch: our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of melanoma management.Melanoma Manag. 2019 Jun 14;6(1):MMT18. doi: 10.2217/mmt-2019-0002.

Robinson M, Primiero C, Guitera P, Hong A, Scolyer RA, Stretch JR, Strutton G, Thompson JF, Soyer HP. Evidence-Based Clinical Practice Guidelines for the Management of Patients with Lentigo Maligna.Dermatology. 2019 Oct 22:1-6. doi: 10.1159/000502470. [Epub ahead of print]

Rozeman EA, Menzies AM, van Akkooi ACJ, Adhikari C, Bierman C, van de Wiel BA, Scolyer RA, Krijgsman O, Sikorska K, Eriksson H, Broeks A, van Thienen JV, Guminski AD, Acosta AT, Ter Meulen S, Koenen AM, Bosch LJW, Shannon K, Pronk LM, Gonzalez M, Ch'ng S, Grijpink-Ongering LG, et al. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.Lancet Oncol. 2019 Jul;20(7):948-960. doi: 10.1016/S1470-2045(19)30151-2. Epub 2019 May 31.

Rtshiladze MA, Stretch JR, Scolyer RA, Guitera P. Diagnosing melanoma: the method matters.Med J Aust. 2019 Sep;211(5):209-210. doi: 10.5694/mja2.50307. Epub 2019 Aug 14.

Scolyer RA, Gershenwald JE, Thompson JF. Isolated Imunohistochemistry-positive Cells Without Morphologic Characteristics of Melanoma Should Not Result in Designation as a Positive Sentinel Lymph Node According to the AJCC 8th Edition Staging System.Am J Surg Pathol. 2019 Oct;43(10):1442-1444. doi: 10.1097/PAS.0000000000001326.

Scolyer RA, Soyer HP, Kelly JW, James C, McLean CA, Coventry BJ, Ferguson PM, Rawson RV, Mar VJ, de Menezes SL, Fishburn P, Stretch JR, Lee S, Thompson JF. Improving diagnostic accuracy for suspicious melanocytic skin lesions: New Australian melanoma clinical practice guidelines stress the importance of clinician/pathologist communication.Aust J Gen Pract. 2019 Jun;48(6):357-362. doi: 10.31128/AJGP-11-18-4759.

Skvortsova K, Masle-Farquhar E, Luu PL, Song JZ, Qu W, Zotenko E, Gould CM, Du Q, Peters TJ, Colino-Sanguino Y, Pidsley R, Nair SS, Khoury A, Smith GC, Miosge LA, Reed JH, Kench JG, Rubin MA, Horvath L, Bogdanovic O, Lim SM, Polo JM, et al. DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns.Cancer Cell. 2019 Feb 11;35(2):297-314.e8. doi: 10.1016/j.ccell.2019.01.004.

Srigley JR, Delahunt B, Samaratunga H, Billis A, Cheng L, Clouston D, Evans A, Furusato B, Kench J, Leite K, MacLennan G, Moch H, Pan CC, Rioux-Leclercq N, Ro J, Shanks J, Shen S, Tsuzuki T, Varma M, Wheeler T, Yaxley J, Egevad L. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.Pathology. 2019 Aug;51(5):463-473. doi: 10.1016/j.pathol.2019.05.001. Epub 2019 Jul 3.

Tay KJ, Amin MB, Ghai S, Jimenez RE, Kench JG, Klotz L, Montironi R, Muto S, Rastinehad AR, Turkbey B, Villers A, Polascik TJ. Surveillance after prostate focal therapy.World J Urol. 2019 Mar;37(3):397-407. doi: 10.1007/s00345-018-2363-y. Epub 2018 Jun 9.

Thompson JF, Lo S, Scolyer RA. Quality of Life Following Surgical Excision of Early-Stage Melanoma of the Head and Neck.JAMA Dermatol. 2019 Apr 1;155(4):502. doi: 10.1001/jamadermatol.2018.5742.

Troy LK, Grainge C, Corte T, Williamson JP, Vallely MP, Cooper W, Mahar AM, Lai S, Mulyadi E, Torzillo PJ, Salamonsen M, Don G, Myers J, Raghu G, Lau EMT; COLDICE Investigator Team.. Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a multicentre study.BMJ Open Respir Res. 2019 Jun 21;6(1):e000443. doi: 10.1136/bmjresp-2019-000443. eCollection 2019.

Tsang VHM, McGrath RT, Clifton-Bligh RJ, Scolyer RA, Jakrot V, Guminski AD, Long GV, Menzies AM. Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes.J Clin Endocrinol Metab. 2019 Nov 1;104(11):5499-5506. doi: 10.1210/jc.2019-00423.

Vargas AC, Maclean FM, Bonar F, Mahar A, Gill AJ. NR4A3 Immunohistochemistry Lacks Sensitivity for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma.Am J Surg Pathol. 2019 Dec;43(12):1726-1728. doi: 10.1097/PAS.0000000000001346.

Vargas AC, Selinger C, Satgunaseelan L, Cooper WA, Gupta R, Stalley P, Brown W, Soper J, Schatz J, Boyle R, Thomas DM, Tattersall MHN, Bhadri V, Maclean F, Bonar SF, Scolyer RA, Karim RZ, McCarthy SW, Mahar A, O'Toole SA. FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary center.Asia Pac J Clin Oncol. 2019 Feb;15(1):38-47. doi: 10.1111/ajco.12980. Epub 2018 May 28.

Vasan K, Satgunaseelan L, Anand S, Asher R, Selinger C, Low TH, Palme CE, Clark JR, Gupta R. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.Pathology. 2019 Dec;51(7):688-695. doi: 10.1016/j.pathol.2019.08.005. Epub 2019 Oct 18.

Wang KYX, Menzies AM, Silva IP, Wilmott JS, Yan Y, Wongchenko M, Kefford RF, Scolyer RA, Long GV, Tarr G, Mueller S, Yang JYH. bcGST-an interactive bias-correction method to identify over-represented gene-sets in boutique arrays.Bioinformatics. 2019 Apr 15;35(8):1350-1357. doi: 10.1093/bioinformatics/bty783.

Wilmott JS, Johansson PA, Newell F, Waddell N, Ferguson P, Quek C, Patch AM, Nones K, Shang P, Pritchard AL, Kazakoff S, Holmes O, Leonard C, Wood S, Xu Q, Saw RPM, Spillane AJ, Stretch JR, Shannon KF, Kefford RF, Menzies AM, Long GV, Thompson JF, Pearson JV, Mann GJ, Haywood NK, Scolyer RA. Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.Int J Cancer. 2019 Mar 1;144(5):1049-1060. doi: 10.1002/ijc.31791. Epub 2018 Nov 21.

Wong XL, Rawson RV, Sebaratnam DF. A teenager with a black nodule on the buttock.J Paediatr Child Health. 2019 Feb;55(2):240. doi: 10.1111/jpc.1_14302.

Zhang AY, Chiam K, Haupt Y, Fox S, Birch S, Tilley W, Butler LM, Knudsen K, Comstock C, Rasiah K, Grogan J, Mahon KL, Bianco-Miotto T, Ricciardelli C, BÃ¶hm M, Henshall S, Delprado W, Stricker P, Horvath LG, Kench JG. An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.Int J Cancer. 2019 Mar 1;144(5):1151-1159. doi: 10.1002/ijc.31906. Epub 2018 Dec 4.

Tissue Pathology and Diagnostic Oncology Research

Selected Grants

Our Publications

2023

Tissue Pathology and Diagnostic Oncology Research

Tissue Pathology and Diagnostic Oncology Research

Our Organisation

Make a Donation

Our Hospitals

Right to Information

Plans

Publications

Quick Links